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Escherichia coli is part of the normal flora of the human large intestine but some strains can 
cause intestinal and extra-intestinal infections. There are many pathogenic strains of E. coli 
and Enteroaggregative E. coli (EAEC) is one of them. EAEC is a common cause of diarrhoea 
in developing and industrialised countries. EAEC has many virulence factors but the most 
important virulence determinant for diarrhoeal illness is the formation of fimbriae, which help 
in attachment to human intestinal cells. A typical pathogenic EAEC strain also contains the 
transcriptional regulator, AggR (the aggregation regulator).  AggR regulates the transcription 
of many genes in EAEC but how AggR achieves this is not still very clear. The objective of 
this project was to identify the promoters which control the expression of the fimbrial genes 
and other AggR-dependent virulence genes in EAEC strain 042 and EAEC strain 17-2, and to 
determine the promoter dependence on AggR, with an aim to locating AggR-binding sites at 
these promoters.  
There are five types of adherence aggregative fimbriae (AAF) systems (i.e. AAF/I –AAF/V), 
classified on the basis of fimbrial subunit sequence, and all are regulated by AggR. In the 
present study, I have investigated the regulation of the promoters which control the expression 
of AAF/II, the anti-aggregating protein (aap) gene in EAEC 042, present on aggregation 
adherence plasmid (pAA2), and type 6 secretion system (T6SS) present on chromosome to 
determine the location of AggR-binding sites. I have also investigated the promoter that 
controls the expression of the genes encoding AAF/I from EAEC strain 17-2, which are 
located on the pAA plasmid. These promoters were identified and analysed on the basis of β-
galactosidase activity measured from lysates of cells which carried these promoter fragments 





In this study, AggR-dependent fimbrial promoters from EAEC 042 were located and 
transcription start sites were identified. The promoters are present upstream of the fimbrial 
operons in Region 1 and Region 2 of plasmid pAA2. An AggR-dependent operon promoter 
was identified upstream of aggD (AAF/I) on pAA in EAEC 17-2. The promoters for aap and 
the T6SS have also been located upstream of the aap and the aaiA gene, respectively and are 
AggR-regulated. The AggR-binding sites and promoter elements were investigated by 
deletion analysis and confirmed by introducing site directed point mutations into the promoter 
fragments. The results were interpreted on the basis of β-galactosidase activity measured from 
lysates of cells carrying these promoter fragments cloned in lacZ expression vector.  
The AggR-binding site from the aafD, an AggR-dependent promoter was also transplanted 
into a non-AggR-dependent promoter and it conferred AggR-dependent activity onto that 
promoter. This semi-synthetic promoter construction also enhances our understanding of 
AggR-dependent promoters, indicating that the distance between the AggR-binding motif and 
the -10 hexamer element is important and that 22 bp is the optimal distance.  Moreover, AggR 
interaction with RNA polymerase was investigated by making point mutations in AggR and 
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Unicellular and multicellular organisms have coexisted side by side on the earth for millions 
of years. Unicellular organisms can live inside multicellular organisms in symbiotic 
relationships, however, in certain conditions this interaction can become disastrous with the 
unicellular organism causing detrimental effects to the multicellular organism. Some 
unicellular organisms such as bacteria and parasites can cause disease in plants, animals and 
humans and these are called pathogens. Even though, the multicellular organisms evolved 
hundreds of millions of years ago along with these unicellular organisms, they still are 
susceptible to these comparatively simpler organisms in certain conditions. 
Escherichia coli is one of the bacterial species that colonise the intestinal tract of many 
animals. It can produce disease in certain individuals and the molecules or structures 
produced by E. coli that help in pathogenesis are called virulence factors (Johnson, 1991). The 
formation of these virulence factors is a multistage process and the biogenesis of certain 
factors, at different stages of bacterial growth, is essential for pathogenesis. Thus, the 
expression of virulence factors at different stages of pathogenesis is tightly controlled. These 
virulence factors can be controlled at any point of the expression pathway, but control at the 
level of transcript initiation is the most economic.  
This thesis focuses on the transcription regulation mechanisms in one of the pathogenic E. 
coli, i.e. Enteroaggregative E. coli (EAEC) strains. In the first section of this chapter (1.1-1.6), 
I describe the characteristics of E. coli and EAEC, including the virulence determinants, 
together with master virulence regulator AggR. In the second part (1.7 and 1.8), I examine 
mechanisms of bacterial transcription regulation, with most of this information obtained from 
the studies in E. coli K-12. In the last part of the chapter, I detail the AraC family of 
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transcription regulators and one of its member, AggR, which plays an important role in EAEC 
virulence.  
1.2 Escherichia coli  
Bacteria are prokaryotic organisms that are found in all environments. In some environments, 
they co-exist with other organisms. Most bacteria are present as harmless commensals that in 
some situations, are beneficial to the host organisms but some bacteria cause disease. Bacteria 
exist in different shapes, from cocci to bacilli and comma shapes, and their sizes can vary 
from 1m-20m.  One of the most studied bacterium is E. coli that is named after its 
discoverer, Theodor Escherich, a German physician (Hacker and Blum-Oehler, 2007). E. coli 
is a Gram negative rod and a member of the Enterobacteriaceae. It forms a part of the normal 
flora of many warm-blooded animals, including human beings. The size of a typical E. coli is 
about 0.5m in width and about 2m in length (El-Hajj and Newman, 2015). The bacterium 
is surrounded by a cell envelope made up of an inner membrane, periplasmic space and an 
outer membrane (Silhavy et al., 2010). The membranes contain a variety of embedded 
proteins that help in various functions including transport of molecules across the membranes, 
secretion of certain proteins and antibiotic resistance (Tenover, 2006; Tseng et al., 2009; 
Lombard, 2014). Some strains of E. coli are surrounded by a polysaccharide capsule that 
protects the bacterium from phagocytosis (Emody et al., 2003). It has peritrichous flagella 
that help in its movement and many strains of E. coli are highly motile (Tecon and Or, 2016). 
Some strains also have fimbriae that help in the attachment to different surfaces during 
colonization of hosts, while other types of fimbriae are also involved in conjugation (Klemm, 
1985). The bacterium has a circular chromosome and may contain plasmids that encode for 
different genes (Carattoli et al., 2005). 
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Some E. coli strains have emerged as pathogens while most are non-pathogenic (Clements et 
al., 2012). The E. coli strain that is mostly used in the laboratory as a model is the non-
pathogenic, E. coli K-12. The E. coli strain K-12 is considered a model organism for the study 
of different biochemical and molecular processes in bacteria (Kuhnert et al., 1995). Specific 
mechanisms and processes can be studied in E. coli K-12, e.g. promoter regulation and 
protein production, and the mechanisms studied in this model organism can often be applied 
to other pathogenic bacteria. In the present study, most of the experiments were carried out in 
E. coli K-12 and it is assumed that similar mechanism of gene expression take place in the 
pathogenic E. coli. 
1.3 Pathogenic Escherichia coli 
Most E. coli are commensals but some pathogenic strains can cause disease, particularly in 
children and immunocompromised adults. The most common infections by pathogenic E. coli 
include diarrhoea in children and urinary tract infections. The major pathotypes of  E. coli that 
cause diarrhoea are EAEC, Enteroinvasive E. coli (EIEC), Enteropathogenic E. coli (EPEC), 
Enterotoxigenic E. coli (ETEC), Enterohaemorrhagic E. coli (EHEC) and Diffuse adhering 
E. coli (DAEC) (Kaper et al., 2004; Iguchi et al., 2009). These pathotypes have been 
identified on the basis of specific pathogenic features. EAEC is one of these common 
pathotypes, associated with diarrhoea in adults and children (Huang et al., 2006a). The exact 
molecular basis for distinction between the pathogenic and the non-pathogenic EAEC is yet to 
be unveiled but it has been proven that some strains of EAEC are typical human pathogens 
(Nataro and Kaper, 1998; Kaper et al., 2004). EAEC as defined by Nataro and Kaper (1998) 
consists of “E. coli strains that do not secrete enterotoxins LT (heat labile toxin) or ST (heat 
stable toxin), and that adhere to HEp-2 cells in an aggregative adherence (AA) pattern”. This 
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definition seems general and it includes the classical pathogenic strains of EAEC as well as 
the non-pathogenic strains.  
1.4 Pathogenicity of EAEC 
EAEC is associated with diarrhoea in children and was reported for the first time by Nataro et 
al. (1987) in Santiago, Chile. In the following years, studies by Bhan et al. (1989) and 
Cravioto et al. (1991) also reported EAEC as the causative agent of diarrhoea but during the 
same era, some investigators found EAEC in healthy individuals as well, without diarrhoea 
(Echeverria et al., 1992; Gomes et al., 1989). Finally, this controversy about pathogenicity of 
EAEC was resolved by a study of Nataro et al. (1995) , that tested four EAEC strains, 042, 
JM221, 17-2 and 34b for the causative agent of diarrhoea in healthy volunteers, only EAEC 
042 could produce diarrhoea, while the other three strains failed to produce symptoms in 
volunteers. Another volunteer study by Mathewson et al. (1986) has shown that JM221 can 
cause diarrhoea in some adult volunteers. So, these studies have established EAEC as a 
pathogenic bacterium that can cause intestinal disease in healthy adults. 
EAEC is a cause of diarrhoea in adults and children in both developing and industrialised 
countries. It is also an important cause of traveller’s diarrhoea, and it can cause acute and 
persistent diarrhoea in the immunocompromised adult patients (Adachi et al., 2001; Huang et 
al., 2006b). EAEC is reported as a cause of food-borne outbreaks in Europe and other 
developed countries (Grad et al., 2012; Harada et al., 2007). EAEC can also produce extra-
intestinal infections and an outbreak of urinary tract infection is also reported in Denmark 
(Olesen et al., 2012; Kaur et al., 2010). EAEC can also cause sepsis in some cases (Herzog et 
al., 2014). 
EAEC pathogenicity is now established as one of the most common causes of diarrhoea in the 
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United States and a large surveillance study in the UK has proven EAEC to be an important 
pathogen (Nataro et al., 2006; Wilson et al., 2001). In addition, a retrospective analysis of 
intestinal infectious disease data from the UK has argued for a detailed investigation of EAEC 
genetic and biochemical properties (Chattaway et al., 2013). Moreover, a recent outbreak of 
diarrhoea with haemolytic uremic syndrome in Germany that led to significant morbidity and 
mortality was associated with EAEC-like virulence properties. The EAEC strain O104:H4, 
responsible for this outbreak, is believed to have acquired a prophage that encodes for shiga 
toxin 2, causing haemolytic uremic syndrome (Frank et al., 2011). This outbreak led to many 
investigations, which aimed to correlate the combinations of virulence determinants in other 
E. coli strains. Recently, two new strains have been found to contain a combination of 
virulence genes from EAEC and EHEC strains (Prager et al., 2014). 
The status of EAEC as a pathogen highlights the importance of understanding pathogenesis 
and the contributing factors. The pathogenesis of EAEC strain 042 (EAEC 042) has been 
studied in detail and revealed that the disease process involves attachment of the bacterium to 
human intestinal cells, hyper-secretion of mucus, the production of toxins, and inflammation 
which result in damage to the mucosa and intestine (Figure 1.1) (Huang et al., 2004). 
Understanding this pathogenesis was enhanced by molecular and genetic studies, which 
showed that the AggR protein (aggregation regulator) is involved in the regulation of 
transcription of many genes important in causing diarrhoea (Sarantuya et al., 2004; Nataro, 
2005). Important genes that are regulated by AggR include AAF (aggregative adherence 





Figure 1.1 Pathogenesis of EAEC 
A. The panel shows EAEC attached to human intestinal cells using attachement adherence fimbriae 
(AAFs). Dispersin prevents the fimbriae from collapsing on to the bacterial cell surface. The protein 
involved in colonization (Pic) is secreted and hypersecretion of mucus occurs. B. The panel illustrates 
the secretion of toxins such as haemolytic pore forming protein (HlyE), plasmid-encoded toxin (Pet), 
enteroaggregative E. coli heat-stable enterotoxin (EAST-1) and Shigella enterotoxin 1 (ShET-1) that 
are taken up by intestinal cells. C. The panel shows the last stage of pathogenesis where the toxins 
disrupt the cytoskeleton of the intestinal cells and the cells produce inflammatory markers like IL-8, 
IL-1β and TNF-α. The neutrophils invade the tissue and this leads to the symptoms of the disease. This 
figure is adapted from Navarro-Garcia and Elias (2011).  
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1.5 Identification of EAEC 
EAEC is a common pathogen and its diagnosis can be achieved using a number of methods. 
However, the most important is the nature of its specific adherence to HEp-2 (Human 
Epithelial type 2) cells, i.e. aggregation in the form of “a stacked brick pattern”. This 
adherence pattern distinguishes EAEC from other strains that attach to HEp-2 cells, e.g. 
EPEC and DAEC, however, the adherence of EAEC to HEp-2 or Caco cells does not 
distinguish pathogenic strains from strains isolated from asymptomatic individuals (Franca et 
al., 2013). 
Aggregation adherence is a complex test and it is not feasible to perform in all diagnostic 
laboratories, so molecular characteristics have been used to find a specific and easy way to 
perform diagnostic tests on EAEC (Santiago et al., 2014; Aslani et al., 2011). Some 
parameters show some specificity for EAEC, e.g. the presence of aat, aap, aggR and 
aggA/aafA within a strain (Franca et al., 2013). Since AggR regulates many virulence genes, 
there was a possibility that aggR would be present in only pathogenic strains. However, it has 
been found that aggR, aap, aat and other genetic markers are present in both pathogenic and 
commensal strains, so identification of any of these markers is not the proof of EAEC 
pathogenicity (Santiago et al., 2014).  
In a recent study, a new protein Aar (AggR activated regulator) has been identified in EAEC, 
and has been shown to repress AggR activity (Santiago et al., 2014). Aar is the first member 
of the family of AraC negative regulators (ANR), found by Santiago et al, (2014). ANR 
family members down-regulate the AraC family regulator activity by interacting with the 
AraC family proteins (Santiago et al., 2016). The identification of ANR protein factors could 
possibly be used in EAEC diagnostics in the future, but, todate no molecular diagnostic tests
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have been found to equal the specificity of the aggregation adherence test. 
1.6 Virulence determinants of EAEC   
EAEC has many virulence factors that include Aggregation adherence fimbriae (AAF), 
dispersin, toxins, and the transcription regulator AggR (Zamboni et al., 2004). Using 
microarray analysis Morin et al. (2013), found that many virulence determinant genes are 
regulated by AggR. AggR is a master transcription regulator of EAEC and  the aggR open 
reading frame is present on a large virulence plasmid, named as pAA2 (Jenkins et al., 2005). 
AggR is a small protein of 30 kDa in size and is a member of the AraC family of transcription 
regulators (Elias et al., 1999). AggR regulates several genes involved in pathogenesis present 
on plasmid pAA2 (i.e. AAF, aap and aat) (Jenkins et al., 2005). A pathogenicity island of 117 
kb is present on the chromosome of EAEC 042 containing the genes for a T6SS, which are 
also regulated by AggR (Dudley et al., 2006). Thus, AggR regulates plasmid and 
chromosomally-encoded genes, which are important for EAEC pathogenesis. In this chapter, 
some of these virulence determinants such as AAF, dispersin, T6SS and plasmid encoded 
toxin, are discussed. 
1.6.1 Attachment Adherence Fimbriae (AAF)  
EAEC pathogenesis initiates with adherence to the human intestinal cells with the help of 
fimbriae and adhesins. For most EAEC strains, a virulence plasmid is present that encodes the 
genes for attachment adherence fimbriae, and the specific stacked-brick pattern of EAEC is 
due to AAF (Zamboni et al., 2004). These AAF have some similarity in biogenesis to another 
fimbriae formation system, the Dr family, present in both uropathogenic E. coli (UPEC) and 
DAEC (Elias et al., 1999). Fimbriae are formed by major fimbrial subunits that are exported 
to the surface of the bacterium and a cap subunit (adhesin or pilin) is present at the tip of each  
 
 10 
fimbrium (Servin, 2005).  
Fimbriae formation is a multi-step process, involving secretion of fimbrial and cap subunits 
into the periplasmic space. These subunits are transported to the periplasm by the Sec system. 
The Sec system is a molecular machine which transports many proteins across the inner 
membrane, and thus is not specific for fimbriae subunit transport (Driessen et al., 1998). The 
fimbrial subunits are transported from the periplasm to the outer membrane by a chaperon-
usher system, and assembled on the outer membrane. The chaperone protein, which is present 
in the periplasm, ensures that the structural subunits (fimbrial and cap subunits) are 
transported in a folded form. The usher protein is present in the outer membrane and this 
exports and assembles the structural subunits into the fimbrium (Figure 1.2) (Piatek et al., 
2005).  
The genes for AAF in EAEC strains are organised in two regions on virulence plasmids; 
referred to as Region 1 and Region 2 (Figure 1.3 and Figure 1.4). In each system there is one 
gene for each chaperone, usher, fimbrial subunit, pilin subunit and the master transcription 
regulator of EAEC AggR (Czeczulin et al., 1997). On the basis of sequence differences of the 
major subunits of the fimbriae, five  AAF systems have been identified in EAEC (Prager et 
al., 2014). The major subunits of fimbriae in AAF/I, AAF/II, AAF/III, AAF/IV and AAF/V 
systems are encoded by aggA, aafA, agg3A, hdaA and aaf5A, respectively (Ito et al., 2014). 
However, there are some EAEC strains that do not have any recognised AAF system (Prager 
et al., 2014). The AAF systems AAF/I present in EAEC strain 17-2 and AAF/II found in 
EAEC strain 042 have been studied extensively, and these will be discussed in more detail in 
this chapter. 








Figure 1.2 The chaperone usher system  
The green circles represent fimbrial subunits and the red squares, the chaperone proteins. The 
chaperone proteins carry fimbrial subunits to the usher protein (blue). Usher protein exports the 
fimbrial subunits to make the fimbrium. The adhesion subunit (light green), helps in the attachment of 
EAEC to surfaces. OM and IM stand for outer and inner membrane, respectively. The pink box in the 
inner membrane represents the Sec system which transports subunits into the periplasm. This figure is 


















Figure 1.3 A schematic representation of the pAA plasmid 
The figure shows a schematic diagram of the pAA plasmid from EAEC strain 17-2 and the two 
regions that are important for AAF/I (attachment adherence fimbriae). Region 1 encodes aggD (a 
chaperone protein), aggC (the usher protein), aggB (the fimbrial adhesin) and aggA (the fimbrial 
subunit) and Region 2 encodes aggR (a transcription activator). Another AggR regulated gene, aap 









Figure 1.4 A schematic representation of the pAA2 plasmid 
The figure shows a schematic diagram of the pAA2 plasmid from EAEC strain 042 and the two 
regions that encode AAF/II (attachment adherence fimbriae).  Region 1 encodes aafD (a chaperone 
protein), aafA (the fimbrial subunit) and aggR (a transcription activator) and Region 2 encodes afaB (a 
chaperone pseudogene), aafC (the usher protein) and aafB (the fimbrial adhesin). Plasmid encoded 
toxin (pet) present between the two fimbriae encoding regions is also shown. A number of other genes 
involved in EAEC pathogenesis that are present on pAA2, are also shown in the diagram which 





genes for AAF are present in two regions. The structural genes are present in Region 1 and 
include aggDCBA, while Region 2 codes for transcription regulator, AggR (Figure 1.3). The 
aggD gene encodes for the chaperone, aggC for the usher protein, aggB for the adhesin 
subunit and aggA for the major pilin subunit (Savarino et al., 1994). The expression of this 
chaperone-usher system genes is regulated by AggR, encoded in Region 2. AAF/II is found in 
EAEC strain 042, and the genes are carried by the pAA2 plasmid. The genes for AAF/II are 
also present in two regions. Region 1 contains aafD, aafA and aggR while Region 2 has afaB, 
aafC and aafB (Figure 1.4). The genes present in Region 1 encodes for the chaperone (aafD), 
the pilin subunit (aafA) and a transcription regulator (aggR). Region 2 encodes for the usher 
protein (aafC) and the fimbrial adhesin (aafB). Region 2 also carries afaB, which is a 
pseudogene that does not generate functional protein. The afaB pseudogene has a sequence 
identity of 57% to the chaperone encoding gene (aafD) of AAF/II and also has similarity in 
sequence to afaB of Dr. family of adhesins (Elias et al., 1999). Thus, although AAF/I and 
AAF/II are encoded by same number of genes and proteins, but there are differences in the 
organisation of these genes on respective plasmids. 
1.6.2 Dispersin and the Aat secretion system 
On plasmid pAA2, the aap gene is located upstream of aggR, and it encodes an anti-
aggregation protein that associates with the EAEC cell surface (Figure 1.5) (Sheikh et al., 
2002). This protein prevents the bacterial fimbriae from collapsing onto the cell surface, 
helping cell dispersal and hence the protein has been named dispersin. It has been shown, that 
aap mutants are more prone to auto-agglutination than wild type EAEC 042, and mutants are 
less able to penetrate through mucin layer of the gut. Thus, the characteristics conferred by 
dispersin are important in the pathogenesis of EAEC 042  (Sheikh et al., 2002).  The precise 







Figure 1.5  The model for dispersin secretion  
The panel shows the working model of dispersin secretion. Dispersin (Aap) is transported 
independently of the Aat secretion system into the periplasm by the Sec system. AatA is located 
within the outer membrane and part of it protrudes into the periplasm, acting as the point of secretion 
for Aap across the outer membrane. The AatPBCD complex is embedded in the inner membrane, and 
it is proposed that AatD contacts AatA in the outermembrane. This figure has been adapted from Nishi 






transporter (Aat) system present in EAEC 042, has been shown to translocate dispersin across 
the cell envelope (Figure 1.5) (Nishi et al., 2003). This system is encoded by five genes, 
aatPABCD, present on pAA2 (Figure 1.4) and deletion of any of the aat locus disrupts 
transport of dispersin outside the cell (Sheikh et al., 2002). The aat operon and aap gene are 
located on pAA2 in different transcription units but both are regulated by the master virulence 
regulator, AggR (Sheikh et al., 2002).  
Figure 1.5 illustrates that translocation of dispersin from the cytoplasm to the periplasm is 
independent of the Aat system and is transported by the Sec system. However, the secretion of 
dispersin from the periplasm to outside the bacterium requires the Aat system.  The roles of 
AatPABCD have been predicted on the basis of their structural resemblance to the proteins of 
secretion systems, and the predicted functions are supported by deletion and mutation analysis 
experiments (Nishi et al., 2003). Thus, AatA is embedded in the outer membrane and has 
homology with the TolC protein, an outer membrane protein in T1SS (type 1 secretion 
system) found in E. coli (Figure 1.5) (Imuta et al., 2008). AatP shows similarity to ABC 
transporter permeases, while AatC has structural homology with ATP-binding proteins. AatB 
does not show any significant amino acid homology to any known protein and AatD is similar 
to an acid inducible protein in Borrelia burgdorferi (Nishi et al., 2003). 
Hence, a working model for dispersin secretion is that dispersin first translocates 
independently of this Aat system into the periplasmic space. The subsequently secretion of 
dispersin from the periplasmic space to the outer environment is through the AatA channel in 
the outer membrane that requires energy provided by ATPases (AatP and AatC) present in 
inner memberane. Dispersin is “conducted” to AatA, in the outer membrane, by either AatD 
or by both AatD and AatB, acting as adaptor proteins. 
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1.6.3 The Aai Type VI secretion system of Enteroaggregative E. coli 
Bacterial proteins and toxins are secreted from the cell, either into the environment or into 
other prokaryotic and eukaryotic cells by various secretion systems. The secretion of effector 
proteins by the T6SSs is a complex process, as the secreted molecules are injected directly 
into other cells (Tseng et al., 2009). This requires a number of proteins organised in a 
complex manner across the cell envelope and effector proteins are assembled inside the 
cytoplasm and secreted through the entire cell envelope into the target cell (Cascales, 2008). 
T6SSs are encoded by large gene clusters and even though the number of the genes varies 
among organisms, some of the components are conserved in all the organisms that form a 
functional T6SS (Cascales, 2008; Murdoch et al., 2011). These conserved components are 
called “the core components” and genes encoding these components are often named tss (type 
six secretion) (Figure 1.6A). The other components that are not present in all T6SS, are called 
“accessory components” and the genes encoding these are named as tag (type six associated 
genes) (Shalom et al., 2007).  
In both EAEC strains 17-2 and 042, the T6SS has three important components, a) the 
membrane complex, b) the baseplate and c) a phage-tail like complex. The membrane 
complex is a transmembrane assembly that holds the baseplate. The membrane complex of 
T6SS consist of three membrane associated components; TssL, TssM and TssJ (Aschtgen et 
al., 2010; Durand et al., 2015). A recent study by Zoued et al. (2016) has shown that another 
protein TssA is also required for the baseplate to attach to the membrane complex. The 
baseplate is formed of the TssEFGK proteins and a valine–glycine repeat protein G, VgrG. 
Note that VgrG is also serves as the spike used to puncture the host membrane (Figure 1.6B). 
The baseplate is a platform where the effector molecules assemble in the form of a long tube 




Figure 1.6 A schematic overview of T6SS protein secretion 
A. The genes encoding a T6SS: The arrows represent genes encoding the core T6SS. There are two 
clusters of genes encoding the membrane complex and the phage related complex of T6SS. 
B. The organization of the T6SS: This represents how the T6SS assembles and functions. TssM, 
TssL, and TssJ represent the membrane complex. VrgG and the baseplate is a platform on which 
assembly of the tail like structure is formed composed of Hcp and TssBC.  
C. A working model of T6SS protein secretion: The figure represents the three stages of T6SS 
protein secretion i.e. assembly of all the proteins necessary for function, contraction of the tail to 
deliver the effector protein into the target cell and disassembly of the proteins after secretion. This 
figure has been adapted from Zoued et al. (2014) and Zoued et al. (2016). 
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haemolysin co-regulated protein (Hcp) stacked over one another to form a tube like structure 
on the baseplate. The interaction of Hcp hexamers with each other is not particularly strong 
but it is stabilised by a contractile sheath formed of TssB and TssC (Lossi et al., 2013).   
The T6SS works in three steps; in the first step, components (such as Hcp) assemble into the 
phage-tail like structure on the baseplate, and the TssBC sheath covers the tail. In the second 
step, the TssBC sheath contacts, making VgrG and Hcp passes through the membrane 
complex channel. VgrG punctures the membrane of the target cells, and the toxins (e.g. Hcp) 
are delivered into the target cell. The final step is disassembly of the system after the delivery 
of product (Figure 1.6C) (Silverman et al., 2011). 
T6SSs help bacteria to secrete effector proteins directly into other cells, which can aid in 
competing with other bacteria in different ecological environments. These systems can also be 
involved in pathogenesis by delivering effector proteins directly into eukaryotic cells. They 
have originally reported in animal pathogens but have now also been found in some human 
pathogens as well i.e. Vibrio cholera, Edwardsiella tarda, Pseudomonas auroginosa and 
EAEC  (Pukatzki et al., 2009). 
Although, a T6SS can help pathogens compete with other bacteria and can influence 
pathogenesis, its exact role in EAEC biology is unclear (Sana et al., 2012). There are two 
clusters of genes i.e. sci-1 and sci-2 which are located on the bacterial chromosome that 
encode for two T6SSs in EAEC. The T6SS, encoded by sci-1 is involved in biofilm formation 
but the role of the T6SS encoded by sci-2 is yet to be determined (Aschtgen et al., 2008). The 
expression of sci-2 is controlled by AggR and this regulation may indicate that the sci-2 
encoded T6SS  has a role in pathogenesis, as AggR-regulates many other virulence factors 
(Dudley et al., 2006).  
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The sci-2 gene cluster is located in a pathogenicity island (PAI) in EAEC 042, and as genes of 
sci-2 are regulated by AggR, it has been termed the AggR Activated Island (aai). The proteins 
encoded by these genes have homology with proteins that form the core system of T6SS 
present in other bacteria. AaiC is secreted by the sci-2, and AaiC is homologue of the Hcp-
1/Hcp-2 proteins, secreted by the sci-1 T6SS of EAEC 042 (Dudley et al., 2006). The exact 
roles of many genes in the secretion of AaiC are unknown, but it has been observed that genes 
aaiA to aaiP are sufficient for secretion of AaiC (Dudley et al., 2006). Furthermore, AaiC 
cannot be secreted in the absence of the sci-2 encoded T6SS components, even when the sci-1 
is intact, indicating that the sci-1 encoded T6SS does not recognise the AaiC as a substrate.  
1.6.4 Plasmid-encoded toxin 
As the name indicates, the Plasmid-encoded toxin (Pet) gene is present on the pAA2 plasmid 
where it is located between the two AggR-regulated fimbrial operons (Figure 1.4). Pet is a 
protein toxin produced by pathogenic prototype EAEC strain 042 and is important for 
virulence of EAEC 042 (Betancourt-Sanchez and Navarro-Garcia, 2009). It is a member of 
the autotransporter family of proteins and acts as a serine protease. Pet has identity with other 
autotransporter toxins, for example EspP from EPEC (49%), EspC from EHEC (45%) and 
SepA from Shigella flexneri (31%) (Eslava et al., 1998). Moreover, Pet is not restricted to 
EAEC but it has also been found in atypical EPEC strains (Ruiz et al., 2014).  
The Pet protein consists of a signal domain, a passenger domain and -barrel domain 
(Domingo Meza-Aguilar et al., 2014). The Pet toxin, like other autotransporters is 
transloacted to the periplasm by the Sec system. As Pet is member of autoransporters, it is 
capable of secretion from the periplasm without the requirement of a dedicated transport 
system. The -barrel domain makes a transmembrane channel and the passenger domain 
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moves through the channel, displaying Pet outside the bacteria. The Pet toxin then undergoes 
an autocleavage reaction, secreting the Pet toxin from EAEC into the intestinal environment 
or medium (Domingo Meza-Aguilar et al., 2014).  
The mode of action of Pet is the alteration of the cytoskeleton of human intestinal cells. This 
results in the loss of actin stress fibers followed by cell rounding and detachment of cells 
(Henderson et al., 2004; Betancourt-Sanchez and Navarro-Garcia, 2009). The production of 
Pet is one of the important virulence determinants of EAEC pathogenesis, and the studies so 
far have shown that pet expression is regulated by FIS and CRP, two important global 
transcription regulators of the E. coli (Rossiter et al., 2011; Rossiter et al., 2015). 
1.7 Bacterial transcription 
Transcription is the process in which the base sequence of one strand of DNA is used as a 
template to produce an RNA copy. The transcription process results in the production of 
various types of RNA molecules, i.e. small RNA molecules, non-coding RNAs, ribosomal 
RNA (rRNA), transfer RNA (tRNA) and messenger RNA (mRNA). mRNA is used as a 
template to make protein, by a process termed translation. A single bacterium has thousands 
of genes and not all of them are transcribed at the same time. Most bacteria are very selective 
in transcribing their genes, only switching on genes that are required for survival in a 
particular environment. Transcription initiation is an important step that controls expression 
of different genes in bacteria. The genes are regulated in response to certain growth and 
environmental condition and interaction with other cells. Transcription regulation requires the 
transcription machinery and this includes the DNA-dependent RNA polymerase (RNAP), 
DNA promoter sequences and numerous transcription factors (Murakami and Darst, 2003).  
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1.7.1 RNA polymerase 
The bacterial multisubunit DNA-dependent RNAP enzyme plays the central role in 
transcription. The enzyme exists in two forms, core-RNAP and holo-RNAP enzyme. In 
E. coli the core RNAP enzyme has five subunits that include the beta (β), beta prime (β'), the 
omega (ω) and two alpha (α) subunits (Figure 1.7). RNAP which has a sigma (σ) subunit 
associated, is termed the holoenzyme (Murakami et al., 2002). Structural studies of RNAP 
have shown that the shape of the RNAP enzyme resembles a crab claw.  One part of the claw 
is formed by the β-subunit, while the β'-subunit contributes to the other part. The two α-
subunits i.e. αI and αII are attached to the β and β'-subunits, respectively at the “hinge” of the 
claw. The small ω-subunit is attached to the β'-subunit at the bottom of the claw. The small ω 
subunit helps in the assembly of a functional core enzyme (α2ββ'ω), acting like a chaperone 
(Mathew and Chatterji, 2006). 
In RNAP, the  and ' subunits are held together by two alpha subunits. Each alpha subunit 
has two domains, amino terminal domain (NTD) that binds to the  and ' subunits and 
carboxyl terminal domain (CTD), that binds to the promoter sequences and can interact with 
transcription factors (Browning and Busby, 2004). The two domains of  subunits are 
connected by a flexible linker that provides the flexibility to the CTD to bind at feasible 
position during transcription (Figure 1.7)  (Blatter et al., 1994; Ebright and Busby, 1995).  
The transcription processes comprise of many stages: promoter recognition, open complex 
formation, transcription initiation, promoter escape, elongation and termination. The process 
starts when a holo-RNAP (core RNAP containing the σ subunit) binds a promoter sequence, 
and, after the initiation of transcription, the σ subunit detaches itself from core-RNAP. The 









Figure 1.7 A schematic diagram of RNAP holoenzyme bound to a promoter  
The figure illustrates the binding of RNAP to a promoter. The αCTDs of RNAP attached to the UP-
element of the promoter and regions σ1, σ2, σ3 and σ4 of RNAP are in contact with the discriminator, 
the -10 hexamer (consensus TATAAT), the extended -10 (TGn) and the -35 hexamer sequences 









RNAP. Only the holo-RNAP has the ability to initiate transcription at specific loci as the 
core-RNAP cannot recognise specific promoter sequences (Murakami et al., 2002). The σ 
subunit enables the RNAP to recognise certain DNA sequences, and this subunit is often 
called the specificity sigma unit (Campbell et al., 2002). The σ subunit is a multidomain 
protein consisting of independently folded domains joined by linkers (Feklistov et al., 2014).  
Most bacteria have multiple sigma factors that help them to recognise different types of 
promoters. In E. coli there are 7 different σ subunits and each regulates a different set of 
promoters. The most abundant is σ70 and it regulates most of the genes in E. coli, and so is 
called the housekeeping σ factor. The σ70 associates with the core-RNAP more often as 
compared to other σ factors and it confers transcription of most of the important genes of the 
organism (Maeda et al., 2000). The other E. coli sigma factors include σ54 (nitrogen stress), 
σ38 (stationary phase), σ32 (heat shock), σ28 (flagellar), σ24 (periplasmic proteins and heat 
stress), σ19 (iron transport) and these regulate promoters of specific genes (Cook and Ussery, 
2013). It has been observed that each σ factors binds to a specific promoter sequence, so each 
sigma factor regulates different set of genes (Cook and Ussery, 2013). 
Structural and sequence analysis has revealed that E. coli σ70 consists of four conserved 
domains namely σ1, σ2, σ3 and σ4.  The  domains are attached to each other by flexible 
linkers and each domain recognise specific promoter element (Figure 1.7) (Murakami and 
Darst, 2003; Feklistov et al., 2014). The σ subunit has three basic functions i.e. to recognise a 
promoter sequence, to align the RNAP to the transcription start site and to help in unwinding 
of the DNA (Feklistov and Darst, 2009; Bae et al., 2015). 
1.7.2 Promoters 
RNAP binds to specific DNA sequences called promoters prior to the initiation of
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transcription. It may initially bind directly to a promoter sequence or scan along the DNA 
until it finds one. The attachment of RNAP to the promoter results in the closed promoter 
complex as the DNA strands are still in the double helical form. In the next step, the double 
stranded DNA helix around the transcription start site is unwound and this structure is termed 
the open complex (Rivetti et al., 1999).   
A typical σ70 dependent promoter has two principal conserved DNA elements, the -10 
hexamer element (consensus 5'-TATAAT-3') and the -35 hexamer element (consensus 5'-
TTGACA-3'), located approximately 10 and 35 bp upstream of the transcription start site 
(+1), respectively. It is important to note that -10 or -35 hexamer elements of naturally 
occurring promoters rarely match this consensus sequence (Busby and Ebright, 1994). These 
two promoter elements are separated by 17±1 bp and the sequence of this spacer region can 
be important for promoter efficiency (Mulligan et al., 1985; Singh et al., 2011). Beside these 
two principal promoter elements, some promoters may have an extended -10 element or a 
sequence upstream of the -35 hexamer element, called the UP-element. The extended -10 
element is a TG motif located one base pair upstream of the -10 hexamer and the UP-element 
is ~20 basepair A/T rich  sequence upstream of the -35 hexamer element (Busby and Ebright, 
1999). In addition to these, there can be a discriminator element (5`-GGG-3`) present in the   -
4 to -6 region of the promoter which can play an important role in RNAP open complex 
stability (Lee et al., 2012; Feklistov, 2013; Gummesson et al., 2013). 
The different promoter elements are recognised primarily by different σ domains  and each σ 
subunit domain is necessary for the recognition of certain promoter element (Busby and 
Ebright, 1994). The -10 hexamer element is recognised by domain σ2 and the -35 hexamer 
sequence by domain σ4. The extended -10 promoter element is recognised by domain σ3 and 
the UP-element is recognised by the CTDs of the RNAP α-subunits (Busby and Ebright, 
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1994). Thus, the domains 4, 3, 2 and 1 of the σ  subunit recognise the -35 hexamer element, 
the extended -10 hexamer element, the -10 hexamer element and the discriminator element, 
respectively (Lee et al., 2012). 
Feklistov (2013) has highlighted the fact that some of the promoter elements e.g. the -10 
hexamer element is recognised by RNAP when the DNA is single stranded while other are 
recognised, when the DNA is double stranded e.g. extended -10 hexamer element and -35 
hexamer element in Thermus aquaticus. The β' and σA3 domain of sigma subunit recognise the 
extended -10 hexamer element when DNA is double stranded and in promoters where the 
extended -10 hexamer element is not present; these domains interact with -17 to -13 
nucleotides. The -10 hexamer element is recognised by σA2 when the DNA is single stranded 
(Bae et al., 2015).  
Beside the core promoter elements, the UP-element interaction with the αCTDs of RNAP is 
important and its effect on promoter activity can vary from 2-fold to more than 90-fold at 
naturally occurring promoters. The UP-element sequence consists of A or T tracts and the UP-
element has two subsites. Each subsite interacts with one αCTD subunit. The αCTD of RNAP 
interacts with the UP-element by binding the minor grove (Busby and Ebright, 1999). 
However, there are some reports of promoters where the interaction of αCTD and the UP-
element has no effect or even a negative effect on promoter expression (Ross et al., 1998). 
This could be due to inappropriate placement of the UP-element with respect to the core 
promoter or the presence of an A tract on the UP-element subsite closer to -35 element (the 
proximal subsite) can enhance the promoter affinity for RNAP so that RNAP escape becomes 
difficult (Tagami and Aiba, 1999; Ellinger et al., 1994). These findings suggest that UP-
element interaction with αCTD can be productive as well as non-productive, depending upon 
the core promoter sequence and UP-element position (Gourse et al., 2000).  
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 It is worth mentioning that no naturally occurring promoter has all promoter elements which 
match the consensus sequence (Browning and Busby, 2004). A study by Miroslavova and 
Busby (2006) showed that, a semi-synthetic promoter with an exact match to consensus 
sequences on all the core promoter elements exhibited weak promoter activity. It was 
suggested that RNAP binds too tightly to the promoter such that RNAP escape becomes 
difficult resulting in reduced promoter activity. The strength of a promoter can be described as 
how efficiently the elongation complex clears the promoter and is available to the next RNAP 
(Brunner and Bujard, 1987). To understand the process of transcription: initiation, elongation 
and termination are discussed below. 
1.7.3 Transcript initiation and open promoter complex formation 
After promoter recognition and formation of the closed complex, the DNA double helix bends 
upstream of the -35 hexamer element and wraps around the back of RNAP, resulting in an 
intermediate promoter complex (Saecker et al., 2011). The next step in transcript initiation is 
the transition of the intermediate complex into the open complex, that includes unwinding of 
the DNA strands and the template strand moving into the active site of RNAP (Dehaseth and 
Helmann, 1995). The stable intermediate promoter complex leads to unwinding of the DNA 
double helix by W433 of the σ70 subunit of RNAP acting like a wedge. The -10 hexamer 
element is recognised when the DNA is single stranded, with the A-11 of the -10 hexamer 
element on the non-template strand flipping into pocket in the σ subunit (Feklistov and Darst, 
2011). This starts DNA melting and then T-7 (from the -10 hexamer element of the non-
template strand) also flips into another pocket on the σ subunit and the template strand moves 
into the active site of RNAP (Feklistov, 2013). The active site is occupied by region σ1.1  
before open complex formation, thus, open complex formation is accompanied by movement 
of region σ1.1 from this position to clear the channel for DNA repositioning (Murakami and 
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Darst, 2003). The different steps in this process, described above, are illustrated in the Figure 
1.8. 
The open promoter complex leads to transcript synthesis at the promoter but the RNA exit 
channel in RNAP is blocked by a loop, in σ3.2, which is in the way of the growing nascent 
RNA chain. When the RNA transcript reaches to length of 6 nucleotide, it displaces the loop 
from its position and RNA elongation can occur (Figure 1.8D) (Basu et al., 2014).  This 
displacement of the σ3.2 loop is important for the dislodging domain σ4 from the β flap and 
finally separation of domain σ4 from the -35 hexamer element.  This dissociation leads to 
complete separation of all the σ subunit from RNAP and the core-RNAP can continue 
transcription from this point (Figure 1.8E and F) (Mukhopadhyay et al., 2001; Korzheva et 
al., 2000). 
1.7.4 Transcript elongation and termination 
When the length of the nascent transcript reaches 8-9 nucleotides, RNAP leaves the promoter 
elements and starts moving along the DNA template, this is called transcription elongation. 
The release of RNAP from the promoter elements results in promoter escape (Robb et al., 
2013). The transition of the transcript initiation complex into the elongation complex can be 
unsuccessful sometimes and the RNAP often releases small RNA fragments as a result of 
abortive transcription (Kapanidis et al., 2006). In this instance RNAP pulls downstream DNA 
into the enzyme transcribing it without releasing the upstream DNA, it results in the 
accumulation of single stranded DNA in the RNAP active site, producing huge stress and the 
process is called DNA scrunching (Zuo and Steitz, 2015). This stress can be released in two 
ways, first by the release of abortive transcripts with the small RNA fragments being released 
and RNAP stays in contact with the promoter elements. The second possibility is successful 




Figure 1.8 Initiation of transcription at a bacterial promoter 
This figure shows the interaction of RNAP with promoter DNA during the different stages of 
transcription initiation. 
A. The binding of RNAP to DNA and the formation of the close promoter complex 
B. Bending of the DNA strand and movement of σ1.1 from its position to adjust template strand into 
active site  
C. Melting and unwinding of the DNA to form the open promoter complex. 
D. Displacement of domain σ3.2 by the growing RNA chain  
E. The weakening of σ factor binding to the core enzyme 
F The transcription elongation, movement of RNAP along the DNA template 
This figure has been adapted from Murakami and Darst (2003). 
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hybrid stays intact, with RNAP moving into the transcript elongation phase (Kapanidis et al., 
2006). Transcription elongation continues until transcription termination occurs either due to 
presence of an intrinsic termination sequence or due to Rho-dependent termination. Intrinsic 
termination occurs due to the presence of an inverted repeat sequence that forms a hairpin 
loop in the RNA which is followed by a run of U residues. This hairpin loop with poly U tail, 
weakens the RNA-DNA hybrid and allows RNAP to dissociate from the template (Nedialkov 
et al., 2013). The alternate transcription termination mechanism, involves the protein Rho, 
which is a hexameric protein that functions as an RNA-DNA helicase. Rho has two RNA-
binding sites, i.e. primary and secondary sites that enable the protein to attach to the RNA and 
terminate the transcription (Skordalakes and Berger, 2003). The primary binding site is 
present towards the N-terminal of the Rho and secondary binding site is present towards the 
C-terminal. The Rho protein binds to the RNA at Rho utilization sites (Rut) using the primary 
binding site (Banerjee et al., 2006). The attachment of Rho to RNA requires an optimum 
length of “naked” non-translated RNA (80-90 nucleotide bases). After attachment of Rho to 
the nascent RNA, Rho moves along the RNA towards the 3' end of RNA. This movement of 
Rho along the RNA requires energy and it is provided by ATP hydrolysis. When RNAP 
pauses during transcription, the Rho protein approaches the 3' end, detaches RNA from the 
template DNA and RNAP is released (Brennan et al., 1987; Hitchens et al., 2006; 
Skordalakes and Berger, 2003). 
Some proteins help in reducing pausing of RNAP and regulate the elongation complex; these 
are called Nus factors (N-utilization substances) and these also help in rho-dependent 
termination process. There are four Nus factors important in E. coli, i.e. NusA, NusB, NusE 
and NusG, and NusG interacts with Rho protein (Burmann and Rosch, 2011). NusG is a 
dimeric protein that attaches to the RNAP by the N-terminal domain and helps in releasing σ 
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from the β' flap of holo-RNAP. NusG stays connected with the RNAP during transcription 
that is followed by translation into protein, when ribosome reaches the stop codon during 
translation, the rho has length of naked-mRNA to load onto the mRNA for termination. NusG 
protein’s C-terminal domain binds to the rho and helps in rho dependent termination (Li et al., 
2016; Burmann and Rosch, 2011).  
1.8 Transcription regulation 
The concept of gene expression being activated and repressed by transcription factors was 
proposed by Jacob and Monod (Jacob and Monod, 1961). This emerged from the idea that a 
protein binding at the regulatory sequence of a gene could either increase or decrease the 
transcription of that gene. Proteins that bind to regulatory sequences are called transcription 
factors. Transcription factor encoding sequences can be present very near or at a distance in 
the genome from the genes that they regulate, and these transcription factor serve as 
“regulatory switches” for genes (Balleza et al., 2009).  
Gene expression can be affected by the environmental conditions and interaction of regulatory 
sequences to certain proteins. Transcription regulation can be very simple, e.g. by just a single 
factor, while in other cases, it may involve more than one transcription factor and each factor 
often relies on a different environmental signal (Browning and Busby, 2004). Most 
transcription factors act as activators or repressors, but some regulation factors can work as 
both (Perez-Rueda and Collado-Vides, 2000). Some transcription factors bind to a specific 
sequence at a single promoter and so regulate a single transcription unit, while others can 
affect the transcription of more than one promoter and so may act as global transcription 
regulators. For example, the cyclic adenosine monophosphate (cAMP) receptor protein (CRP) 
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regulates more than 200 different promoters in E. coli (Martinez-Antonio and Collado-Vides, 
2003).  
The strength of transcription regulation depends upon the affinity between the transcription 
factor and the regulatory sequence. The same transcription factor may produce different 
effects on rate of transcription at different promoters, depending upon the transcription 
regulatory sequences. Transcription factors are divided into two broad categories, activators 
and repressors, on the base of their effect on promoter activity. How each of the transcription 
factor can interact with a promoter is discussed below.  
1.8.1 Activation of transcription by activator proteins 
Studies with the CRP protein, showed that it could activate using two mechanisms: Class I 
and Class II. In Class I activation, CRP binds upstream of the -35 hexamer element, at 
specific points on the same face of the DNA helix (e.g. near positions of -62, -72, -83 or -93) 
and αCTD makes contact with a face of the activator called the activation region (Figure 
1.9A) (Carattoli et al., 2005; Browning and Busby, 2004). The lac promoter, which is 
activated by CRP, is an example of a Class I activated promoter, where the transcription 
factor binds upstream of the -35 hexamer element (Igarashi et al., 1991). However, if the 
activator protein binding site overlaps the -35 hexamer element, it is called a Class II 
activated promoter. In Class II activation, the transcription factor interacts with the σ subunit 
of RNAP, helps in both the recruitment of RNAP and activation of transcription initiation 
(Figure 1.9B) (Browning and Busby, 2016). Class II activators can also bind to the αCTD and 
αNTD subunits in addition to the σ subunit (Feng et al., 2016). The activation of the coo 
promoter in ETEC by Rns and the Pm promoter in Pseudomonas putida (P. putida) by XylS 




Figure 1.9 Mechanisms of transcription activation 
 A. Class I activation: The figure shows the binding of an activator (yellow) upstream of the -35 
hexamer element, where it interacts with αCTD to promote transcription.  
B. Class II activation: The figure shows the binding of an activator (yellow) overlapping the -35 
hexamer element in such a manner that it interacts with αCTD and σ4 to promote transcription. 
C. Activation by conformational change: The figure shows the binding of the transcription activator 
between the -10 hexamer element and -35 hexamer element, which brings about a conformational 
change in the DNA to promote transcription.  
D. Complex activation: The panel shows the binding of more than one activator (yellow) with the 
DNA strand either at Class I and Class II binding sites or two Class I activator binding sites. 
This figure is adapted from Browning and Busby (2004). 
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At some promoters, the activators can bind to the DNA and bring about conformational 
changes that allow RNAP to bind the promoter DNA (Figure 1.9C). The majority of 
transcription activators that activate by this mechanism, are the MerR family of transcription 
regulators and they induce a conformational change in the DNA to realign the -10 and -35 
hexamer elements (Brown et al., 2003). An example of this class of promoters is the copA 
promoter, (a gene encoding for a copper export protein), activated by CueR (Stoyanov et al., 
2001).  
If only one activator binds to the promoter, then it is relatively simple to explain its mode of 
action but at some promoters, two transcription activators bind to the promoter sequence 
independently to co-regulate transcription. This could be due to different combinations of 
activators, for example, two Class I activators on the same promoter or a Class I and a Class II 
activator (Figure 1.9D) (Lee et al., 2012). An example of this type of activation is at the 
acetate synthetase promoter 2 (acs2), that is activated by two CRP molecules bind at positions 
-69.5 and -122.5 upstream of the transcription start site (Beatty et al., 2003). 
1.8.2 Repression by transcription factors 
Repressors are proteins that bind to promoters and decrease transcription initiation by 
destabilising or blocking RNAP binding to the promoter. There are three simple mechanisms 
of RNA transcription repression. One of the mechanisms is when the repressor protein binds 
near the core promoter elements, and thus results in the failure of RNAP to bind to the 
promoter and start transcription. This kind of repressor directly minimises transcription by 
blocking RNAP binding (Figure 1.10A). For example, the lac promoter is repressed by 
binding of the LacI repressor, at the core promoter sequence (Muller-Hill, 1998). 





Figure 1.10 Mechanisms of transcription repression 
A. The repressor (red) binds between the promoter core elements, preventing RNAP from binding to 
the promoter. 
B. The repressors bind to the DNA making a loop, and preventing RNAP from binding the promoter. 
C. The repressor (red) binds to the DNA near the activator (yellow) and modifies the activator in such 
a way that it cannot recruit RNAP effectively. 
This figure is adapted from Browning and Busby (2004). 
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promoter and result in DNA looping. This can result in promoter core elements keeping 
trapped in the loop and RNAP cannot bind to the promoter (Figure 1.10B). For example, 
GalR binding induces DNA looping and repression of the gal promoter (Swint-Kruse and 
Matthews, 2009). The third type of repression mechanism involves inhibition of an activator 
protein. In this instance, the repressor binds to the target promoter in such a way that it 
prevents the activator from performing its function (Figure 1.10C). For example, the 
interaction of CytR with CRP to inactivate the cytR promoter is an example of this type of 
repression (Valentin-Hansen et al., 1996).  
1.8.3 Promoter regulation by modifications 
Transcription can also be regulated by the modification of the DNA sequences. One of the 
most common processes is, transcription regulation by modification of the specific nucleotide 
bases by the Dam methylase enzyme. The Dam methylase adds the methyl group to adenine 
nucleotide base in GATC motif and this can effect transcription at certain promoters. The 
process was identified by Blyn et al. (1990) who showed that methylation can switch ON or 
OFF a promoter. For example, there are two GATC sites present in the regulatory region of 
pyelonephritis-associated gene pilus (pap) operon in UPEC. When the distal GATC site, in 
relation to the pap genes is methylated, the promoter turned OFF and the gene is not 
expressed. When the proximal GATC is methylated, this turns the promoter to ON in pap 
expression and pili formation.  
An additional epigenetic mechanism that regulates the gene expression is switching promoter 
orientation (Browning and Busby, 2016). In the ON phase, the promoter is located in such a 
position that if RNAP binds to the promoter, and transcription will lead into the gene. In the 
OFF phase, the promoter is inverted with the help of inversion enzymes and other regulatory 
protein so it cannot express the gene. An example of such a gene regulation is the fim operon 
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that encodes for type I fimbriae in E. coli. The 314 bp promoter of fimA is inverted by FimB 
and FimE with the help of IHF and HNS (Blumer et al., 2005).  
Another mechanism that can affect transcription is the variation of spacing between promoter 
elements by the addition or deletion of a single nucleotide or dinucleotide repeat. An example 
of this type of promoter regulation is the hifA and hifB promoters that controls the expression 
of the fimbrial components in Haemophilus influenzae. The promoters have different numbers 
of AT repeats between the -10 hexamer element and -35 hexamer element. Thus, in bacterial 
population different bacteria have different spacing between these elements. This leads to the 
different levels of gene expression (Bruant et al., 2002).  
1.8.4 Transcription regulation by second messengers and factors interacting with RNAP  
Bacteria can sense changes in external environment and can react to the environmental signals 
by a change in metabolism that alters the expression of certain genes. They often produce 
signalling molecules or second messangers, and important examples of these are cyclic 
adenosine monophosphate (cAMP), cyclic diguanylate monophosphate (c-di-GMP) and 
guanosine pentaphosphate (p)ppGpp (Kariisa et al., 2015).  
cAMP is one of the important second messengers and its concentration changes in response to 
glucose or lactose concentration in the medium. When the interacellular glucose concentration 
is low, the adenylyl cyclase present in the cytoplasm senses the dearth of the carbon source 
and produces cAMP from AMP. The cAMP binds to CRP and activates the transcription of 
genes required for alternate source of energy. The role of cAMP in E. coli is limited to 
interact with CRP. The cAMP-CRP complex is important for regulation of genes involved in 
catabolism (Gorke and Stulke, 2008).  
Another important second messenger in E. coli is ppGpp that affects transcription of many
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genes. When the bacterium is experiencing starvation, there are less free amino acids 
available to synthesise new proteins. This results in the presence of more uncharged tRNAs 
within the cell and this activates the ribosomal associated protein RelA to produce ppGpp 
(Hauryliuk et al., 2015). When the cells experience starvation for other carbon sources, the 
cytoplasmic enzyme SpoT is activated and it also produces guanosine tetraphosphate 
(ppGpp). Increased levels of ppGpp shifts the pattern of transcription with more expression of 
stress response genes and less or no expression of genes involved in rapid growth and the cell 
division, e.g. rRNA operons. This is possible as ppGpp can stabilise the transcription bubble 
of certain genes and destabilise the transcription bubble of other genes. One result of 
increased levels of ppGpp is an increase in the expression of genes for amino acids production 
in bacteria (Paul et al., 2005). Note that in E. coli the protein factor, DksA, binds to RNAP 
transiently and increases the RNAP-ppGpp complex stability facilitating the response to 
ppGpp (Paul et al., 2005; Perederina et al., 2004).  
Transcription elongation is not a continuous process, rather there are stops and starts as the 
RNAP moves along the DNA. Some pauses are brief and they are resolved quickly with the 
resumption of elongation. However, some of the pauses are longer and can end up in RNAP 
backtracking. Backtracking is a process in which RNAP trails back on RNA-DNA hybrid 
from 1 nucleotide to few nucleotides (Nudler, 2012). When backtracking occurs, transcription 
is arrested and the transcription factors GreA and GreB are able to resolve this complex. 
These factors cleave the nascent RNA from the 3' end and relieve the transcription blockage 
(Roberts et al., 2008). GreA and GreB are similar in structure to DksA and all of these 




1.9 Overview of AraC transcription activation 
Transcription regulation in EAEC is complex and global regulators and local transcription 
regulators are important for growth, multiplication, metabolism and survival. AraC is a 
transcription regulator of E. coli and it regulates the genes for arabinose metabolism. A 
number of transcription factors have been classified as AraC/XylS family members on the 
basis of their sequence homology to AraC of E. coli and XylS of P. putida. The AraC/XylS 
family of transcription regulators has more than 800 members. Family members have a 
conserved DNA binding domain in the C-terminal that generally consists of two helix turn 
helix (HTH) motifs which interact with promoter DNA. Members of this family can also exist 
either as monomers or dimers, depending upon the particular protein (Egan, 2002). Family 
members are involved in the regulation of a diverse range of genes (Munson and Scott, 2000). 
Some members regulate carbon metabolism and responses to environmental stress, while 
others may regulate virulence factor expression in animal and plant pathogens.  
Many AraC family members activate expression of a range of virulence determinants. 
Fimbriae are important virulence determinants and AraC family members that increase the 
expression of fimbrial genes include AggR from EAEC and CsvR and Rns from ETEC 
(Gallegos et al., 1997). As AggR regulates the expression of many virulence determinants in 
EAEC, a brief review of AraC family of transcription regulators is necessary (Nataro et al., 
1994). 
In E. coli, the araBAD operon encodes for arabinose metabolising enzymes whilst araC 
encodes for the AraC, a transcription regulator (Figure 1.11A). AraC exists as a dimeric 
protein and there are three binding sites for AraC upstream of the araBAD promoter i.e. 




Figure 1.11 Regulation of the araBAD promoter by AraC  
 A. A map of the ara control region. There are four AraC binding sites (araO1, araO2, aral1, and 
aral2). The bent arrows show the transcriptional units regulated by AraC.  
B. Domain organization of a single subunit of AraC protein. 
C. Negative control of araBAD expression. In the absence of arabinose, AraC binds to araO2 and 
aral1, blocking access of RNAP to the promoter. 
D. Positive control of araBAD expression: arabinose binds to AraC, changing its shape so it binds as a 
dimer to aral1 and aral2. This allows RNAP to bind to the promoter and active transcription can 




araI2, each of these regions can be bound by one monomer of AraC (Hamilton and Lee, 
1988). Whilst cells are growing in the medium without arabinose, they do not require the 
enzymes for arabinose metabolism and so AraC represses transcription of araBAD by forming 
a loop, binding to araO2 and araI1 (Figure 1.11B and C). In this arrangement the binding of 
RNAP to the araBAD promoter is blocked by DNA loop formation. When cells are grown in 
the presence of arabinose, AraC undergoes a conformational change, as arabinose binds to it, 
and this results in the binding of AraC to araI1 and araI2, instead of binding to araO2 (Figure 
1.11D). The switching of AraC from one conformation to another has been also termed the 
light switch model (Schleif, 2010). This alternate AraC binding arrangement results in the up 
regulation of araBAD promoter as the repression loop is released and RNAP is able to bind to 
the promoter. As, AraC binding site also overlaps the -35 hexamer element, it is suggested 
AraC interacts with RNAP in the transcription initiation (Dhiman and Schleif, 2000). AraC 
can also bind to the araO1 binding site but this binding site autoregulates its own transcription 
from the araC promoter (Gallegos et al., 1997). 
1.10 An overview of the AggR regulon in EAEC 
AggR is a member of the AraC family of transcriptional regulators and the aggR gene is 
present on the large virulence plasmids present in EAEC strains (Nataro et al., 1994; Boll et 
al., 2012). AggR has high level of amino acid similarity with CfaD (68%) and Rns (66%) 
from ETEC (Munson, 2013). To date, there is little direct information regarding the 
mechanism of regulation by AggR but related regulators, such as Rns, have been studied in 
some detail. A study by Mahon et al. (2012) has shown that Rns can exist as a dimer, and on 
the basis of in vivo experiment with a bacterial two hybrid system, it has been suggested that 
AggR may also dimerise when it activates transcription (Santiago et al., 2016). But, on the 





as monomer in in vitro, so these members of AraC family are monomeric or dimeric, is still 
under consideration (Basturea et al., 2008; Munson and Scott, 1999; Munson, 2013). 
The AraC family of regulators are defined on the basis of their conserved DNA binding 
domains, present in the C-terminus, (i.e. two HTH regions). Each HTH consists of a 21 amino 
acid motif and AraC/XylS transcription factors interact with the DNA through these HTH 
regions. Figure 1.12 shows the sequence of the HTHs of AggR compared to the other closely 
related members (i.e. Rns, CsvR and VirF). The HTH regions sequences of these closely 
related transcription factors show high amino acid identity to AggR. Figure 1.12 also shows 
the sequence alignment of AraC, MelR and AggR HTH domains (Gallegos et al. (1997).  
Little is known about AggR-dependent regulation but the AggR promoter has been identified 
and investigated (Morin et al., 2010). Two AggR-binding sites have been identified at the 
aggR promoter and both are similar to the Rns consensus sequence (i.e., AnnnnnnTATC), 
moreover, it is also shown that AggR also regulates its expression from these sites. It has also 
been demonstrated that the E. coli global regulators FIS (Factor Inversion Stimulation) and H-
NS (Histone like-nucleiod structuring protein), play a role in regulating aggR expression 
(Morin et al., 2010). Santiago et al. (2016) found that AraC family members are negatively 
regulated by AraC negative regulators (ANR) which are small proteins that interact with 
AraC family members. The first member of the ANR family was found in EAEC 042 and it 
was named as Aar (AggR activated regulator) (Santiago et al., 2014). Expression of the Aar 
negative regulator is activated by AggR and once expressed Aar binds to AggR and impairs 
its ability to activate transcription. The exact binding sites are not known but bacterial two 
hybrid system results show that the middle part of AggR is important for Aar-AggR 








Figure 1.12 Alignment of the helix turn helix motifs of AggR with that of Rns, CsvR, 
VirF, AraC and MelR 
The figure shows the schematic representation of AggR as two rectangular boxes with N and C 
terminal domains. The green cylindrical shapes represent the HTHs of AggR. Alignment of amino 
acid sequences of HTHs motifs of AggR, Rns, CvsR and VirF are shown from Munson (2013). 
Alignment of amino acid sequences AraC and MelR to HTH of AggR is from Gallegos et al. (1997). 








Morin et al. (2013) have examined the AggR regulon in EAEC strain 042 using microarray 
analysis, and found that AggR regulates more than 40 genes present on pAA2, as well as on 
the bacterial chromosome. Most of the AggR-regulated genes identified are already identified 
as important virulence determinants, whilst a number of the genes encode for proteins of 
unknown function. As AggR regulates virulence in EAEC, it is likely that these proteins of 
unknown function may have a role in pathogenesis as well. Figure 1.13A and Figure 1.14A 
show the schematic diagrams of some of the genes on the chromosome and pAA2, 
respectively. Morin et al. (2013), determined using a microarray, that 23 AggR-regulated 
genes were located on the chromosome and 21 AggR-dependent genes were present on pAA2 
plasmid of EAEC 042, which were verified using qPCR. The numbering below the genes 
represent that expression of these genes is regulated by AggR Figure 1.13A and  Figure 1.14A 
and Figure 1.13B and  Figure 1.14B contain the results of the qPCR experiment showing the 
fold change in decrease gene expression in the  the absence of AggR on the chromosome and 
pAA2 plasmid, respectively.  
Previous studies have provided information concerning AggR and the genes it regulates. 
However, there is very little information on the regulation of AggR-dependent promoters and 
the mechanism by which it activates transcription. Only the aggR gene promoter has been 
analysed with the AggR-binding sites (Morin et al., 2010). The present study was designed 
with the aim of understanding AggR-dependent promoter regulation.  
For this purpose, the AggR-dependent genes that are important in virulence of the EAEC 
prototype strain 042 were chosen in order to understand AggR-dependent regulation at these 
promoters. Therefore, the AAF/II and dispersin genes were selected from the pAA2 plasmid 
and T6SS genes from the chromosome to study AggR-dependent promoters using molecular 






Figure 1.13 The AggR-dependent genes on the chromosome 
A. The panel shows the schematic representation of chromosomally located genes regulated by AggR. 
The genes are present in two loci and names are shown above each gene representation. The number 
below each gene represents AggR-dependent gene present on EAEC 042 chromosome. 
B. The panel shows AggR-dependent expression levels of genes present on the chromosome and 
pAA2. The fold expression column shows the value of fold decrease in expression in absence of AggR 







Figure 1.14 The AggR-dependent genes on the pAA2 plasmid 
A. The panel shows a schematic representation of genes present on pAA2 that are regulated by AggR. 
The gene names are shown above each gene. A number is shown below each AggR-dependent gene. 
B. The panel shows AggR-dependent expression levels of genes present on the chromosome and 
pAA2. The fold expression column shows the value of fold decrease in expression in absence of AggR 





studied and the AggR-dependent model was verified by making semi-synthetic promoters.  
1.11 Aims and objectives of the project 
The overall aim of the project was to determine the organisation of AggR-dependent 
promoters and understand how the AggR-dependent genes are regulated in EAEC. Although 
the whole genome sequence of EAEC is available and AggR-dependent genes have been 
identified, the architecture of many AggR-dependent promoters has not been described. 
Therefore, the intended aim of this study was to choose a number of different AggR-
dependent promoters from EAEC, with a view to build up a step-by-step picture of AggR-
dependent regulation. 
In order to do this, the key functional elements of the fimbrial promoters that control 
expression of AAF/II on pAA2 plasmid from EAEC 042 were determined and discussed in 
Chapter 3. These results gave us an understanding of the organization of AggR-dependent 
promoters and AggR-mediated regulation. In Chapter 4, I examined the aap, aaiA and semi-
synthetic promoters to further understand the architecture of AggR-dependent promoters. 
Chapter 5 contains the details about mutational analysis of AggR protein and affect of AggR 
on pet expression. 
To understand the role of AggR-dependent promoters present in other strains of EAEC, the 
fimbrial promoter of the EAEC strain 17-2 was studied using the same principles. It is 
pertinent to mention here that the AggR construct used in this study was taken from EAEC 
042 and the promoter architecture of fimbrial genes of EAEC 17-2 was studied using the 
same principles (Chapter 6). The overall aim of the study was to determine the location of 























2.1 Suppliers  
All chemicals used in this study were purchased from Sigma-Aldrich, BDH and Fisher 
Scientific UK, unless otherwise stated. T4 DNA ligase, calf intestinal alkaline phosphatase 
(CIP), Phusion DNA polymerase, Q5 DNA polymerase and all restriction enzymes were 
obtained from New England Biolabs (NEB). Biomix red DNA polymerase, Mytaq red DNA 
polymerase and dNTPs were ordered from Bioline. All the deoxy-oligonucleotides were made 
by ALTA Biosciences (University of Birmingham). Where appropriate, solutions were 
autoclaved at 121°C under 15 lbin-2 for 15 minutes or filter-sterilised using 0.2 µm pore size 
filters (Acrodisc®). 
2.2 Bacterial growth media 
2.2.1 Liquid media 
All E. coli strains were grown in Lysogeny broth (LB) at 37°C with shaking unless otherwise 
stated. LB was made by mixing 10 g peptone, 5 g yeast and 5 g NaCl in one liter of distilled 
water (dH2O). For the selection of plasmid-encoded resistances the medium was 
supplemented with the appropriate antibiotic. Super Optimal broth with Catabolite repression 
(SOC) medium contained 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 10 ml KCl (250 mM), 
5 ml MgCl2 (2M), 20 ml glucose (1M) in one liter of distilled water. Glucose was added after 
autoclaving. Dulbecco’s modified Eagle medium (DMEM) with high glucose concentration 
(4.5 gl–1) was purchased from Sigma Aldrich in liquid form.   
2.2.2 Solid media 
E. coli strains were grown on LB agar (Sigma) (15 g agar, 10 g tryptone, 5 g yeast extract and 
5 g NaCl in one liter of dH2O), Nutrient agar (Oxoid) (15 g agar, 1 g meat extract, 5 g 





Difco) (13 g agar, 17 g pancreatic digest of gelatin, 3 g peptones (meat and casein), 5 g NaCl, 
10 g lactose, 1.5 g bile salts, 0.03 g neutral red and 0.001 g crystal violet in one liter of dH2O) 
plates. Media were prepared using distilled water according to manufacturer’s instructions 
and autoclaved. After autoclaving, the medium was cooled to between 50°C - 55°C and the 
appropriate antibiotics were added as required. 
2.2.3 Antibiotics and other supplements 
The strains carrying plasmid-encoded resistance genes were selected for, by the addition of 
the appropriate antibiotic to both liquid and solid media, after autoclaving. For stock solutions 
of antibiotics, the powder of respective antibiotics was dissolved as follow, 100 mgml-1 of 
ampicillin in dH2O, 50 mgml-1 of kanamycin in dH2O, 10 mgml-1 of tetracycline in methanol 
(50% v/v) and 25 mgml-1 of Chloramphenicol in methanol (100%). All the stock solutions of 
antibiotics were sterile filtered through 0.2 μm syringe filters (Acrodisc®) and stored at -20°C. 
The final concentration of the antibiotics used was 100 µgml-1 for ampicillin, 15 µgml-1 for 
tetracycline, 50 µgml-1 for chloramphenicol and 25 µgml-1 for kanamycin. Arabinose was 
used to induce protein expression using the pBAD expression system where appropriate at a 
concentration of 0.2% (w/v) and a stock solution 20% (w/v) was made to achieve this 
concentration.  
2.3 Bacterial strains and plasmids 
2.3.1 Bacterial strains and growth conditions 
The E. coli K-12 strain BW25113 used throughout this study and its genotype is shown in the 
Table 2.1. EAEC strain 042 was also used, its genotype, and that of its variants are detailed in 
Table 2.1. Overnight cultures were grown by inoculating a single bacterial colony into 5 ml of 





Table 2.1 Strains used in this study 
 
 
Strains Genotype References/ 
Source 
BW25113 lacI
q, rrnBT14, ∆lacZWJ16, hsdR514, 
∆araBADAH33, ∆rhaBADLD78 
(Baba et al., 
2006) 
EAEC 042 
Wild type, prototype strain, SmR, TetR, 
CmR, Diarrhoeagenic in volunteers, 
expresses AAF/II, biofilm positive, 
harbours pAA2 
(Nataro et al., 
1995) 
EAEC 042 ∆aggR 
Wild type, prototype strain, SmR, TetR, 
CmR, harbours pAA2. The aggR gene 
present on pAA2 has been deleted. 
(Dudley et al., 
2006) 
EAEC DFB042 
Wild type, prototype strain, SmR, TetS, 
CmS, expresses AAF/II, biofilm 





Wild type, prototype strain, SmR, TetS, 
CmS, AmpR expresses AAF/II, biofilm 
positive, harbours pAA2. Containing 




Wild type, prototype strain, SmR, TetS, 
CmS, biofilm negative, harbours 
pAA2. The aggR gene has been 







16-18 hours. Bacteria were sub-cultured by diluting the overnight culture 1:100 into the 
appropriate medium. Growth of bacterial cultures was monitored by measuring the optical 
density at 650 nm (OD650) using a Helios Gamma Spectrophotometer (Thermo Fisher 
Scientific Inc.). Glycerol stocks for long term storage were made from overnight cultures by 
mixing glycerol stock, 850 µl of culture with 150 µl of glycerol in a cryofuge tube and the 
samples were stored at -80°C.  
2.3.2 Plasmids 
Plasmids used in this study are listed in Table 2.2.  
2.4 Gel electrophoresis 
2.4.1 Agarose gel electrophoresis 
Agarose gels were used to resolve and purify DNA fragments and plasmids of different sizes 
ranging from 1 kb to 10 kb. Agarose gels contained and were run using a TBE based buffer 
system. The 5x TBE stock solution was prepared by dissolving 54 g Tris, 27.5 g borate and 
4.65 g of EDTA in one litre of distilled water. The gels contained and were run in 0.5x TBE 
buffer by diluting the 5x stock with distilled water. Gels were made by mixing 15 ml molten 
agarose (0.8-1% (w/v) agarose in 0.5x TBE) with 1 µl of ethidium bromide (10 mgml-1), 
which was poured into a gel casting plate. Wells of the desired width that could hold 10-40 µl 
of a sample, were created by placing a comb in vertical position into the casting tray to make 
sample wells. Once solidified, the comb was removed and the gel was immersed in 0.5x TBE 
buffer in a horizontal electrophoresis tank. DNA samples were prepared for loading by 
mixing one volume of loading dye (bromophenol blue (0.025% (w/v)), xylene cyanol F 
(0.025% (w/v)), glycerol (20% (v/v)), Tris (10 mM, pH 7.5) and EDTA (1 mM)) with 6 





Table 2.2 Plasmids used in this study (continued on pages 49-57) 
Plasmids Description Source 
pRW50 oriV, lacZYA, tet
R. Broad-host range, low-copy-




A derivative of pRW50, which allows cloning of 
promoter fragments as transcriptional or 
translational fusions to lacZ carrying pUC9 linker 




A derivative of pRW224-U9, which allows 
cloning of promoter fragments using EcoRI and 




A derivative of pRW50 carrying the EcoRI-
HindIII aafD100 promoter fragment cloned as a 
lacZ transcriptional fusion. 
This study 
pRW50/aafD99 
A derivative of pRW50 carrying an aafD99 
promoter fragment constructed by deletion of 100 
bp from aafD100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aafD98 
A derivative of pRW50 carrying an aafD98 
promoter fragment constructed by deletion of 200 
bp from aafD100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aafD97 
A derivative of pRW50 carrying an aafD97 
promoter fragment constructed by deletion of 300 
bp from aafD100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aafD96 
A derivative of pRW50 carrying an aafD96 
promoter fragment constructed by deletion of 320 
bp from aafD100 promoter fragment, and cloned 







Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW50/aafD95 
A derivative of pRW50 carrying an aafD95 
promoter fragment constructed by deletion of 340 
bp, from aafD100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aafD94 
A derivative of pRW50 carrying an aafD94 
promoter fragment constructed by deletion of 360 
bp, from aafD100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aafD96-90C 
A derivative of pRW50/aafD96 carrying an 
aafD96-90C promoter fragment constructed from 
aafD96 by a substituting of T to C at position 90 




A derivative of pRW50/aafD96 carrying an 
aafD96-90C92C promoter fragment constructed 
from aafD96 by substituting Ts to Cs at position 
90 and 92 and cloned using an EcoRI-HindIII. 
This study 
pRW50/aafD96-65C 
A derivative of pRW50/aafD96 carrying an 
aafD96-65C promoter fragment constructed from 
aafD96 by a substituting of an A to C at position 
65 and cloned using an EcoRI-HindIII. 
This study 
pRW225/aafD1001 
A derivative of pRW225, carrying aafD1001 
promoter fragment constructed by from aafD100 
with 10 bp deletion adjacent to HindIII site and 
cloned into pRW225 using an EcoRI-HindIII. 
This study 
pRW225/aafD1002 
A derivative of pRW225, carrying aafD1002 
promoter fragment constructed by from aafD100 
with 19 bp deletion adjacent to HindIII site and 






Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW224/aafD500 
A derivative of pRW224, carrying aafD500 
promoter fragment constructed by from aafD96 
with 43 bp deletion adjacent to HindIII site and 
cloned into pRW224 using an EcoRI-HindIII. 
This study 
pRW50/afaB100 
A derivative of pRW50 carrying the EcoRI-
HindIII afaB100 promoter fragment cloned as a 
lacZ transcriptional fusion. 
This study 
pRW50/afaB99 
A derivative of pRW50 carrying an afaB99 
promoter fragment constructed by deletion of 100 
bp, from afaB100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/afaB98 
A derivative of pRW50 carrying an afaB98 
promoter fragment constructed by deletion of 200 
bp, from afaB100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/afaB97 
A derivative of pRW50 carrying an afaB97 
promoter fragment constructed by deletion of 300 
bp, from afaB100 promoter fragment, and cloned 




A derivative of pRW50 carrying an afaB100-
320C318C promoter fragment constructed from 
afaB100 promoter fragment by substituting Ts to 





A derivative of pRW50 carrying an afaB100-293C 
promoter fragment constructed from afaB100 
promoter fragment by substituting an A to C at 






Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW224/afaB100 
A derivative of pRW224 carrying an EcoRI-




A derivative of pRW50 carrying the EcoRI-
HindIII afaBC100 promoter fragment cloned as a 
lacZ transcriptional fusion. 
This study 
pRW50/afaBC99 
Derivative of pRW50 carrying a afaBC99 
promoter fragment constructed from afaBC100 by 
deletion of 400 bp sequence and the promoter 




A derivative of pRW50 carrying the EcoRI-
HindIII aafA100 promoter fragment cloned as a 
lacZ transcriptional fusion. 
This study 
pRW50/aafC100 
A derivative of pRW50 carrying the EcoRI-
HindIII aafC100 promoter fragment cloned as a 
lacZ transcriptional fusion. 
This study 
pRW50/aaiA100 
A derivative of pRW50 carrying the EcoRI-
HindIII aaiA100 promoter fragment cloned as a 
lacZ transcriptional fusion. 
This study 
pRW50/aaiA99 
A derivative of pRW50 carrying an aaiA99 
promoter fragment constructed by deletion of 172 
bp, from aaiA100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aaiA98 
A derivative of pRW50 carrying an aaiA98 
promoter fragment constructed by deletion of 207 
bp, from aaiA100 promoter fragment, and cloned 






Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW50/aaiA97 
A derivative of pRW50 carrying an aaiA97 
promoter fragment constructed by deletion of 228 
bp, from aaiA100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aaiA96 
A derivative of pRW50 carrying an aaiA96 
promoter fragment constructed by deletion of 255 
bp, from aaiA100 promoter fragment, and cloned 
using an EcoRI-HindIII. 
This study 
pRW50/aaiA95 
A derivative of pRW50 carrying an aaiA95 
promoter fragment constructed by deletion of 335 
bp, from aaiA100 promoter fragment, and cloned 




A derivative of pRW50 carrying an aaiA98-
254C252C promoter fragment constructed from 
aaiA98 promoter fragment by substituting Ts to 





A derivative of pRW50 carrying an aaiA98-226C 
promoter fragment constructed from aaiA98 
promoter fragment by substituting an A to C at 
position 226 and cloned using an EcoRI-HindIII. 
This study 
pRW50/aap100 
A derivative of pRW50 carrying the EcoRI-
HindIII aap100 promoter fragment cloned as a 





A derivative of pRW50 carrying an aap100-
151C149C promoter fragment constructed from 
aap100 promoter fragment by substituting Ts to 







Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW50/aap100-
124C 
A derivative of pRW50 carrying an aap100-124C 
promoter fragment constructed from aap100 
promoter fragment by substituting an A to C at 
position 124 and cloned using an EcoRI-HindIII. 
This study 
pRW50/CC(-41.5) 
A derivative of pRW50 carrying the EcoRI-
HindIII CC(-41.5) promoter fragment cloned as a 




A derivative of pRW50 carrying DAM20, a semi-
synthetic promoter fragment constructed by 
transplanting a 19 bp AggR-binding motif from 
aafD promoter into CC(-41.5) between positions -
47 to -29 from transcription start site. The AggR-




A derivative of pRW50 carrying DAM21, a semi-
synthetic promoter fragment constructed by 
transplanting a 19 bp AggR-binding motif from 
aafD promoter into CC(-41.5) and the AggR-




A derivative of pRW50 carrying DAM22, a semi-
synthetic promoter fragment constructed by 
transplanting a 19 bp AggR-binding motif from 
aafD promoter into CC(-41.5) and the AggR-




A derivative of pRW50 carrying DAM23, a semi-
synthetic promoter fragment constructed by 
transplanting a 19 bp AggR-binding motif from 
aafD promoter into CC(-41.5) and the AggR-







Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW50/DAM22-(-
38C-36C) 
A derivative of pRW50 carrying a DAM22-(-38C-
36C) promoter fragment constructed from DAM22 
promoter fragment by substituting Ts to Cs at 
position -38 and -36 from transcription start site 
and cloned using an EcoRI-HindIII. 
This study 
pRW50/aggD100 
A derivative of pRW50 carrying the EcoRI-
HindIII aggD100 promoter fragment cloned as a 




A derivative of pRW50 carrying an aggD50 
promoter fragment constructed by a deletion of 
268 bp, from aggD100 promoter fragment, and 
cloned using an EcoRI-HindIII. 
This study 
pRW50/aggD49 
A derivative of pRW50 carrying an aggD49 
promoter fragment constructed by a deletion of 
305 bp, from aggD100 promoter fragment, and 
cloned using an EcoRI-HindIII. 
This study 
pRW50/aggD48 
A derivative of pRW50 carrying an aggD48 
promoter fragment constructed by a deletion of 
326 bp, from aggD100 promoter fragment, and 




A derivative of pRW50 carrying an aggD49-86C 
promoter fragment constructed from aggD49 
promoter fragment by substituting T to C at 




A derivative of pRW50 carrying an aggD49-60C 
promoter fragment constructed from aggD49 
promoter fragment by substituting an A to C at 






Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pRW50/aggD101 
A derivative of pRW50 carrying the EcoRI-
HindIII aggD101 promoter fragment cloned as a 




A derivative of pRW50 carrying aggD102 
promoter fragment, constructed by six bp deletion 
from aggD101 fragment and cloned using EcoRI 




A derivative of pRW50 carrying the EcoRI-
HindIII nlpA100 promoter fragment cloned as a 




A donor plasmid for gene doctoring carrying sacB 
gene for counter selection (ampRsacB). It also 
contains a kanamycin resistance cassette. 




A donor plasmid for gene doctoring with the 
aggR400 fragment cloned in homology region 1 
using an EcoRI-BamHI and the aggR401 fragment 
in homology region 2 using a XhoI-SalI. 
This study 
pACBSR 
A plasmid encoding the  red gene and secI under 
the control of an arabinose inducible promoter for 




A derivative of pBAD30 carrying aggR cloned 




pBAD/aggR-I14T A derivative of pBAD/aggR carrying I14T substitution. 
Rita 
Godfray 







Table 2.2   Plasmids used in this study (continued) 
Plasmids Description Source 
pBAD/aggR-Q230G A derivative of pBAD/aggR carrying Q230G substitution. 
Rita 
Godfray 




A derivative of pBAD vector series carrying 
restriction sites to clone the gene of interest under 









NEB or Bioline was used in every gel to size the DNA fragments. Samples were subject to 
electrophoresis in 0.5x TBE tank at 80 V for 30 to 45 minutes and viewed and imaged using 
300 nm UV light with an XR Gel Doc system (Bio-Rad). For DNA fragment purification, the 
sample were visualised by using High Performance Ultraviolet Transilluminator (Ultra Violet 
Products Ltd.) and DNA bands were excised for DNA purification with a QIAquick gel 
extraction kit (Qiagen).  
2.4.2 Polyacrylamide gel electrophoresis (PAGE) of DNA 
Polyacrylamide gels were used to identify and purify DNA fragments of 50 to 800 bp in 
length. Acrylamide gel solution of 7.5% (w/v) was made by mixing 100 ml of 5x TBE 
solution (section 2.4.1), 125 ml of 30% (w/v) acrylamide (National Diagnostics), 20 ml of 
glycerol per 500 ml. The acrylamide gel was made by adding 100 µl of freshly prepared 10% 
(w/v) of ammonium persulphate (APS) and 10 µl of N, N, N', N'-Tetramethylethylenediamine 
(TEMED) per 10 ml of 7.5% (w/v) polyacrylamide gel mix.  The mixture was poured 
between two glass plates held apart by ~0.15 cm thick spacers. The wells were made by 
placing a comb at the top of the gel and the comb and bottom spacer were removed when the 
mixture had polymerised. The glass plates with polymerised gel were fixed into a vertical 
electrophoresis apparatus and the upper and lower tanks were filled with 1x TBE. DNA 
samples were prepared by mixing with loading dye with DNA samples in a ratio of 1:6 and 
loaded into washed wells in the gel. Samples were then subject to electrophoresis at 40 mA 
for 45 to 60 minutes. The gel was stained in a 0.5 µgml-1 ethidium bromide solution for 15 
minutes and viewed at 300 nm using an XR Gel Doc system (Bio-Rad). For DNA fragment 
purification, the DNA bandds were visualised using a High Performance Ultraviolet 
Transilluminator (Ultra Violet Products Ltd.) and the desired DNA bands were excised for 





2.4.3 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)  
Protein separation was carried out using sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and gels were made using minigel glass plates (Bio-Rad). The 
SDS-PAGE gels contain two parts with different acrylamide concentrations, i.e. the resolving 
gel and the stocking gel. A 12% (w/v) resolving gel mixture (4 ml of 30% (w/v) acrylamide 
(National Diagnostics), 2.5 ml of lower stock solution (1.5 M Tris-HCl (pH 8.8), 0.4% (w/v) 
SDS, 0.001% (v/v) TEMED), 200 l of APS (10% (w/v)) and 3.3 ml of dH2O) was poured 
into assembled glass plates ¾ of the way up the glass plates. The resolving gel was left for 
polymerization and an isopropanol layer was added on top. After polymerization, isopropanol 
was tipped off and the of the gel was rinsed with dH2O and dried with filter paper. Another 10 
ml mixture of 4% (w/v) stacking gel mixture (1 ml of 30% (w/v) acrylamide (National 
Diagnostics), 2.5 ml of lower buffer stock solution (0.5 M Tris-HCl, pH 6.8, 0.4% (w/v) SDS, 
0.002% (v/v) TEMED), 200 l of APS (10% (w/v)) and 6.3 ml of dH2O) was poured into the 
glass plates and a comb of desired well width was inserted. The stocking gel was allowed to 
polymerise, and then the comb was removed. The glass plates were fixed in an 
electrophoresis tank with running buffer (25 mM Tris-HCl, 0.1% (w/v) SDS (v/v), 190 mM 
glycine) in the tank. Protein samples were mixed with cracking buffer and heated for 10 
minutes. The samples were centrifuged and loaded into wells along with a prestained protein 
ladder. The gel was electrophoresed with running buffer in the tanks (BioRed) at 120V for 1.5 
to 2 hours. Protein was detected by staining gels with Coomassie blue R dye (methanol 
(50%v/v), acetic acid (10%v/v) and brilliant blue R (2% (w/v)) for one hour at room 
temperature with shaking. The gel was destained using destain solution (10% (v/v) glacial 





2.5 Extraction and purification of nucleic acids 
2.5.1 Phenol/chloroform extraction of DNA 
In order to purify DNA after restriction enzyme digestion, phenol/chloroform extraction was 
used. The DNA solution was mixed with an equal volume of phenol chloroform and 
isoamylalcohol solution (25, 24 and 1 parts, respectively) (Sigma Aldrich), vortexed and 
centrifuged at 15700 g for 2 minutes. This separated the solution into two layers: the lower 
turbid layer of phenol cholorform and the upper clear aqueous layer, containing DNA. The 
upper aqueous layer was carefully transferred into a clean microfuge tube and the DNA was 
concentrated by ethanol precipitation as detailed below. 
2.5.2 Ethanol precipitation of DNA 
For ethanol precipitation, the aqueous supernatant from the phenol chloroform extraction was  
adjusted to 400 µl by adding sterile distilled water. Then 4 µl (1/100th volume) of 1M MgCl2, 
40 µl (1/10 volume) of 3 M sodium acetate (pH 5.2) and 888 µl (2 volumes) of ice cold 
absolute ethanol were added to the DNA solution and the mixture was incubated at -20°C. 
The microfuge tube was then centrifuged for 15 minutes at 4°C, the supernatant removed and 
the pellet was washed with 1 ml of ice-cold 70% (v/v) ethanol. The microfuge tube was 
centrifuged for another 10 minutes at 4°C and the supernatant was removed. The pellet was 
washed with 1 ml of ice cold 100% ethanol and centrifuged for 10 minutes at 4°C. The 
supernatant was again removed and the pellet was dried for 40-45 minutes in a vacuum drier. 
The pellet was resuspended in 20-50 µl sterile distilled water. For ethanol precipitation of 
single stranded DNA, the same precipitation method was used, except 3 M ammonium acetate 
(pH 4.8) was used instead of sodium acetate. For ethanol precipitation of RNA, the same 





2.5.3 Extraction of DNA fragments from agarose gels 
As described in section 2.4.1, DNA samples were mixed with loading dye in a ratio of 6:1 and 
run on 0.8% (w/v) agarose gel. DNA bands were visualised on High Performance Ultraviolet 
Transilluminator (Ultra Violet Products Ltd.) and excised. The excised DNA was then 
purified using a QIAquick Gel Extraction Kit (Qiagen), according to the manufacturer’s 
instructions. Extracted DNA fragments were eluted from the QIAquick columns in 50 µl of 
sterile distilled water.  
2.5.4 Electroelution of DNA fragments from polyacrylamide gels 
As described in section 2.4.2, the DNA samples were mixed with loading dye, were also run 
on 7.5% (w/v) polyacrylamide gels. DNA bands were visualised on High Performance 
Ultraviolet Transilluminator (Ultra Violet Products Ltd.) and excised from the gel. Gel slices 
were then placed into 6 mm dialysis tubing (Medicell International Ltd.), containing 200 µl of 
0.1x TBE buffer, and the ends of tubing were sealed with dialysis clips. These samples in 
dialysis tubing were subject to electroelution by passing a current through them at 30 mA for 
20-30 minutes. The buffer was removed from the dialysis tubing and transferred into a 
microfuge tube. The dialysis tubing was rinsed with 200 µl of sterile distilled water and the 
water was added to the same microfuge tube. The sample volume was adjusted to 400 µl and 
the DNA fragment was extracted from the buffer by phenol/chloroform extraction and ethanol 
precipitation (sections 2.5.1 and 2.5.2). 
2.5.5 Small-scale preparation of plasmid DNA using the QIAprep Spin miniprep kit 
For preparation of plasmid DNA, a single colony was inoculated into 5 ml of LB medium 
containing the appropriate antibiotic. The overnight culture was transferred into a 15 ml 
sterile Falcon tube and centrifuged for 5 minutes at 2844 g at room temperature. The pellet 





extracted using QIAprep Spin miniprep Kit, following the manufacturer’s instructions. 
2.5.6 Large-Scale preparation of plasmid DNA using QIAprep Spin maxiprep kit 
For preparation of large quantities of plasmid DNA a single colony was inoculated into 250 
ml of LB medium containing the appropriate antibiotic. The overnight culture (250 ml) was 
transferred into a centrifugation tube and the culture was centrifuged at 5400 gfor 15 minutes 
at 4°C. The pallet was resuspended in P1 buffer and transferred into a 50 ml falcon tube. 
Plasmid DNA was extracted using a QIAprep Spin maxiprep Kit, according to the 
manufacturer’s instructions.  
2.6 Transformation of E. coli with plasmid DNA 
2.6.1 Preparation of chemically competent cells using the CaCl2 transformation method 
A single bacterial colony was picked and inoculated into 5 ml of LB medium containing 
antibiotic, where appropriate and grown overnight at 37°C with shaking. The culture was 
diluted 1:100 into 50 ml of fresh LB medium and incubated at 37°C with shaking until 
bacteria reached the mid-logarithmic phase of growth (OD600 = 0.3 - 0.6). The culture was 
then transferred to a pre-cooled 50 ml Falcon tube, kept on ice for 10 minutes and then 
centrifuged at 2844 g at 4°C for 15 minutes. The pellet was resuspended in 25 ml of ice cold 
0.1 M CaCl2 and kept on ice for a further 30 minutes. Cells were centrifugated for 15 minutes 
at 2844 g at 4°C and the pellet was resuspended in 3.5 ml of ice cold 0.1 M CaCl2 with 10% 
(v/v) glycerol. Competent cells were kept on ice for upto 24 hours before being stored at -
80°C in 500 µl aliquots.  
2.6.2 Transformation of plasmid DNA into chemically competent cells  
For transfer of plasmid DNA into competent cells, the frozen competent cells were thawed on 





for 30 minutes. The cells were heat-shocked at 42°C for 2 minutes and then placed on ice for 
another 2 minutes. After addition of 1 ml LB medium, the cells were incubated for 1 hour at 
37°C with shaking. After incubation, the cells were centrifuged for 1 minute at 15700 g rpm 
and the pellet resuspended in approximately 100 µl of the supernatant. The resuspended pellet 
was plated onto LB agar or MacConkey agar supplemented with the appropriate antibiotic(s), 
and incubated overnight at 37°C. 
2.6.3 Preparation of electrocompetent cells 
A single bacterial colony was picked and inoculated into 5 ml of LB containing antibiotic 
where appropriate and grown overnight at 37°C with shaking. The overnight culture was then 
diluted 1:100 into 50 ml of LB and incubated at 37°C with shaking until the culture reached 
mid-logarithmic phase (OD600= 0.3 - 0.6). The culture was transferred to a pre-cooled 50 ml 
Falcon tube and centrifuged at 2844 g at 4°C for 15 minutes. The pellet was then resuspended 
in 25 ml ice-cold 10% (v/v) glycerol and this process was repeated three times to remove any 
traces of salt. Following the removal of all supernatant after the last centrifugation, the pellet 
was resuspended in 500 µl of ice-cold 10% (v/v) glycerol  and the cells were kept on ice to be 
used on the same day. 
2.6.4 Transformation of E. coli electrocompetent cells by plasmid DNA 
For electroporation, 100 µl of electrocompetent cells were mixed with 10 µl of plasmid DNA 
in a pre-cooled 2 mm electroporation cuvette (Invitrogen). The mixture was left for one 
minute in the cuvette and cells were electroporated at 2.1 kV using a Gene Pulser (BioRad). 
1 ml of pre-warmed SOC medium at 37°C was added to the cuvette and then the cells were 
transferred to a pre-warmed microfuge tube at 37°C. Cells were incubated at 37°C for one 
hour with shaking. After which they were centrifuged at 15700 g for one minute and plated at 





2.7 Recombinant DNA techniques 
2.7.1 Polymerase chain reaction (PCR) 
Phusion™ High-Fidelity DNA polymerase, Q5 DNA polymerase (New England BioLabs® 
Inc.), Biomix red DNA polymerase and Mytaq red DNA polymerase (Bioline) were used in 
the study to amplify the DNA of interest using PCR. Q5 DNA polymerase was used routinely 
due to its high fidelity. The DNA templates used in this study were from three sources; 
bacterial cell lysates, purified bacterial genomic DNA and purified bacterial plasmids.  
For a typical 50 µl reaction for Q5 DNA polymerase the reaction buffer contained 10 µl of 5x 
Q5 buffer, 10 µl of Q5 GC buffer, 10 µl of forward primer (2.5 µM), 10 µl of reverse primer 
(2.5 µM), 1 µl of 0.8 mM dNTPs (Bioline), 5 µl of of template DNA (1:100 diluted), 0.5 µl of 
Q5 DNA polymerase (New England BioLabs® Inc.) and 3.5 µl of dH2O. DNA amplification 
was performed in a thermal cycler (GeneAmp® PCR System, Applied Biosystems) and PCR 
cycling conditions are shown in the Table 2.3 and primers used in this study are detailed in 
Table 2.4. PCR products were run on agarose or polyacrylamide gels whenever the PCR 
product visualization was required. Biomix red DNA or Mytaq red DNA polymerase was 
typically used for colony PCR and error prone PCR. 
2.7.2 Colony PCR 
Colony PCR was used to screen for clones or confirm the presence of a DNA segment in a 
bacterial genome and cell lysates of candidate colonies was used as template DNA. The DNA 
template, was prepared by mixing a single colony off an agar plate in 100 µl of distilled water 
in microfuge tube which was heated at 100°C for 10 minutes. The cell debris was palleted by 
centrifugation of the microfuge tube and 5 µl of the supernatant was used as template in 50 µl 








Table 2.3 PCR cycling conditions 
 
 
Cycle Step Temp. Time Cycles 
Initial denaturation 98°C 30 s 1 
Denaturation 98°C 10 s 
25-30 Annealing x°C 30 s 
Extension 72°C 15-30 s/1 kb amplified 
Final extension 72°C 10 minutes 
1 






Table 2.4 Oligonucleotide primers (continued on pages 67-73) 
Code Sequence (5' to 3') Use 
D10520 CCCTGCGGTGCCCCTCAAG Anneals upstream of the EcoRI site in 
pRW50/ pRW224/ pRW225. Used for 




Anneals downstream of the HindIII site in 
pRW50. Used for sequencing and 
amplification of inserts in this vector. 
D78264 GGCTGTAATGTTCTGGCATTTGGTC
AGC 
Anneals downstream of the HindIII site in 
pRW50. Used for sequencing and 
amplification of inserts in this vector 
D19897 GGCGATTAAGTTGGGTAACGCCAG
GG 
Anneals downstream of the HindIII site in 
pRW225/ pRW224. Used for sequencing and 
amplification of inserts in these vectors 
D49274 GGTTGGACGCCCGGCATAGTTTTTC
AGCAGGTCGTTG 
Anneals to pRW50 sequence downstream of 





aafD upstream primer containing an EcoRI 
site for amplification of the aafD100, 






aafD downstream primer containing a 
HindIII site for amplification of the aafD100, 
aafD99, aafD98, aafD97, aafD96, aafD95 




aafD upstream primer containing an EcoRI 







Table 2.4     Oligonucleotide primers (continued) 




aafD upstream primer containing an EcoRI 





aafD upstream primer containing an EcoRI 





aafD upstream primer containing an EcoRI 





aafD upstream primer containing an EcoRI 





aafD upstream primer containing an EcoRI 




aafD upstream primer containing an EcoRI 





aafD upstream primer containing an EcoRI 




aafD upstream primer containing an EcoRI 
site for amplification of the aafD96-99N 






Table 2.4     Oligonucleotide primers (continued) 
Code Sequence (5' to 3') Use 
D78637 GGGGGGAAGCTTCATTTTATACATT
CTCCATCCTCTTTAG 
aafD downstream primer containing a 
HindIII site for amplification of the 




aafD downstream primer containing a 
HindIII site for amplification of the 




aafD downstream primer containing a 






afaB upstream primer containing an EcoRI 




afaB downstream primer containing a 





afaB upstream primer containing an EcoRI 





afaB upstream primer containing an EcoRI 





afaB upstream primer containing an EcoRI 






Table 2.4     Oligonucleotide primers (continued) 
Code Sequence (5' to 3') Use 
D80520  GTGTTTTTATCACCATTATGTGACA
TTCCTGC 
afaB upstream primer for megaprimer PCR 





afaB upstream primer for megaprimer PCR 




afaB upstream primer containing an EcoRI 




aafA upstream primer containing an EcoRI 





aafA downstream primer containing a 





aafC upstream primer containing an EcoRI 





aafC downstream primer containing a 




aggD upstream primer containing an EcoRI 




aggD upstream primer containing an EcoRI 






Table 2.4     Oligonucleotide primers (continued) 
Code Sequence (5' to 3') Use 
D80571 GGGGGGGAATTCTTAGCGTTATATG
ATTTGAGTC 
aggD upstream primer containing an EcoRI 




aggD upstream primer containing an EcoRI 




aggD upstream primer for megaprimer PCR 




aaiA upstream primer containing an EcoRI 




aaiA downstream primer containing a 




aaiA upstream primer containing an EcoRI 




aaiA upstream primer containing an EcoRI 




aaiA upstream primer containing an EcoRI 




aaiA upstream primer containing an EcoRI 






Table 2.4     Oligonucleotide primers (continued) 
Code Sequence (5' to 3') Use 
D80523 GGGGGGGAATTCCTTTCGAAAACA
TCTGTGCGGTAGC 
aaiA upstream primer containing an EcoRI 




aaiA upstream primer containing an EcoRI 
site for amplification of the aaiA98-254C-
252C promoter fragment. 
D82313 CTTTTTATGGTCTCACTATATAGAA
TCC 
aaiA upstream primer for megaprimer PCR 




aap upstream primer for megaprimer PCR 




aap upstream primer for megaprimer PCR 





Upstream primer for megaprimer PCR 





Upstream primer for megaprimer PCR 





Upstream primer for megaprimer PCR 





Upstream primer for megaprimer PCR 






Table 2.4     Oligonucleotide primers (continued) 




Upstream primer for megaprimer PCR 





Upstream primer containing an EcoRI site 
for amplification of the aggR400 to clone the 





Downstream primer containing a BamHI site 
for amplification of the aggR400 to clone the 





Upstream primer containing a XhoI site for 
amplification of the aggR401 to clone the 





Downstream primer containing a SalI site for 
amplification of the aggR401 to clone the 




Anneals to the pDOC-K plasmid upstream of 
the EcoRI restriction site and used for 





Anneals to the pDOC-K plasmid 
downstream of the SalI restriction site. Used 






polymerase, the mixture contained 25 µl of 2x reaction mix, 10 µl of forward primer (2.5 
µM), 10 µl of reverse primer (2.5 µM) (Table 2.4) and 5 µl of of template DNA (bacterial cell 
lysate). DNA amplification was performed in a thermal cycler (GeneAmp® PCR System, 
Applied Biosystems).  PCR cycling conditions are shown in the Table 2.3. 
2.7.3 Error prone PCR 
Error prone PCR was used to introduce random mutations into the aafD promoter. In this 
PCR reaction, low fidelity Taq DNA polymerase was used. For each 50 µl reaction, 
containing either Biomix Red DNA polymerase or Mytaq Red DNA polymerase, 25 µl of 2x 
reaction mix, 10 µl of forward primer (2.5 µM), 10 µl of reverse primer (2.5 µM) (Table 2.4) 
and 5 µl of of template DNA (1:100 diluted) was used. The PCR cycling conditions were as 
in Table 2.3 except the number of PCR cycles were increased from 30 to 40.  
2.7.4 Megaprimer PCR 
Megaprimer PCR was used to introduce site directed mutations into the recombinant DNA 
fragments at positions that were not adjacent to suitable restriction sites (e.g. the 
afaB320C318C promoter fragment). This PCR reaction involved two separate PCR reactions, 
and require 3 separate primers, two primers which anneal to the ends of the DNA fragment 
and a third primer that annealed internally and contained the desired substitution. The first 
round of PCR used the internal annealing primer and one of the end primers. After the first 
round of PCR, the product was run on a polyacrylamide gel, and purified (sections 2.5.1 and 
2.5.2). In the second round of PCR, the purified PCR product from the first round was used as 
one of the primers with the second end primer in the reaction to generate the full length 






2.7.5 Restriction digestion of DNA  
Both plasmid DNA and purified PCR products were digested using restriction enzymes for 
DNA cloning. For high copy number plasmids, 12 µl of a plasmid DNA miniprep was 
digested in a final volume of 60 µl using 1.5 µl of each restriction enzyme (New England 
BioLabs® Inc.) in 1x NEB 4 buffer or cutsmart buffer and each reaction mixture was 
incubated at 37°C for 3 hours. The digested vector was also incubated with 1 µl of calf 
intestinal alkaline phosphatase (CIP) (New England BioLabs® Inc.) for another one hour to 
avoid re-ligation of plasmid by removing terminal 5' phosphate groups. The digested DNA 
was run on a 0.8% (w/v) agarose gel and DNA bands were excised and purified using the 
Qiagen Gel Extraction Kit (section 2.5.3). 
For low copy plasmids (e.g. pRW50), nine DNA minipreps were pooled together and 360 µl 
of this miniprep DNA was used with 40 µl of NEB 4 or cutsmart buffer and 10 µl of each 
restriction enzyme to make a final volume of 400 µl. The mixture was incubated at 37°C for 4 
hours and to remove the terminal 5' phosphate groups, 4 µl CIP was added and incubated for 
another hour at 37°C. The digested vector was then purified using phenol/chloroform 
extraction and ethanol precipitation (sections 2.5.1 and 2.5.2). 
For purified PCR products, ethanol precipitated DNA was resuspended in 48 µl of sterile 
distilled water and 6 µl of 10x NEB buffer 4 (or cutsmart buffer) and 3 µl of each restriction 
enzyme was added to make a final volume of 60 µl. The mixture was incubated at 37°C for 
2.5 hours. Digested DNA fragments were run on either a polyacrylamide gel or an agarose gel 






The ligation reaction is a process in which an insert is melded to an appropriate vector. DNA 
ligation was used in this study to clone the promoter fragments or genes of interest into 
appropriate vectors. For ligation reactions, a final volume of 20 µl was used containing, 5-
10 µl of restricted insert DNA, 3-7 µl of vector DNA, 1 µl T4 DNA ligase (New England 
BioLabs® Inc.), 2 µl 10x T4 DNA ligase buffer and a suitable amount of sterile dH2O where 
required to make a final volume of 20 µl. Once setup, ligation mixes were initially kept on ice 
for 10 minutes and then incubated for at least 10 minutes at room temperature. The mixture 
was then placed on ice for 5 minutes before the addition of 100 µl of CaCl2 competent cells. 
The transformation was performed as in section 2.6.2. In order to select for transformants, 
cells were plated onto MacConkey agar with lactose, supplemented with the appropriate 
antibiotic. To screen for successful candidates, transformants were grown overnight and 
plasmid minipreps were prepared. Plasmids were digested with appropriate restriction 
enzymes to excise the cloned fragment and run on 7.5% (w/v) polyacrylamide gel or 0.8% 
(w/v) agarose gel to check for the presence of an insert of the expected size.  
2.7.7 DNA sequencing 
Plasmid-to-profile sequencing was carried out by the Functional Genomics and Proteomics 
Laboratory, University of Birmingham, UK. For sequencing of a fragment cloned into a low 
copy plasmid, 7 µl of template was used with 3 µl of primer (1 µM). For a high copy number 
plasmid, 3 µl of template was used with 3 µl of primer (1 µM) and the volume was adjusted 





2.8 Strategy to locate potential AggR-binding sites in promoter fragments  
DNA target sites for the binding of AggR and the closely related Rns  protein have been 
previously investigated, using in vivo and in vitro approaches (Munson and Scott, 1999; 
Morin et al., 2010). From these studies, it has been proposed that the potential AggR-binding 
site consensus sequence is 5-AnnnnnnTATC-3 on the forward strand and thus, 5-
GATAnnnnnnT-3 on the reverse strand. Therefore, based on this consensus, the promoter 
fragments used in this work were screened for potential AggR-binding sites on both strands  
allowing for one mismatch to the concensus sequence. When from the deletion analysis 
predicted sites were found to be inessential using deletion analysis experiments, they were 
discounted, and potential AggR-binding sequence present in the smallest AggR-regulated 
fragment was analysed by mutational analysis to identify the functional site.  
2.9. Cloning of promoter fragments and/or target genes 
All the promoter fragments or target genes used in this study were amplified from EAEC 
genome using by PCR. For nested deletions, in-phase deletions or site directed mutations, the 
plasmid containing the starting wild type promoter fragment was used as a template. A list of 
all the primers used to generate each DNA fragment is shown in Table 2.4. PCR primers were 
designed such that the forward and reverse primers incorporate restriction enzyme sites 
upstream and downstream of the amplified target region, respectively. The cloning of each 
DNA fragment was, therefore, achieved using these restriction sites to introduce inserts into 
the relevant DNA plasmid. 
2.9.1 Construction of pRW50 derivatives  





details are in Figure 2.1) and DNA was digested with EcoRI and HindIII, treated with alkaline 
phosphatase and purified as in sections 2.5.1 and 2.5.2. DNA fragments were amplified, using 
the primers detailed in the Table 2.4, and digested with EcoRI and HindIII. Each EcoRI-
HindIII promoter fragment was then ligated into pRW50 vector (sections 2.6.1 and 2.6.2).  
To investigate the fimbrial operon promoters of EAEC 042, approximately, 400 bp of DNA 
was amplified upstream of aafD, aafA, afaB and aafC using the relevant forward and reverse 
primers (Figure 2.2 and Table 2.4). The customary numbering of, bases in relation to 
transcription start site was not followed because the transcription start sites of these promoters 
are not confirmed yet. The DNA fragments afaB100, aafC100, aafD100 and aafA100 are 
shown in Figure 2.2, were cloned into the lacZ expression vector pRW50 using EcoRI and 
HindIII sites. In order to locate the aafD promoter deletion analysis of aafD100 promoter 
fragment was carried out. The primers used for deletion analysis are described in the Table 
2.4 and pRW50/aafD100 was used as template (Figure 2.3). This deletion analysis generated 
promoter fragments aafD99 to aafD94. Point mutations were introduced into the aafD 
promoter fragment to confirm the position of promoter elements and AggR-binding sites. This 
mutation analysis generated promoter fragments aafD96-90C, aafD96-92C90C and aafD96-
65C (Figure 2.4). 
In order to investigate afaB promoter in more detail, a series of nested deletions were also 
made using PCR with the relevant primers listed in the Table 2.4 and pRW50/afaB100 as a 
template. The DNA sequence of these afaB promoter fragments (afaB99 to afaB97) are 
detailed in Figure 2.5. Fragments were cloned into pRW50, as transcription fusions, again 
using EcoRI and HindIII sites. To investigate the promoter -10 hexamer element and the 
AggR-binding site that control expression, point mutations were introduced into the afaB100 









Figure 2.1 Map of plasmid pRW50 
The figure shows a map of the pRW50 lacZ expression vector and its associated open reading frames. 
EcoRI and HindIII sites are located upstream of the lacZYA operon and are used to clone in promoter 






afaB100 (413 bp) 
     413          400 
      .  .         .         .         .         .         .         .      
GAATTCGACATGATAACGAATTAAGCAAGGAGGCTGAACAATTTATAATAAGATAACAAAATACTCCTGTTTTAT 
                                           300 
    .         .         .         .         .         .         .         . 
ATTTTAATGATTCCGTGTTTTTATTATCATTATGTGACATTCCTGCACTGTATCTTTAATAGGTGGGCTGGGCAG 
                                                                    200 
         .         .         .         .         .         .         .      
GTTTGCTATCGTAGATGGACAATAATAAATTAAGGATAAATAATAATTGTTAATTACCTTTCACAGGTAATGCAG 
 
    .         .         .         .         .         .         .         . 
ATGGATTAAAGAAAGTGTGTCGAATAATTTTTACGGAGCTTTCTGGGCTGTATGAATATGCGGGACGTGTTTATA 
                   100 
         .         .         .         .         .         .         .   
TTCGGTGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAG 
                                           1 







aafC100 (410 bp) 
     410       400 
      .         .         .         .         .         .         .      
GAATTCAGGCTGACGATAAATGGGAGGAAGGCGATAAGATGATGCTGAATGTACAGCTTTCATTAAGTTATTGTA 
                                        300 
 .         .         .         .         .         .         .         . 
TCAAACTATTTGTTCGCCCGCCAAGAGTGAAGGGACGTCCTGATGAGATGGCAGGAAAAGTAGAGTGGCAGAAGT 
                                                                 200 
      .         .         .         .         .         .         .       
CAGTAACAAACTGAAGGGAATAAACCCGCACCATTTTATATCAATATGTCTGAACTAATGGTGGGAACGGTAAGG 
 
 .         .         .         .         .         .         .         . 
TCCAGTGGACGGTGGTGACGGATTATGGTGGAAGTAGTAAGCAATTTGAGGCCGATCTTAAGGGGTAATAATCTA 
               100 
      .         .         .         .         .         .         . 
GTTAATCATTTTTTCATGAGTTATGAAAGGGTAATAATCCGTGTGTGAATTTTCTCTGTGGCAGATAAAGACAAG 
                                        1 













aafD 100(433 bp) 
     433                              400 
      .  .         .         .         .         .         .         .    
GAATTCGCGTAAATAGTTGGAAAAGTTCATGCAGCATGTGGATGCTTACAGCAGATGGTATAACGAGCGGCGT 
                                                                 300 
      .         .         .         .         .         .         .          
ATAAAATTATCGCTGGGTGCAGTCAGCCCTGAAATGTACCGCCAACAATGCGGGCTGGCATAATAAAGCAGTCCA 
 
 .         .         .         .         .         .         .         . 
GGAAATCGTCCGCATCCCCTAACGGTCAAACATCGTGGCCTTGACAGCTCCCTTGGCGCGTAGTATTGCCAACTG 
               200 
      .         .         .         .         .         .         .         
AATCCCCCGTCAATACGGTTCTCACCGTATGCTCACTGCTTACAATTGCCTGACAGTAGCAACCAACTGAGAGGA 
                                        100 
 .         .         .         .         .         .         .         .  
TGCTATCTCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAG 
                                                                 1 






aafA100 (433 bp) 
     433                              400 
      .  .         .         .         .         .         .         .  
GAATTCAAATCAACAAACTCTAATTCTAGTACAGAACGAAAAACACGCCGTATTACAGAAAATATAAACCAGTTA 
                                                               300 
    .         .         .         .         .         .         .         . 
CTTGGTCTATGCGGATATATAAGTGCATCATATAATACATCTTGGAATAATATCCTTCTTACTAGATTACTCATA 
 
         .         .         .         .         .         .         .     
CAACCGTAATATAATTGATTACTATGGTAACAAGAAAATCTCAAGAAACCTTATGGCGACATACATATCAAAAAA 
             200 
    .         .         .         .         .         .         .         .    
ATAGTTTCACAGCACAAGATACTAGTATGCATGAATTATTAAGTACTGGACCACCGAAATGGCCATTCTTCTGTT 
                                      100 
         .         .         .         .         .         .         .          
TCAGGTCAGAACGTATCGTAATGATAGAGTGTAAATAAAACGCTCTTTCTTTCTGTAGATGAATAAATATATACG 
                                                              1 
    .         .         .         .         .         .       . 
GAAACCACCTGTATATTTAAATGAAAAATAGATGTATTTTTAGAGGTTGACATGAAAAAAATCAAAGCTT 
Figure 2.2 The DNA base sequence upstream of the genes encoding the AAF/II 
A. The panel shows the 413 bp DNA sequence of the afaB100 promoter fragment.  
B. The panel shows the 410 bp DNA sequence of the aafC100 promoter fragment.  
C. The panel shows the 433 bp DNA sequence of the aafD100 promoter fragment.  
D. The panel shows the 433 bp DNA sequence of the aafA100 promoter fragment.  
In all panels open reading frame sequence is highlighted blue, the potential AggR-binding sites are 






aafD100 (433 bp) 
        430       420       410       400       390       380       370 
      .  .         .         .         .         .         .         .    
GAATTCGCGTAAATAGTTGGAAAAGTTCATGCAGCATGTGGATGCTTACAGCAGATGGTATAACGAGCGGCGTAT 
   360       350       340       330       320       310       300       290 
    .         .         .         .         .         .         .         .  
AAAATTATCGCTGGGTGCAGTCAGCCCTGAAATGTACCGCCAACAATGCGGGCTGGCATAATAAAGCAGTCCAGG 
        280       270       260       250       240       230       220 
         .         .         .         .         .         .         . 
AAATCGTCCGCATCCCCTAACGGTCAAACATCGTGGCCTTGACAGCTCCCTTGGCGCGTAGTATTGCCAACTGAA 
   210       200       190       180       170       160       150      140 
    .         .         .         .         .         .         .         . 
TCCCCCGTCAATACGGTTCTCACCGTATGCTCACTGCTTACAATTGCCTGACAGTAGCAACCAACTGAGAGGATG 
        130       120       110       100        90        80        70 
         .         .         .         .         .         .         .  
CTATCTCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTA 
    60        50        40        30        20        10       1 







aafD99 (333 bp) 
        330       320       310       300       290       280       270 
         .         .         .         .         .         .         .     
GAATTCATGTACCGCCAACAATGCGGGCTGGCATAATAAAGCAGTCCAGGAAATCGTCCGCATCCCCTAACGGTC 
   260       250       240       230       220       210       200      190 
    .         .         .         .         .         .         .         . 
AAACATCGTGGCCTTGACAGCTCCCTTGGCGCGTAGTATTGCCAACTGAATCCCCCGTCAATACGGTTCTCACCG 
        180       170       160       150       140       130       120 
         .         .         .         .         .         .         . 
TATGCTCACTGCTTACAATTGCCTGACAGTAGCAACCAACTGAGAGGATGCTATCTCACCTGATTTATTCAATAA 
   110       100        90        80        70        60        50       40 
    .         .         .         .         .         .         .         . 
AGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAAAAGCC 
         30        20        10       1 


















        230       220       210       200       190       180       170  
         .         .         .         .         .         .         . 
GAATTCCGTAGTATTGCCAACTGAATCCCCCGTCAATACGGTTCTCACCGTATGCTCACTGCTTACAATTGCCTG 
 
   160       150       140       130       120       110       100       90 
    .         .         .         .         .         .         .         . 
ACAGTAGCAACCAACTGAGAGGATGCTATCTCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTAT 
 
         80        70        60        50       40         30        20 
         .         .         .         .         .         .         . 
CTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAAAAGCCTCTAAAGAGGATGGAGAATGTATAA 
    10       1 







aafD97 (133 bp) 
        130       120       110       100       90         80        70 
         .         .         .         .         .         .         .  
GAATTCCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTA 
    60        50        40        30        20        10       1 







aafD96 (113 bp) 
        110       100        90        80        70        60        50 
         .         .         .         .         .         .         .   
GAATTCGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAA 
    40        30        20        10       1 
















aafD95 (93 bp) 
         90        80        70        60        50        40        30 
         .         .         .         .         .         .         .   
GAATTCTTATCTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAAAAGCCTCTAAAGAGGATGGA 
    20        10       1 








aafD94 (73 bp) 
         70        60        50        40        30        20        10 
         .         .         .         .         .         .         .   
GAATTCTTTTAAGTAGCATATTAACTTAATCGTAAAAGCCTCTAAAGAGGATGGAGAATGTATAAAATGAAAATA 
   1 
   . 
CGGAAAGCTT 
 
Figure 2.3 DNA base sequence of different aafD promoter fragments 
A. The panel shows DNA sequence of the 433 bp aafD100 promoter fragment.  
B. The panel shows DNA sequence of the 333 bp aafD99 promoter fragment. 
C. The panel shows DNA sequence of the 233 bp aafD98 promoter fragment. 
D. The panel shows DNA sequence of the 133 bp aafD97 promoter fragment.  
E. The panel shows DNA sequence of the 113 bp aafD96 promoter fragment. 
F. The panel shows DNA sequence of the 93 bp aafD95 promoter fragment. 
G. The panel shows DNA sequence of the 73 bp aafD94 promoter fragment. 
The aafD open reading frame sequence is highlighted blue, the potential AggR-binding sites are green 










        110       100        C        80        70        60        50 
         .         .                  .         .         .         .   
GAATTCGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAA 
    40        30        20        10       1 








        110       100      C C         80        70        60        50 
         .         .                 .         .         .         .   
GAATTCGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAA 
    40        30        20        10       1 








        110       100        90        80        70   C    60        50 
         .         .         .         .         .        .         .   
GAATTCGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTAGCATATTAACTTAATCGTAA 
    40        30        20        10       1 
    .         .         .         .        . 
AAGCCTCTAAAGAGGATGGAGAATGTATAAAATGAAAATACGGAAAGCTT 
 
Figure 2.4 The DNA base sequence of aafD96 promoter fragment carrying point 
mutations 
A. The panel shows the DNA sequence of the aafD96 promoter fragment with arrows that show the 
position of the substitution at position 90 (T to C) carried by the aafD96-90C promoter fragment.  
B. The panel shows the DNA sequence of the aafD96 promoter fragment with arrows that show the 
position of the substitution at positions 90 and 92 (Ts to Cs) carried by the aafD96-90C92C promoter 
fragment. 
C. The panel shows the DNA sequence of the aafD96 promoter fragment with arrows that show the 
position of the substitution at position 65 (A to C) carried by the aafD96-65C promoter fragment. 
The aafD open reading frame sequence is highlighted blue, the potential AggR-binding sites green, the 






afaB100 (413 bp) 
        410       400       390       380       370       360       350 
         .         .         .         .         .         .         .      
GAATTCGACATGATAACGAATTAAGCAAGGAGGCTGAACAATTTATAATAAGATAACAAAATACTCCTGTTTTAT 
   340       330       320       310       300       290       280      270 
    .         .         .         .         .         .         .         . 
ATTTTAATGATTCCGTGTTTTTATTATCATTATGTGACATTCCTGCACTGTATCTTTAATAGGTGGGCTGGGCAG 
        260       250       240       230       220       210       200 
         .         .         .         .         .         .         .      
GTTTGCTATCGTAGATGGACAATAATAAATTAAGGATAAATAATAATTGTTAATTACCTTTCACAGGTAATGCAG 
   190       180       170       160       150       140       130      120 
    .         .         .         .         .         .         .         . 
ATGGATTAAAGAAAGTGTGTCGAATAATTTTTACGGAGCTTTCTGGGCTGTATGAATATGCGGGACGTGTTTATA 
        110        100       90        80        70        60        50 
         .         .         .         .         .         .         .   
TTCGGTGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAG 
    40        30        20        10       1 







afaB99 (313 bp) 
        310       300       290       280       270       260       250    
         .         .         .         .         .         .         .      
GAATTCATGTGACATTCCTGCACTGTATCTTTAATAGGTGGGCTGGGCAGGTTTGCTATCGTAGATGGACAATAA 
   240       230       220       210       200       190       180      170 
    .         .         .         .         .         .         .         . 
TAAATTAAGGATAAATAATAATTGTTAATTACCTTTCACAGGTAATGCAGATGGATTAAAGAAAGTGTGTCGAAT 
        160       150       140       130       120       110       100      
         .         .         .         .         .         .         .      
AATTTTTACGGAGCTTTCTGGGCTGTATGAATATGCGGGACGTGTTTATATTCGGTGATGTATTGGTAGGGGCCT 
    90        80        70        60        50        40        30       20 
    .         .         .         .         .         .         .         . 
TATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAGTCGAAATAAAAGGGAGCTAGAAGCC 
         10       1 



















afaB98 (213 bp) 
        210       200       190       180       170       160       150 
         .         .         .         .         .         .         .      
GAATTCCCTTTCACAGGTAATGCAGATGGATTAAAGAAAGTGTGTCGAATAATTTTTACGGAGCTTTCTGGGCTG 
 
   140       130       120       110       100        90        80       70 
    .         .         .         .         .         .         .         . 
TATGAATATGCGGGACGTGTTTATATTCGGTGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATT 
 
         60        50        40        30        20        10       1 








        110       100        90        80        70        60        50 
         .         .         .         .         .         .         . 
GAATTCGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAG 
    40        30        20        10       1 
    .         .         .         .        . 
TCGAAATAAAAGGGAGCTAGAAGCCAACTCCAGAGTATTTTCCCAAGCTT 
 
Figure 2.5 The DNA base sequences of the afaB nested promoter deletions 
A. The panel shows the DNA sequence of the 413 bp afaB100 promoter fragment.  
B. The panel shows the DNA sequence of the 313 bp afaB99 promoter fragment. 
C. The panel shows the DNA sequence of the 213 bp afaB98 promoter fragment. 
D. The panel shows the DNA sequence of the 113 bp afaB97 promoter fragment.  
The afaB pseudogene is highlighted blue, the potential AggR-binding sites are green and EcoRI and 







        410       400       390       380       370       360       350 
         .         .         .         .         .         .         .      
GAATTCGACATGATAACGAATTAAGCAAGGAGGCTGAACAATTTATAATAAGATAACAAAATACTCCTGTTTTAT 
   340       330        C C      310       300       290       280      270 
    .         .                 .         .         .         .         . 
ATTTTAATGATTCCGTGTTTTTATTATCATTATGTGACATTCCTGCACTGTATCTTTAATAGGTGGGCTGGGCAG 
        260       250       240       230       220       210       200 
         .         .         .         .         .         .         .      
GTTTGCTATCGTAGATGGACAATAATAAATTAAGGATAAATAATAATTGTTAATTACCTTTCACAGGTAATGCAG 
   190       180       170       160       150       140       130      120 
    .         .         .         .         .         .         .         . 
ATGGATTAAAGAAAGTGTGTCGAATAATTTTTACGGAGCTTTCTGGGCTGTATGAATATGCGGGACGTGTTTATA 
        110        100       90        80        70        60        50 
         .         .         .         .         .         .         .   
TTCGGTGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAG 
    40        30        20        10       1 






        410       400       390       380       370       360       350 
         .         .         .         .         .         .         .      
GAATTCGACATGATAACGAATTAAGCAAGGAGGCTGAACAATTTATAATAAGATAACAAAATACTCCTGTTTTAT 
   340       330       320       310       300       290       280      270 
    .         .         .         .         .        .         .         . 
ATTTTAATGATTCCGTGTTTTTATTATCATTATGTGACATTCCTGCACTGTATCTTTAATAGGTGGGCTGGGCAG 
        260       250       240       230       220       210       200 
         .         .         .         .         .         .         .      
GTTTGCTATCGTAGATGGACAATAATAAATTAAGGATAAATAATAATTGTTAATTACCTTTCACAGGTAATGCAG 
   190       180       170       160       150       140       130      120 
    .         .         .         .         .         .         .         . 
ATGGATTAAAGAAAGTGTGTCGAATAATTTTTACGGAGCTTTCTGGGCTGTATGAATATGCGGGACGTGTTTATA 
        110        100       90        80        70        60        50 
         .         .         .         .         .         .         .   
TTCGGTGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAG 
    40        30        20        10       1 
    .         .         .         .        . 
TCGAAATAAAAGGGAGCTAGAAGCCAACTCCAGAGTATTTTCCCAAGCTT 
Figure 2.6 The DNA base sequence of afaB100 promoter fragment carrying various 
point mutations 
A. The panel shows the DNA sequence of the afaB100 promoter fragment and arrows indicate the 
base substitutions introduced into the AggR-binding site at positions 320 and 318 (Ts to Cs), used to 
generate the afaB100-320C318C.  
B. The panel shows the DNA sequence of the afaB100 promoter fragment and arrows indicate the 
base substitutions introduced into the AggR-binding site at positions 293 (A to C), used to generate 
the afaB100-320C318C.  
The afaB pseudogene sequences are highlighted blue, the potential AggR-binding sites are green, -10 





determine if another promter was present downstream of the afaB promoter, all the sequence 
to aafC gene was cloned, using relevant primers from the Table 2.4. This generated afaBC100 
and afaBC99 fragments and these were cloned into pRW50 using EcoRI-HindIII (Figure 2.7).  
To examine the regulation of the fimbrial genes in EAEC strain 17-2, the DNA upstream of 
aggD was investigated. A promoter fragment from another EAEC strain 17-2 was 
investigated for AggR-binding site. A promoter fragment of 413 bp, named aggD100, was 
cloned into pRW50 and was acquired from Douglas Browning. In order to investigate the 
promoter elements and AggR-binding site, nested deletions were made using relevant primers 
from the Table 2.4 and pRW50/aggD100 as template. This generated aggD50 to aggD48 
promoter fragments detailed in Figure 2.8. The point mutations were made in order to confirm 
the AggR-binding site and promoter elements of aggD. To make the site directed mutations, 
the relevant primers were used from Table 2.4 and pRW50/aggD49 was used as template to 
generate aggD49-86C and aggD49-60C promoter fragments (Figure 2.9). 
To investigate the promoter controlling the expression of the aai T6SS system, the promoter 
fragment aaiA100 (479 bp) was cloned into pRW50 using EcorRI and HindIII sites and this 
was provided by Douglas Browning (Figure 2.10). For investigation of promoter element and 
AggR-binding site, a deletion analysis of aaiA100 fragment was performed in order to 
identify minimum DNA fragment with promoter activity. The primer used for deletion 
analysis are detailed in the Table 2.4 and pRW50/aaiA100 was used as template. This 
deletion analysis resulted in aaiA99 to aaiA95 promoter fragments (Figure 2.10). In order to 
confirm the AggR-binding site and the promoter elements, site directed point mutations were 
made using primers listed in the Table 2.4 and pRW50/aaiA98 as template generating 


































































































Figure 2.7 DNA base sequences of the promoter fragments between afaB100 and aafC  
A. The panel shows the DNA sequence of the 413 bp afaB100 promoter fragment contains afaB (red) 
and upstream of afaB sequence (black). 
B. The panel shows the 1088 bp afaBC100 promoter fragment which contains the DNA sequence 
carried by afaB (red), aafC (blue) fragment, and the upstream of afaB pseudogene and aafC sequence 
(black). 
C. The panel shows the 688 bp afaBC99 promoter fragment which contains afaB pseudogene 
sequence (red), aafC (blue), amd the upstream of aafC sequence (black). 
D. The panel shows the 410 bp aafC100 promoter fragment, contains part of afaB (red), aafC (blue) 
and upstream of aafC sequence (black). 






aggD100 (413 bp) 
        410       400       390       380       370       360       350 
         .         .         .         .         .         .         . 
GAATTCTTCTGGTGCTTCAGGTGTGTGACATGGGAACTCATTCTGGATGGTTACTCTGAAAGCTCATATTCTGCC 
   340       330       320       310       300       290       280      270 
    .         .         .         .         .         .         .         . 
ACACCCCGATTTGCAGCCTCCAGGCTGCCGTGGTTCAGGAAATCGTCCACATCCCCTTAACGGACTTCGGGGGAA 
        260       250       240       230       220       210       200 
         .         .         .         .         .         .         .  
AACGTGTATTTTTCGTTATCCTATTTACCTCTTTCAGGGAGTTTAGTTTCCAGGATTTCCGGGACGGCCTAGCTA 
   190       180       170       160       150       140       130      120 
    .         .         .         .         .         .         .         . 
ATAACGTGATAAATAATTATCTTTATGCGAAAAGTGTAATTTTTGGAGAAAATGGGGGCGGAATCCTAGTGTTAG 
        110       100        90        80        70        60        50 
         .         .         .         .         .         .         .   
AAGATTGAAATATGTTAAATAATGCTATTTTTTTAGCGTTATATGATTTGAGTCTTTATATAATCAAGTTCAAGT 
    40        30        20        10       1 







aggD99 (145 bp) 
          140       130       120       110       100        90        80    
           .         .         .         .         .         .         . 
GAATTCAAATGGGGGCGGAATCCTAGTGTTAGAAGATTGAAATATGTTAAATAATGCTATTTTTTTAGCGTTATA 
      70        60        50        40        30        20        10 
      .         .         .         .         .         .         .   
TGATTTGAGTCTTTATATAATCAAGTTCAAGTTCAAGTTCAAGTTCAAGTTCAAGTGATAGCGATGAAGATTCGA 
1 



























aggD98 (108 bp) 
             100        90        80        70        60        50       40   
              .         .         .         .         .         .         . 
GAATTCATGTTAAATAATGCTATTTTTTTAGCGTTATATGATTTGAGTCTTTATATAATCAAGTTCAAGTTCAAG 
         30        20        10       1 







aggD97 (87 bp) 
             80        70        60        50        40        30       20 
             .         .         .         .         .         .         . 
GAATTCTTAGCGTTATATGATTTGAGTCTTTATATAATCAAGTTCAAGTTCAAGTTCAAGTTCAAGTTCAAGTGA 
        10       1 
        .        .                   
TAGCGATGAAGATTCGAAAAGCTT  
Figure 2.8 The DNA base sequences of the aggD nested promoter deletions 
A. The panel shows the 413 bp DNA sequence of the aggD100 promoter fragment cloned from EAEC 
strain 17-2. 
B. The panel shows the 145 bp DNA sequence of the aggD99 promoter fragment cloned from EAEC 
strain 17-2. 
C. The panel shows the 108 bp DNA sequence of the aggD98 promoter fragment cloned from EAEC 
strain 17-2. 
D. The panel shows the 87 bp DNA sequence of the aggD97 promoter fragment cloned from EAEC 
strain 17-2.  
The aggD open reading frame sequence is highlighted blue, the potential AggR-binding sites are green 








             100        90        80        70        60        50       40   
              .         .        .         .         .         .         . 
GAATTCATGTTAAATAATGCTATTTTTTTAGCGTTATATGATTTGAGTCTTTATATAATCAAGTTCAAGTTCAAG 
         30        20        10       1 








             100        90        80        70        C         50       40   
              .         .         .         .                  .         . 
GAATTCATGTTAAATAATGCTATTTTTTTAGCGTTATATGATTTGAGTCTTTATATAATCAAGTTCAAGTTCAAG 
         30        20        10       1 
         .         .         .        .        
TTCAAGTTCAAGTTCAAGTGATAGCGATGAAGATTCGAAAAGCTT 
Figure 2.9 The DNA base sequences of the aggD98 promoter fragment carrying 
different point mutations 
A. The panel shows the DNA sequence of the aggD98 promoter fragment, with the DNA substitution 
introduced at position 86 (T to C) used to disrupt the AggR-binding site in the aggD98-86C promoter 
fragment. 
B. The panel shows the DNA sequence of the aggD98 promoter fragment, with the DNA substitution 
introduced at position 60 (A to C) used to disrupt the AggR-binding site in the aggD98-60C promoter 
fragment. 
The aggD open reading frame sequence is highlighted blue, the AggR-binding site is green, the 






aaiA100 (479 bp) 
              470       460       450       440       430       420 
               .         .         .         .         .         .      
GAATTCTCCTTTGTTTTATGGATAGTTTTCTGCATCAGGCGTCGTTCTGTTCTGGGGATTGGTGTTATGATCGGC 
410      400       390       380       370       360       350       340 
.         .         .         .         .         .         .         .      
ATCGCTCAGTCCGGTTGGTGATTTTTTCTTTTTGGCGATTGATCAGATCGCACAATCCGGGCTGAGTTCCCTCAA 
    330       320       310       300       290       280       270 
     .         .         .         .         .         .         .      
AGTGACCTACTATTCCGCGCAGCTATTTAGTTAGTAAATACGAAAAATTATATAGAGTTATATCATTAATCAGCA 
260      250       240       230       220       210       200       190 
.         .         .         .         .         .         .         .      
AAAATGTATCACATGCTCACTTTCTTTTTATGGTATCACTATATAGAATCCATGAATATAACAAGAGATTGATAC 
    180       170       160       150       140       130       120 
     .         .         .         .         .         .         .      
AATCTTTTGCCAAAGATATAACTTTATATCAGATATTTTCACTTTCGAAAACATCTGTGCGGTAGCTATGGTATT 
110       100        90        80        70        60        50       40 
.         .         .         .         .         .         .         .      
TAGGTCATATAATTATGCTATGTTCATCAATATTATGATAGTAGATTATAGTGTTCTTAATAAAAAAGAATTTAA 
     30        20        10       1 







aaiA99 (307 bp) 
            300       290       280       270       260       250       240 
             .         .         .         .         .         .         . 
GAATTCAGTTAGTAAATACGAAAAATTATATAGAGTTATATCATTAATCAGCAAAAATGTATCACATGCTCACTT 
       230       220       210       200       190       180       170 
        .         .         .         .         .         .         .      
TCTTTTTATGGTATCACTATATAGAATCCATGAATATAACAAGAGATTGATACAATCTTTTGCCAAAGATATAAC 
  160       150       140       130       120       110       100       90 
   .         .         .         .         .         .         .         .  
TTTATATCAGATATTTTCACTTTCGAAAACATCTGTGCGGTAGCTATGGTATTTAGGTCATATAATTATGCTATG 
        80        70        60        50        40        30        20         
        .         .         .         .         .         .         .      
TTCATCAATATTATGATAGTAGATTATAGTGTTCTTAATAAAAAAGAATTTAAAAGCTGTTTGTAGGATAGAAAC 
   10       1 



















       270       260       250       240       230       220       210     
        .         .         .         .         .         .         .      
GAATTCCATTAATCAGCAAAAATGTATCACATGCTCACTTTCTTTTTATGGTATCACTATATAGAATCCATGAAT 
  200       190       180       170       160       150       140       130 
   .         .         .         .         .         .         .         .  
ATAACAAGAGATTGATACAATCTTTTGCCAAAGATATAACTTTATATCAGATATTTTCACTTTCGAAAACATCTG 
       120       110       100        90        80        70        60 
        .         .         .         .         .         .         .      
TGCGGTAGCTATGGTATTTAGGTCATATAATTATGCTATGTTCATCAATATTATGATAGTAGATTATAGTGTTCT 
   50        40        30        20        10       1 







aaiA97 (251 bp) 
      250       240       230       220       210       200       190 
       .         .         .         .         .         .         .  
GAATTCCACATGCTCACTTTCTTTTTATGGTATCACTATATAGAATCCATGAATATAACAAGAGATTGATACAAT 
 180       170       160       150       140       130       120       110 
  .         .         .         .         .         .         .         .      
CTTTTGCCAAAGATATAACTTTATATCAGATATTTTCACTTTCGAAAACATCTGTGCGGTAGCTATGGTATTTAG 
      100        90        80        70        60        50        40 
       .         .         .         .         .         .         .  
GTCATATAATTATGCTATGTTCATCAATATTATGATAGTAGATTATAGTGTTCTTAATAAAAAAGAATTTAAAAG 
  30        20        10       1 






















aaiA96 (224 bp) 
         220       210       200       190       180       170       160        
          .         .         .         .         .         .         .  
GAATTCCACTATATAGAATCCATGAATATAACAAGAGATTGATACAATCTTTTGCCAAAGATATAACTTTATATC 
    150       140       130       120       110       100        90 
     .         .         .         .         .         .         .      
AGATATTTTCACTTTCGAAAACATCTGTGCGGTAGCTATGGTATTTAGGTCATATAATTATGCTATGTTCATCAA 
80        70        60        50        40        30        20        10 
.         .         .         .         .         .         .         .  
TATTATGATAGTAGATTATAGTGTTCTTAATAAAAAAGAATTTAAAAGCTGTTTGTAGGATAGAAACATGAGCAA 
    1 




aaiA95 (144 bp) 
         140       130       120       110       100        90        80 
          .         .         .         .         .         .         .      
GAATTCCTTTCGAAAACATCTGTGCGGTAGCTATGGTATTTAGGTCATATAATTATGCTATGTTCATCAATATTA 
     70        60        50        40        30        20        10       1 






Figure 2.10 The DNA base sequences of the aaiA nested promoter deletion 
A. The panel shows the DNA sequence of the 479 bp aaiA100 promoter fragment.  
B. The panel shows the DNA sequence of the 307 bp aaiA99 promoter fragment. 
C. The panel shows the DNA sequence of the 272 bp aaiA98 promoter fragment. 
D. The panel shows the DNA sequence of the 251 bp aaiA97 promoter fragment. 
E. The panel shows the DNA sequence of the 224 bp aaiA96 promoter fragment. 
F. The panel shows the DNA sequence of the 144 bp aaiA95 promoter fragment. 
The aaiA open reading frame sequence is highlighted blue, the potential AggR-binding sites are green 






       270       260    C C250       240       230       220       210     
        .         .       .         .         .         .         .      
GAATTCCATTAATCAGCAAAAATGTATCACATGCTCACTTTCTTTTTATGGTATCACTATATAGAATCCATGAAT 
  200       190       180       170       160       150       140       130 
   .         .         .         .         .         .         .         .  
ATAACAAGAGATTGATACAATCTTTTGCCAAAGATATAACTTTATATCAGATATTTTCACTTTCGAAAACATCTG 
       120       110       100        90        80        70        60 
        .         .         .         .         .         .         .      
TGCGGTAGCTATGGTATTTAGGTCATATAATTATGCTATGTTCATCAATATTATGATAGTAGATTATAGTGTTCT 
   50        40        30        20        10       1 








       270       260       250       240       230  C    220       210     
        .         .         .         .         .        .         .      
GAATTCCATTAATCAGCAAAAATGTATCACATGCTCACTTTCTTTTTATGGTATCACTATATAGAATCCATGAAT 
  200       190       180       170       160       150       140       130 
   .         .         .         .         .         .         .         .  
ATAACAAGAGATTGATACAATCTTTTGCCAAAGATATAACTTTATATCAGATATTTTCACTTTCGAAAACATCTG 
       120       110       100        90        80        70        60 
        .         .         .         .         .         .         .      
TGCGGTAGCTATGGTATTTAGGTCATATAATTATGCTATGTTCATCAATATTATGATAGTAGATTATAGTGTTCT 
   50        40        30        20        10       1 
   .         .         .         .         .        .      
TAATAAAAAAGAATTTAAAAGCTGTTTGTAGGATAGAAACATGAGCAATACACAAGCTT 
 
Figure 2.11 The DNA base sequence of aaiA98 promoter fragments carrying various 
point mutations 
A. The panel shows the aaiA98 promoter fragment with substitutions at positions 254 and 252 (Ts to 
Cs) marked with small arrows which disrupt the AggR-binding in the aaiA98-254C252C promoter 
fragment.  
B. The panel shows the aaiA98 promoter fragment with substitutions at positions 226 (A to C) marked 
with small arrow which disrupt the -10 hexamer element in the aaiA98-226C promoter fragment. 
The aaiA open reading frame sequence is highlighted blue, the potential AggR-binding site is green, 





For the study of the dispersin (aap) promoter, a promoter fragment: aap100 (262) which had 
been cloned into pRW50 using the EcoRI and HindIII sites, was received from Rita Godfrey 
(Figure 2.12). In order to confirm the AggR-binding site and the promoter element, point 
mutations were made in aap100 promoter fragment, using relevant primers from the Table 2.4 
and pRW50/aap100 was used as template. This generated aap100-151C149C and aap100-
124C promoter fragments as described in the Figure 2.12.  
To confirm that placing an AggR-binding site into a promoter can confer AggR-dependent 
regulation. The AggR-binding motif from the aafD promoter was introduced into the well-
studied CRP-dependent semi-synthetic promoter, CC(-41.5) (Figure 2.13). A range of 
different semi-synthetic promoters were made with on AggR-binding motif at different 
distances from the -10 hexamer element of the promoter, generating DAM20 to DAM23 
promoter fragments shown in Figure 2.13. To confirm, that the regulation observed was due 
to the transplanted sequence and AggR mediated activation, point mutations were also 
introduced into the aafD AggR-binding site, generating the DAM22-(-38C-36C) (Figure 
2.14).  
For studying mutational analysis of AggR protein, point mutations were made by substituting 
amino acids at position 14, 16, 230 and 234 of the AggR. To investigate, these mutations, 
may have affected the DNA binding ability of AggR, a known promoter fragment (nlpA100), 
repressed by AggR was used (Figure 2.15).  The promoter fragment was received from Chiara 
and was cloned into pRW50 using EcoRI and HindIII sites.  
2.9.2 Construction of pRW224-U9 and pRW225 derivatives  
QIAprep Spin miniprep kits were used to prepare both pRW224-U9 and pRW225 vectors 






aap100 (262 bp) 
       260       250       240       230       220       210       200 
        .         .         .         .         .         .         .  
GAATTCGTATTGTTAAATTACAAATGGATGGTTAACATGTATTATAAAATAATATAAAAATAAAAATGGGCATCC 
  190       180       170       160       150       140       130       120 
   .         .         .         .         .         .         .         .      
CTCAGTCGAAACGAGTAACACTCGATATATGTTGCTATTTTTTATCTGGCCGCAACTCTTATTTATGCTAGCCTT 
       110       100        90        80        70        60        50 
        .         .         .         .         .         .         .  
CTAAAAGGAGGGGCGGCATTGGCTGAATTATAACCTCTAAATATCGTAATTATTTATTGTGAAAAATACCTCTAT 
   40        30        20        10       1 








       260       250       240       230       220       210       200 
        .         .         .         .         .         .         .  
GAATTCGTATTGTTAAATTACAAATGGATGGTTAACATGTATTATAAAATAATATAAAAATAAAAATGGGCATCC 
  190       180       170       160       C C       140       130       120 
   .         .         .         .        .        .         .         .      
CTCAGTCGAAACGAGTAACACTCGATATATGTTGCTATTTTTTATCTGGCCGCAACTCTTATTTATGCTAGCCTT 
       110       100        90        80        70        60        50 
        .         .         .         .         .         .         .  
CTAAAAGGAGGGGCGGCATTGGCTGAATTATAACCTCTAAATATCGTAATTATTTATTGTGAAAAATACCTCTAT 
   40        30        20        10       1 





























       260       250       240       230       220       210       200 
        .         .         .         .         .         .         .  
GAATTCGTATTGTTAAATTACAAATGGATGGTTAACATGTATTATAAAATAATATAAAAATAAAAATGGGCATCC 
  190       180       170       160       150       140       130    C  120 
   .         .         .         .         .         .         .        .      
CTCAGTCGAAACGAGTAACACTCGATATATGTTGCTATTTTTTATCTGGCCGCAACTCTTATTTATGCTAGCCTT 
       110       100        90        80        70        60        50 
        .         .         .         .         .         .         .  
CTAAAAGGAGGGGCGGCATTGGCTGAATTATAACCTCTAAATATCGTAATTATTTATTGTGAAAAATACCTCTAT 
   40        30        20        10       1 
   .         .         .         .        .  
ATACATGGGGAATATCTAGAGAGAAGTCATATGAAAAAAATTAAAGCTT 
 
Figure 2. 12 The DNA base sequences of the different aap100 promoter fragments 
A. The panel shows the DNA sequence of the 262 bp aap100 promoter fragment.   
B. The panel shows the aap100 promoter fragment with substitutions at positions 151 and 149 (Ts to 
Cs) marked with small arrows which disrupt the AggR-binding in the aap100-151C149C promoter 
fragment. 
C. The panel shows the aap100 promoter fragment with substitutions at positions 124 (A to C) 
marked with small arrow which disrupt -10 hexamer element in the aap100-124C promoter fragment. 
The aap open reading frame sequence is highlighted blue, the potential AggR-binding site is green, 






CC(-41.5) (111 bp) 
 -80       -70       -60       -50       -40       -30       -20       -10  
  .         .         .         .         .         .         .         .  
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGTGATGTACATCACATGGATCCCCCCTCACTCCTGCCATA 
        +1      +10        +20     +30       +40 







DAM20 (109 bp) 
-80      -70       -60       -50       -40       -30       -20       -10   
.         .         .         .         .         .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGGTGTTTATTTATCTTTTATCCCCTCACTCCTGCCATAAT 
      +1       +10       +20       +30      +40 








-80       -70       -60       -50       -40       -30       -20       -10   
 .         .         .         .         .         .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGGTGTTTATTTATCTTTTATCCCCCTCACTCCTGCCATAAT 
      +1       +10       +20       +30      +40 











Figure 2.13 The DNA base sequences of the different semi-synthetic promoter 
















DAM22 (111 bp) 
 -80       -70       -60       -50       -40       -30       -20       -10   
  .         .         .         .         .         .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGGTGTTTATTTATCTTTTATCCCCCCTCACTCCTGCCATAAT 
      +1       +10       +20       +30      +40 








DAM23 (112 bp) 
  -80       -70       -60       -50       -40       -30       -20       -10   
   .         .         .         .         .         .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGGTGTTTATTTATCTTTTATCCCCCCCTCACTCCTGCCATAAT 
      +1       +10       +20       +30      +40 
      .         .         .         .        . 
TCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
 
Figure 2. 13 The DNA base sequences of the different semi-synthetic promoter 
fragments containing AggR-binding sites 
A. The panel shows the DNA sequence of the CC(-41.5) promoter fragment from Savery et al. 
(1995b), numbered in relation to the start site of transcription (+1). The CRP-binding site centred at 
position -41.5 and is underlined. 
B. The panel shows the sequence of the DAM20 promoter fragment, a variant of CC(-41.5) in which 
the AggR-binding site from aafD (shown in red) has been cloned 20 bp upstream of the -10 hexamer 
element. 
C. The panel shows the sequence of the DAM21 promoter fragment, a variant of CC(-41.5) in which 
the AggR-binding site from aafD (shown in red) has been cloned 21 bp upstream of the -10 hexamer 
element. 
D. The panel shows the sequence of the DAM22 promoter fragment, a variant of CC(-41.5) in which 
the AggR-binding site from aafD (shown in red) has been cloned 22 bp upstream of the -10 hexamer 
element. 
E. The panel shows the sequence of the DAM23 promoter fragment, a variant of CC(-41.5) in which 
the AggR-binding site from aafD (shown in red) has been cloned 23 bp upstream of the -10 hexamer 
element. 
The potential AggR-binding site is green, the potential -10 hexamer element is yellow and EcoRI and 












 -80       -70       -60       -50       -40C C    -30       -20       -10   
  .         .         .         .         .       .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGGTGTTTATTTATCTTTTATCCCCCCTCACTCCTGCCATAAT 
      +1       +10       +20       +30      +40 






Figure 2.14 The DNA base sequence of DAM22 promoter fragment carrying point 
mutations 
 
The figure details the DNA sequence of the DMA22 promoter fragment and shows the positions of 
substitutions introduced at -38 and -36 (marked with arrows and text) to disrupt the AggR-binding site 
and generate the DAM22-(-38C-36C) promoter fragment. The red colour text shows AggR-binding 
motif sequence cloned from aafD, the potential AggR-binding sites are highlighted green, the -10 


































      1        10        20        30        40        50        60 
      .        .         .         .         .         .         .  
GAATTCCTGATAATGACGCCTGTGGCGTGCAAATTTTACGTAAATCTTGCAATACCGTGGTCTTTTCTTTTGCCG 
70        80        90       100       110       120       130       140 
.         .         .         .         .         .         .         .  
ACTGTAGAGAACTGAATGGCGATTCGGCCTGAGAAATGGCTGAAAAAGTCAGGAATACGGTAATCATGAGTAGCA 
    150       160       170       180       190       200       210 
     .         .         .         .         .         .         .  
TCGTTGGCTTCATAGCTGCAACCTTCTGCAAATGTGCATCGAATGAAGCATAAGTGTAGTTTGCTTTTGCCGCTC 
220      230       240       250       260       270       280       290 
.         .         .         .         .         .         .         . 
TCATCATGCTGTACGAAAGGTGTTTGCGTGGTCAGTAAGAAGTGCCAGTTTTATATACCTTTTTCTTCTATTCGA 
    300       310       320       330       340       350       360 
     .         .         .         .         .         .         .  
TAGCTTTTCGTTTTTTAAATCGTAGTGATCTTGCCATTATAGTCAGTTAACGATTAAAAAAAGGATAAAAAAGTG 
370      380       390       400       410     408 








Figure 2.15 The DNA sequence of nlpA100 promoter fragment  
 
The figure details the DNA sequence of the 408 bp nlpA100 promoter fragment. The coding sequence 


























Figure 2.16 A map of the pRW224-U9 plasmid 
Plasmid pRW224-U9 is a derivative of pRW50 in which the trpBA region has been removed, so that 
either transcriptional or translational lacZ fusion can be generated. The sequences of the multiple 
cloning sites are shown in the lower part of the panel. The DNA promoter fragment can be cloned into 
this plasmid using either EcoRI-HindIII to generate a transcription fusion or EcoRI-BamIII to produce 











Figure 2.17 A map of plasmid pRW225 
 
The panel shows a diagram of the pRW225 lacZ expression vector, a derivative of pRW224 plasmid 
which lacks lac operon translation start site. The sequences of the multiple cloning sites are shown in 
the lower part of the panel. EcoRI-HindIII sites are used to clone in the desired DNA promoter 
fragment to generate translational fusions. Note that the DNA fragment must provide its own SD and 






HindIII, treated with CIP and purified using phenol/chloroform extraction and ethanol 
precipitation (sections 2.5.1 and 2.5.2). DNA fragments, of interest, were amplified using 
PCR and the primers detailed in Table 2.4, digested with EcoRI and HindIII and ligated into 
pRW224-U9 and pRW225 EcoRI-HindIII (sections 2.6.1 and 2.6.2).  
pRW224-U9 is a lacZ expression vector that has been designed to investigate transcription 
regulation of cloned promoter fragments. The vector has its own Shine-Dalgarno (SD) 
sequence and translation start, such that transcripts produced from the upstream promoter 
fragment can be translated into -galactosidase. If there is a difference in -galactosidase 
produced by different promoters, it is due to a difference in the level of transcription from 
each promoter. For example, to investigate the strength of the aafD and afaB promoters, 
aafD500 and afaB100 promoter fragments were made by PCR using primers listed in Table 
2.4 and cloned into pRW224-U9 (Figure 2.2 and Figure 2.18). 
The pRW225 vector has been designed to investigate translation start sites such that SD 
sequence and translation start of the cloned promoter fragment serve as the translation start 
site of lacZ present on the vector. For the investigation of the aafD translation start site, the 
promoter fragments with different in-frame translation starts sites to lacZ of vector, aafD1001 
and aafD1002, were generated using PCR, with the relevant primers form Table 2.4 and 
cloned into pRW225 vector using EcoRI-HindIII sites (Figure 2.18). 
2.9.3 Construction of pDOC-K derivatives for gene doctoring of AggR 
A QIAprep Spin miniprep kit was used to prepare pDOC-K vector DNA (Figure 2.19) and 
plasmid DNA was initially digested with EcoRI and BamHI, treated with CIP and purified by 
phenol/chloroform extraction and ethanol precipitation (sections 2.5.1 and 2.5.2). Two DNA 





aafD1001 (423 bp) 
        430       420       410       400       390       380       370 
      .  .         .         .         .         .         .         .    
GAATTCGCGTAAATAGTTGGAAAAGTTCATGCAGCATGTGGATGCTTACAGCAGATGGTATAACGAGCGGCGTAT 
   360       350       340       330       320       310       300       290 
    .         .         .         .         .         .         .         .  
AAAATTATCGCTGGGTGCAGTCAGCCCTGAAATGTACCGCCAACAATGCGGGCTGGCATAATAAAGCAGTCCAGG 
        280       270       260       250       240       230       220 
         .         .         .         .         .         .         . 
AAATCGTCCGCATCCCCTAACGGTCAAACATCGTGGCCTTGACAGCTCCCTTGGCGCGTAGTATTGCCAACTGAA 
   210       200       190       180       170       160       150      140 
    .         .         .         .         .         .         .         . 
TCCCCCGTCAATACGGTTCTCACCGTATGCTCACTGCTTACAATTGCCTGACAGTAGCAACCAACTGAGAGGATG 
        130       120       110       100        90        80        70 
         .         .         .         .         .         .         .  
CTATCTCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTA 
    60        50        40        30        20      11       







aafD1002 (414 bp) 
        430       420       410       400       390       380       370 
      .  .         .         .         .         .         .         .    
GAATTCGCGTAAATAGTTGGAAAAGTTCATGCAGCATGTGGATGCTTACAGCAGATGGTATAACGAGCGGCGTAT 
   360       350       340       330       320       310       300       290 
    .         .         .         .         .         .         .         .  
AAAATTATCGCTGGGTGCAGTCAGCCCTGAAATGTACCGCCAACAATGCGGGCTGGCATAATAAAGCAGTCCAGG 
        280       270       260       250       240       230       220 
         .         .         .         .         .         .         . 
AAATCGTCCGCATCCCCTAACGGTCAAACATCGTGGCCTTGACAGCTCCCTTGGCGCGTAGTATTGCCAACTGAA 
   210       200       190       180       170       160       150      140 
    .         .         .         .         .         .         .         . 
TCCCCCGTCAATACGGTTCTCACCGTATGCTCACTGCTTACAATTGCCTGACAGTAGCAACCAACTGAGAGGATG 
        130       120       110       100        90        80        70 
         .         .         .         .         .         .         .  
CTATCTCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAGTA 
    60        50        40        30        20     















aafD500 (70 bp) 
        110       100        90        80        70        60        50     





Figure 2.18 DNA base sequence of aafD promoter fragments with different 
downstream deletions 
A. The panel shows the DNA sequence of 423 bp aafD1001 promoter fragment, which is a derivative 
of aafD100 that has a 10 bp deletion adjacent to the HindIII site. 
B. The panel shows the DNA sequence of 423 bp aafD1002 promoter fragment, which is a derivative 
of aafD100 that has a 19 bp deletion adjacent to the HindIII site. 
C. The panel shows DNA sequence of the 70 bp aafD500 promoter fragment, which is a derivative of 
aafD96 that has a 43 bp deletion adjacent to the HindIII site. 
The aafD open reading frame is highlighted blue, the potential AggR-binding site are green, the 












Figure 2.19 A map of the pDOC-K donor plasmid used for gene doctoring  
The panel shows a diagram of the pDOC-K plasmid used to introduce deletion into EAEC. There are 
two multiple cloning sites regions, that were used to clone the flanking sequence of gene of interest 
(e.g. aggR). The plasmid carries kanamycin (KanR)and ampicillin (AmpR) resistance genes. The sacB 
open reading frame confers sucrose sensitivity. Black line show SecI restriction sites and FLP 







using PCR and named aggR400 and aggR401, respectively. The fragment aggR400 in Figure 
2.20 was amplified using PCR and the primers detailed in Table 2.4. The purified DNA 
fragment was then digested with EcoRI and BamHI and ligated into pDOC-K to generate 
pDOC-K/aggR400 (sections 2.6.1 and 2.6.2).  
The pDOC-K/aggR400 vector was then prepared and digested with XhoI and SalI, treated 
with CIP and purified by phenol/chloroform extraction and ethanol precipitation (sections 
2.5.1 and 2.5.2). The aggR401 was then amplified by PCR using the primers detailed in Table 
2.4 and sequence is shown in Figure 2.20. Purified DNA fragment was digested with XhoI 
and SalI and then ligated into the pDOC-K/aggR400 vector to generate pDOC-K/aggR400/ 
aggR401 (sections 2.6.1 and 2.6.2). The  system was provided by plasmid pACBSR (Figure 
2.21).  
2.9.4 Construction of pBAD/aggR derivatives 
In order to examine the role of AggR in E. coli K-12 strains, an inducible system was required 
to express AggR. Therefore, the vector pBAD/aggR, a variant of pBAD30 with aggR cloned 
under the control of the araBAD promoter, was acquired from J.P.Nataro (Figure 2.22) 
(Sheikh et al., 2002). To investigate whether certain amino acids in AggR are important for 
promoter regulation, specific point mutations were introduced into aggR on pBAD/aggR 
(Figure 2.23). Two point mutations were introduced into the N-terminal region of AggR at 
position 14 and 16 (Figure 2.24 and Figure 2.25 respectivley) and two mutations were 
introduced into the C-terminal region of AggR at positions (Figure 2.26 and Figure 2.27, 
respectively). Therefore, aggR DNA fragments carrying point mutations at positions 14, 16, 
230 and 234 of AggR were amplified using megaprimer PCR and each fragment was cloned 
into pBAD using an EcoRI-XbaI (sections 2.6.1 and 2.6.2). These pBAD/aggR derivatives 






     400 
      .         .         .         .         .         .         . 
GAATTCTAATGAGCGAAAATAGCCTGTTACCATCACGACAGCAGCGGGAACATAAAGGCCGAATATCGGTGAAG 
                               300 
  .         .         .         .         .         .         .         . 
GAAATCAACCAGCGTTGGTGTTCCGATGGCTTTGAGTTTGGTTGCGATGATAGCGAAAAACTGTGTGTTACGTT 
                                                         200 
        .         .         .         .         .         .         . 
CTCCCTGGACTGTTGCGATCGTGAAGCCATAGACTGAGCTGCAATTAAGATACAACCCCTGTCTGGAAATAAGG 
 
    .         .         .         .         .         .         . 
GGGCAAGAATACGATAAATAATTTCCTATTGTAATTATAAGCGTAAAAATCATATCCCACATGACGATGTGGAA 
         100 
.         .         .         .         .         .         .         . 
ATTAACAAACGTATTTTATATGAGTTAAAAATATATCTTTTTATTGATAAGAGTTAGGTCATTCTAACGCAGAT 
                                   1 







      .         .         .         .         .         .         . 
CTCGAGAAACATGTTTCATATCATTATTTGAGATTGCTATAAACATATTGAGATGGCTGAAGTTGGTGATGCTG 
                               300 
  .         .         .         .         .         .         .         . 
CCAACTTACTGATTTAGTGTATGATGGTGTTTTTGAGGTGCTCCAGTGGCTTCTGTTTCTATCAGCTGTCCCTC 
                                                         200 
        .         .         .         .         .         .         . 
CTGTTCAGCTACTGACGGAGTGGTGCGTAACGGCAAAAGCACTGCCGGACATCAGCGCTATCTCTGCTCTCACT 
 
    .         .         .         .         .         .         . 
GCCGTAAAACATGGCAACTGCAGTTCACTTACACCGCTTCTCAACCCGGTACGCACCAGAAAATCATTGATATG 
         100 
.         .         .         .         .         .         .         . 
GCCATGAATGGCGTTGGCTGCCGGGCAACTGCCCGCATTATGGGCGTTGGCCTCAACACGATTTTACGTCACTT 
                                   1 
      .         .         .        . 
AAAAAACTCAGGCCGCAGTCGGTAACCTCGCGCATAGTCGAC 
Figure 2.20 The DNA sequence of the homology regions used to disrupt aggR by gene 
doctoring  
A. The panel shows the 400 bp sequence upstream of aggR (cloned in multiple cloning sites of 
region 1) that was cloned in the pDOC-K donor plasmid in multiple cloning region 1 using EcoRI 
and BamHI sites, (highlighted grey).  
B. The panel shows the 400 bp sequence downstream of aggR (cloned in multiple cloning sites of 
region 1) that was cloned in the pDOC-K donor plasmid in multiple cloning region 2 using XhoI 












Figure 2.21 A map of the pACBSR plasmid  
The panel depicts the pACBSR plasmid and shows that sceI and lambda () red genes are under the 
control of araBAD promoter and are thus, arabinose inducible. The plasmid also contains a 
chloramphenicol (CmR) resistance gene. This plasmid expresses SceI and -red and is used for gene 












Figure 2.22 A map of the pBAD/aggR plasmid 
The panel depicts the pBAD/aggR plasmid and shows that aggR expression is under the control of 
araBAD promoter and is inducible by arabinose. The plasmid also contains ampicillin (AmpR) 
resistance gene. This plasmid expresses aggR and was used to study AggR-dependent promoters in 







                                                        M  K  L  K  Q  N   
GAATTCGAGCTCCGCAAAGTTGCTGATAAAGACATTTTTTTCATGTGAGAATGATATGAAATTAAAACAAAACA 
        10                             20                            30 
I  E  K  E  I  I  K  I  N  N  I  R  I  H  Q  Y  T  V  L  Y  T  S  N  C  T 
TCGAAAAAGAGATTATAAAAATCAACAATATCAGAATACATCAGTACACTGTACTATATACATCTAATTGTACA 
                         40                            50                  
 I  D  V  Y  T  K  E  G  S  N  T  Y  L  R  N  E  L  I  F  L  E  R  G  I  N 
ATCGATGTATACACAAAAGAAGGAAGCAATACATATCTTAGAAATGAACTCATATTTCTTGAGAGAGGAATAAA 
           60                            70                           80 
  I  S  V  R  L  Q  K  K  K  S  T  A  N  P  F  I  A  I  R  L  S  S  D  T   
TATATCAGTAAGATTGCAAAAGAAGAAATCAACAGCAAATCCATTTATCGCAATCAGATTAAGCAGCGATACAT 
                           90                           100               
L  R  R  L  K  D  A  L  M  I  I  Y  G  I  S  K  V  D  A  C  S  C  P  N  W 
TAAGACGCCTAAAGGATGCCCTGATGATAATATACGGAATATCAAAAGTAGATGCTTGTAGTTGTCCGAATTGG 
            110                           120                          130 
 S  K  G  I  I  V  A  D  A  D  D  S  V  L  D  T  F  K  S  I  D  N  N  D  D 
TCAAAAGGAATAATTGTAGCTGATGCTGACGATTCTGTATTAGATACATTCAAGAGTATCGATAATAATGATGA 
                            140                           150               
  S  R  I  T  S  D  L  I  Y  L  I  S  K  I  E  N  N  K  K  I  I  E  S  I  
TTCAAGAATTACTTCAGATTTGATATATCTTATATCAAAGATCGAAAACAACAAAAAAATTATAGAGTCAATTT 
              160                           170                           
Y  I  S  A  V  S  F  F  S  D  K  V  R  N  I  I  E  K  D  L  S  K  R  W  T 
ATATATCGGCTGTAAGCTTCTTTTCTGATAAAGTCAGAAACATAATCGAGAAAGACTTATCAAAGAGATGGACT 
180                          190                           200  
L  A  I  I  A  D  E  F  N  V  S  E  I  T  I  R  K  R  L  E  S  E  Y  I  T  
CTAGCTATTATTGCAGATGAATTTAATGTATCAGAGATAACAATAAGGAAAAGGCTTGAGTCAGAGTATATTAC 
                210                           220                           
  F  N  Q  I  L  M  Q  S  R  M  S  K  A  A  L  L  L  L  D  N  S  Y  Q  I  
TTTTAACCAGATCCTTATGCAATCAAGAATGAGCAAAGCAGCATTGCTGTTGCTTGATAACTCATATCAGATAT 
  230                           240                           250 
S  Q  I  S  N  M  I  G  F  S  S  T  S  Y  F  I  R  L  F  V  K  H  F  G  I 
CACAAATATCTAATATGATAGGATTTTCCAGTACATCATATTTCATTAGGCTTTTTGTAAAACATTTTGGCATA 
                  260            265 




Figure 2.23 The sequence of aggR from EAEC 042 
 
The figure shows DNA sequence of aggR, its leader sequence and the restriction sites, EcoRI and 
XbaI, used to clone this fragment into pBAD30. The start and stop codons of AggR are highlighted 
yellow and all the alternate codons are underlined. The letters (in blue) above each codon represent the 
amino acids coded by these codons. The numbers represent the numbering of amino acids in AggR. 
Restriction sites are highlighted grey and the sequence between EcoRI and the start codon is part of 











                                                        M  K  L  K  Q  N   
GAATTCGAGCTCCGCAAAGTTGCTGATAAAGACATTTTTTTCATGTGAGAATGATATGAAATTAAAACAAAACA 
        10                            20                            30 
I  E  K  E  I  I  K  T  N  N  I  R  I  H  Q  Y  T  V  L  Y  T  S  N  C  T 
TCGAAAAAGAGATTATAAAAACCAACAATATCAGAATACATCAGTACACTGTACTATATACATCTAATTGTACA 
                         40                            50                  
 I  D  V  Y  T  K  E  G  S  N  T  Y  L  R  N  E  L  I  F  L  E  R  G  I  N 
ATCGATGTATACACAAAAGAAGGAAGCAATACATATCTTAGAAATGAACTCATATTTCTTGAGAGAGGAATAAA 
           60                            70                           80 
  I  S  V  R  L  Q  K  K  K  S  T  A  N  P  F  I  A  I  R  L  S  S  D  T   
TATATCAGTAAGATTGCAAAAGAAGAAATCAACAGCAAATCCATTTATCGCAATCAGATTAAGCAGCGATACAT 
                           90                           100               
L  R  R  L  K  D  A  L  M  I  I  Y  G  I  S  K  V  D  A  C  S  C  P  N  W 
TAAGACGCCTAAAGGATGCCCTGATGATAATATACGGAATATCAAAAGTAGATGCTTGTAGTTGTCCGAATTGG 
            110                           120                          130 
 S  K  G  I  I  V  A  D  A  D  D  S  V  L  D  T  F  K  S  I  D  N  N  D  D 
TCAAAAGGAATAATTGTAGCTGATGCTGACGATTCTGTATTAGATACATTCAAGAGTATCGATAATAATGATGA 
                            140                           150               
  S  R  I  T  S  D  L  I  Y  L  I  S  K  I  E  N  N  K  K  I  I  E  S  I  
TTCAAGAATTACTTCAGATTTGATATATCTTATATCAAAGATCGAAAACAACAAAAAAATTATAGAGTCAATTT 
              160                           170                           
Y  I  S  A  V  S  F  F  S  D  K  V  R  N  I  I  E  K  D  L  S  K  R  W  T 
ATATATCGGCTGTAAGCTTCTTTTCTGATAAAGTCAGAAACATAATCGAGAAAGACTTATCAAAGAGATGGACT 
180                          190                           200  
L  A  I  I  A  D  E  F  N  V  S  E  I  T  I  R  K  R  L  E  S  E  Y  I  T  
CTAGCTATTATTGCAGATGAATTTAATGTATCAGAGATAACAATAAGGAAAAGGCTTGAGTCAGAGTATATTAC 
                210                           220                           
  F  N  Q  I  L  M  Q  S  R  M  S  K  A  A  L  L  L  L  D  N  S  Y  Q  I  
TTTTAACCAGATCCTTATGCAATCAAGAATGAGCAAAGCAGCATTGCTGTTGCTTGATAACTCATATCAGATAT 
  230                           240                           250 
S  Q  I  S  N  M  I  G  F  S  S  T  S  Y  F  I  R  L  F  V  K  H  F  G  I 
CACAAATATCTAATATGATAGGATTTTCCAGTACATCATATTTCATTAGGCTTTTTGTAAAACATTTTGGCATA 
                  260            265 
 T  P  K  Q  F  L  T  Y  F  K  S  Q 
ACACCAAAACAATTCTTGACTTATTTTAAAAGCCAATAGTCTAGA 
 
Figure 2.24 The DNA and amino acids sequence of AggR-I14T variant  
 
The figure shows the DNA and amino acid sequence of the AggR-I14T variant, which was cloned into 
pBAD30 using EcoRI and XbalI restriction sites (grey). The start and stop codons of AggR are 
highlighted yellow and alternate codons are underlined. The amino acid sequence is shown above each 
codon and the amino acid numbering is above. At position 14 the codon has been changed from ATC 






                                                        M  K  L  K  Q  N   
GAATTCGAGCTCCGCAAAGTTGCTGATAAAGACATTTTTTTCATGTGAGAATGATATGAAATTAAAACAAAACA 
        10                             20                            30 
I  E  K  E  I  I  K  I  N  D  I  R  I  H  Q  Y  T  V  L  Y  T  S  N  C  T 
TCGAAAAAGAGATTATAAAAATCAACGATATCAGAATACATCAGTACACTGTACTATATACATCTAATTGTACA 
                         40                            50                  
 I  D  V  Y  T  K  E  G  S  N  T  Y  L  R  N  E  L  I  F  L  E  R  G  I  N 
ATCGATGTATACACAAAAGAAGGAAGCAATACATATCTTAGAAATGAACTCATATTTCTTGAGAGAGGAATAAA 
           60                            70                           80 
  I  S  V  R  L  Q  K  K  K  S  T  A  N  P  F  I  A  I  R  L  S  S  D  T   
TATATCAGTAAGATTGCAAAAGAAGAAATCAACAGCAAATCCATTTATCGCAATCAGATTAAGCAGCGATACAT 
                           90                           100               
L  R  R  L  K  D  A  L  M  I  I  Y  G  I  S  K  V  D  A  C  S  C  P  N  W 
TAAGACGCCTAAAGGATGCCCTGATGATAATATACGGAATATCAAAAGTAGATGCTTGTAGTTGTCCGAATTGG 
            110                           120                          130 
 S  K  G  I  I  V  A  D  A  D  D  S  V  L  D  T  F  K  S  I  D  N  N  D  D 
TCAAAAGGAATAATTGTAGCTGATGCTGACGATTCTGTATTAGATACATTCAAGAGTATCGATAATAATGATGA 
                            140                           150               
  S  R  I  T  S  D  L  I  Y  L  I  S  K  I  E  N  N  K  K  I  I  E  S  I  
TTCAAGAATTACTTCAGATTTGATATATCTTATATCAAAGATCGAAAACAACAAAAAAATTATAGAGTCAATTT 
              160                           170                           
Y  I  S  A  V  S  F  F  S  D  K  V  R  N  I  I  E  K  D  L  S  K  R  W  T 
ATATATCGGCTGTAAGCTTCTTTTCTGATAAAGTCAGAAACATAATCGAGAAAGACTTATCAAAGAGATGGACT 
180                          190                           200  
L  A  I  I  A  D  E  F  N  V  S  E  I  T  I  R  K  R  L  E  S  E  Y  I  T  
CTAGCTATTATTGCAGATGAATTTAATGTATCAGAGATAACAATAAGGAAAAGGCTTGAGTCAGAGTATATTAC 
                210                           220                           
  F  N  Q  I  L  M  Q  S  R  M  S  K  A  A  L  L  L  L  D  N  S  Y  Q  I  
TTTTAACCAGATCCTTATGCAATCAAGAATGAGCAAAGCAGCATTGCTGTTGCTTGATAACTCATATCAGATAT 
  230                           240                           250 
S  Q  I  S  N  M  I  G  F  S  S  T  S  Y  F  I  R  L  F  V  K  H  F  G  I 
CACAAATATCTAATATGATAGGATTTTCCAGTACATCATATTTCATTAGGCTTTTTGTAAAACATTTTGGCATA 
                  260            265 
 T  P  K  Q  F  L  T  Y  F  K  S  Q 
ACACCAAAACAATTCTTGACTTATTTTAAAAGCCAATAGTCTAGA 
 
Figure 2.25 The DNA and amino acids sequence of AggR-N16D variant  
 
The figure shows the DNA and amino acid sequence of the AggR-N16D variant, which was cloned 
into pBAD30 using EcoRI and XbalI restriction sites (grey). The start and stop codons of AggR are 
highlighted yellow and alternate codons are underlined. The amino acid sequence is shown above each 
codon and the amino acid numbering is above. At position 16 the codon has been changed from AAT 









                                                        M  K  L  K  Q  N   
GAATTCGAGCTCCGCAAAGTTGCTGATAAAGACATTTTTTTCATGTGAGAATGATATGAAATTAAAACAAAACA 
        10                             20                            30 
I  E  K  E  I  I  K  I  N  N  I  R  I  H  Q  Y  T  V  L  Y  T  S  N  C  T 
TCGAAAAAGAGATTATAAAAATCAACAATATCAGAATACATCAGTACACTGTACTATATACATCTAATTGTACA 
                         40                            50                  
 I  D  V  Y  T  K  E  G  S  N  T  Y  L  R  N  E  L  I  F  L  E  R  G  I  N 
ATCGATGTATACACAAAAGAAGGAAGCAATACATATCTTAGAAATGAACTCATATTTCTTGAGAGAGGAATAAA 
           60                            70                           80 
  I  S  V  R  L  Q  K  K  K  S  T  A  N  P  F  I  A  I  R  L  S  S  D  T   
TATATCAGTAAGATTGCAAAAGAAGAAATCAACAGCAAATCCATTTATCGCAATCAGATTAAGCAGCGATACAT 
                           90                           100               
L  R  R  L  K  D  A  L  M  I  I  Y  G  I  S  K  V  D  A  C  S  C  P  N  W 
TAAGACGCCTAAAGGATGCCCTGATGATAATATACGGAATATCAAAAGTAGATGCTTGTAGTTGTCCGAATTGG 
            110                           120                          130 
 S  K  G  I  I  V  A  D  A  D  D  S  V  L  D  T  F  K  S  I  D  N  N  D  D 
TCAAAAGGAATAATTGTAGCTGATGCTGACGATTCTGTATTAGATACATTCAAGAGTATCGATAATAATGATGA 
                            140                           150               
  S  R  I  T  S  D  L  I  Y  L  I  S  K  I  E  N  N  K  K  I  I  E  S  I  
TTCAAGAATTACTTCAGATTTGATATATCTTATATCAAAGATCGAAAACAACAAAAAAATTATAGAGTCAATTT 
              160                           170                           
Y  I  S  A  V  S  F  F  S  D  K  V  R  N  I  I  E  K  D  L  S  K  R  W  T 
ATATATCGGCTGTAAGCTTCTTTTCTGATAAAGTCAGAAACATAATCGAGAAAGACTTATCAAAGAGATGGACT 
180                          190                           200  
L  A  I  I  A  D  E  F  N  V  S  E  I  T  I  R  K  R  L  E  S  E  Y  I  T  
CTAGCTATTATTGCAGATGAATTTAATGTATCAGAGATAACAATAAGGAAAAGGCTTGAGTCAGAGTATATTAC 
                210                           220                           
  F  N  Q  I  L  M  Q  S  R  M  S  K  A  A  L  L  L  L  D  N  S  Y  Q  I  
TTTTAACCAGATCCTTATGCAATCAAGAATGAGCAAAGCAGCATTGCTGTTGCTTGATAACTCATATCAGATAT 
                                240                           250 
S  G  I  S  N  M  I  G  F  S  S  T  S  Y  F  I  R  L  F  V  K  H  F  G  I 
CAGCGATATCTAATATGATAGGATTTTCCAGTACATCATATTTCATTAGGCTTTTTGTAAAACATTTTGGCATA 
                  260            265 
 T  P  K  Q  F  L  T  Y  F  K  S  Q 
ACACCAAAACAATTCTTGACTTATTTTAAAAGCCAATAGTCTAGA 
 
Figure 2.26 The DNA and amino acids sequence of AggR-Q230G variant  
The figure shows the DNA and amino acid sequence of the AggR-Q230G variant, which was cloned 
into pBAD30 using EcoRI and XbalI restriction sites (grey). The start and stop codons of AggR are 
highlighted yellow and alternate codons are underlined. The amino acid sequence is shown above each 
codon and the amino acid numbering is above. At position 230 the codon has been changed from CAA 







                                                        M  K  L  K  Q  N   
GAATTCGAGCTCCGCAAAGTTGCTGATAAAGACATTTTTTTCATGTGAGAATGATATGAAATTAAAACAAAACA 
        10                             20                            30 
I  E  K  E  I  I  K  I  N  N  I  R  I  H  Q  Y  T  V  L  Y  T  S  N  C  T 
TCGAAAAAGAGATTATAAAAATCAACAATATCAGAATACATCAGTACACTGTACTATATACATCTAATTGTACA 
                         40                            50                  
 I  D  V  Y  T  K  E  G  S  N  T  Y  L  R  N  E  L  I  F  L  E  R  G  I  N 
ATCGATGTATACACAAAAGAAGGAAGCAATACATATCTTAGAAATGAACTCATATTTCTTGAGAGAGGAATAAA 
           60                            70                           80 
  I  S  V  R  L  Q  K  K  K  S  T  A  N  P  F  I  A  I  R  L  S  S  D  T   
TATATCAGTAAGATTGCAAAAGAAGAAATCAACAGCAAATCCATTTATCGCAATCAGATTAAGCAGCGATACAT 
                           90                           100               
L  R  R  L  K  D  A  L  M  I  I  Y  G  I  S  K  V  D  A  C  S  C  P  N  W 
TAAGACGCCTAAAGGATGCCCTGATGATAATATACGGAATATCAAAAGTAGATGCTTGTAGTTGTCCGAATTGG 
            110                           120                          130 
 S  K  G  I  I  V  A  D  A  D  D  S  V  L  D  T  F  K  S  I  D  N  N  D  D 
TCAAAAGGAATAATTGTAGCTGATGCTGACGATTCTGTATTAGATACATTCAAGAGTATCGATAATAATGATGA 
                            140                           150               
  S  R  I  T  S  D  L  I  Y  L  I  S  K  I  E  N  N  K  K  I  I  E  S  I  
TTCAAGAATTACTTCAGATTTGATATATCTTATATCAAAGATCGAAAACAACAAAAAAATTATAGAGTCAATTT 
              160                           170                           
Y  I  S  A  V  S  F  F  S  D  K  V  R  N  I  I  E  K  D  L  S  K  R  W  T 
ATATATCGGCTGTAAGCTTCTTTTCTGATAAAGTCAGAAACATAATCGAGAAAGACTTATCAAAGAGATGGACT 
180                          190                           200  
L  A  I  I  A  D  E  F  N  V  S  E  I  T  I  R  K  R  L  E  S  E  Y  I  T  
CTAGCTATTATTGCAGATGAATTTAATGTATCAGAGATAACAATAAGGAAAAGGCTTGAGTCAGAGTATATTAC 
                210                           220                           
  F  N  Q  I  L  M  Q  S  R  M  S  K  A  A  L  L  L  L  D  N  S  Y  Q  I  
TTTTAACCAGATCCTTATGCAATCAAGAATGAGCAAAGCAGCATTGCTGTTGCTTGATAACTCATATCAGATAT 
  230                           240                           250 
S  Q  I  S  N  G  I  G  F  S  S  T  S  Y  F  I  R  L  F  V  K  H  F  G  I 
CACAAATATCTAATGCGATAGGATTTTCCAGTACATCATATTTCATTAGGCTTTTTGTAAAACATTTTGGCATA 
                  260            265 
 T  P  K  Q  F  L  T  Y  F  K  S  Q 
ACACCAAAACAATTCTTGACTTATTTTAAAAGCCAATAGTCTAGA 
 
Figure 2.27 The DNA and amino acids sequence of AggR-M234G variant  
The figure shows the DNA and amino acid sequence of the AggR-M234G variant, which was cloned 
into pBAD30 using EcoRI and XbalI restriction sites (grey). The start and stop codons of AggR are 
highlighted yellow and alternate codons are underlined. The amino acid sequence is shown above each 
codon and the amino acid numbering is above. At position 234 the codon has been changed from ATG 














promoter activity was examined by myself by measuring -galactosidase expression. The 
negative control used for aggR expression was pBAD24 plasmid (Figure 2.28). 
2.10 β-galactosidase assays 
In this study, β-galactosidase assays were used to measure promoter activity and in each case 
promoter fragments were cloned upstream of lacZ in the expression vectors, pRW50, 
pRW224 and pRW225. 
2.10.1 β-galactosidase assays during exponential growth and stationary phase  
Transformants, containing the desired promoter fragment in lacZ expression vector 
derivatives, were picked from a MacConkey agar plate, inoculated into 5 ml of appropriate 
media containing antibiotics and grown overnight at 37°C with shaking. Cultures were then 
diluted 1:100 in appropriate media and incubated at 37°C with shaking until mid-logarithmic 
phase (OD650= 0.4 - 0.6).  Cultures were then lysed by the addition of 3 drops of toluene and 3 
drops of 1% (w/v) sodium deoxycholate and vortexed. Culture lysates were shaken at 37°C 
for 10 -15 minutes to evaporate the toluene. Lysates were used to assay β-galactosidase 
activity in Z-buffer. 
Z-buffer was prepared using 0.75 g of potassium chloride (KCl), 0.25 g of magnesium 
sulphate 7 hydrate (MgSO4.7H2O), 8.53 g of disodium hydrogen orthophosphate (Na2HPO4), 
4.87 g of sodium dihydrogen orthophosphate dihydrate (NaH2PO4.2H2O) and distilled water 
up to 1 liter. Before use, 2.7 ml of β-mercaptoethanol and 400 mg of ortho-nitrophenol-β-D-
galactopyranoside (ONPG) (a final concentration 13 mM) were added per 1 liter of Z-buffer. 
The β-galactosidase assays were carried out in Z-buffer at 30°C and the reaction was started 
by adding 100 µl of the lysate. The mixture was incubated until a yellow colour developed. 











Figure 2.28 A map of the pBAD24 plasmid 
 
The figure depicts the pBAD24 plasmid showing the location of araC gene, the araBAD promoter and 
multiple cloning sites. The plasmid also contains ampicillin (AmpR) resistance gene. This plasmid is 















2.5 = factor for conversion of OD650 into bacterial mass, based on OD650 of 1 being equivalent 
to 0.4 mgml-1 bacteria (dry weight). 
3.6 = final assay volume (ml) 
1000/4.5 = factor for conversion of OD420 into nmol Ortho-nitrophenyl-b-D-
galactopyranoside (ONPG), based on 1 nmol ml-1 ONPG having an OD420 of 0.0045 
t = incubation time (minutes) 
v = volume of lysate added (ml) 
The β-galactosidase activity of cells containing plasmids each carrying promoter fragment 
was measured using three independent transformants and the mean β-galactosidase level and 
standard deviation was calculated for each promoter fragment. In all assays, cells containing 
empty vector were used as negative control. 
2.11 Primer Extension 
Primer extension was carried out to find the transcription start site of various promoters 
cloned into the pRW50 vector. In this experiment, mRNA was isolated and used as a template 
to produce complementary DNA (cDNA) using a radioactive labelled primer. The length of 
cDNA corresponds to the transcription start site and is measured by running reactions on a gel  
alongside M13mp18 sequence reaction as a ladder.  
1000 x 2.5 x 3.6 x OD420nm 
OD650nm x 4.5 x t x v 




2.11.1 Isolation of RNA using the QIAGEN RNeasy kit 
In this experiment, the recombinant plasmid of interest was transformed into E. coli strain 
BW25113, carrying either pBAD24 or pBAD/aggR. Three independent transformants were 
used to setup over night cultures, each inoculated into 5 ml of LB medium supplemented with 
ampicillin 100 mgml-1 and tetracycline 10 mgml-1. The overnight cultures were diluted (1:50) 
into 10 ml of fresh LB with the antibiotics (tetracycline 10 mgml-1 and ampicillin 100 mgml-1) 
and 0.2% (w/v) arabinose and incubated at 37°C with shaking until an OD600 of 0.4 - 0.5. The 
cultures were transferred into Falcon tubes and centrifuged for 20 minutes at 2844 g. The 
supernatant was discarded and the pellet was resuspended in 200 µl of TE buffer containing 
40 µgml-1  lysozyme and incubated at room temperature for 15 minutes. RNA was isolated 
using, QIAGEN RNeasy kit according to manufacturer’s specifications and the RNA was 
eluted from the column in 60 µl of the elution buffer.  
Any DNA contamination was removed from the RNA sample, by the addition of 1 µl of 
Turbo DNase (Ambion) and 3.5 µl of Turbo DNase buffer and tubes were incubated at 37°C 
for 30 minutes. DNA digestion was stopped by the addition of 6.1 µl of DNase inactivation 
reagent (Ambion) and samples were incubated at room temperature for 2 minutes with 
occasional mixing.  Microfuge tubes were centrifuged for 1.5 minutes at 9300 g and the 
supernatant was transferred to a clean tube. The RNA concentration of each sample was 
quantified using a Nanodrop ND-1000 spectrophotometer and the RNA was stored at -80°C 
in aliquots, each containing 35 µg of RNA. 
2.11.2 Labelling of primers  
Primer D49274 was labelled with 32P by mixing 0.5 µl of primer (100 µM), 2 µl 




polynucleotide kinase (NEB) (Table 2.4). The mixture was incubated for 30 minutes at 37°C 
and then 10 minutes at 68°C to inactivate the enzyme. The labelled primer was stored at -
20°C.  
2.11.3 Sequencing reactions for primer extension 
A sequencing reaction is used as a marker for primer extension reactions run on acrylamide 
gel and was prepared using a T7 sequencing kit (USB). The single stranded M13mp18 phage 
DNA provided with the kit was used as a template to prepare sequence reactions, according to 
manufacturer’s instructions (Figure 2.29 ). 2 μl of the Universal primer (10 pmol) were used 
per reaction with 10 μl of the diluted template, and 2 μl of the annealing buffer. This was 
mixed and incubated at 65C for 5 minutes, and then transferred to 37C for 10 minutes. T7-
polymerase stock (8 unitsμl-1) was diluted 1:5 in dilution buffer for the labelling reaction. For 
each labelling reaction, 15 μl of the annealed template/primer reaction mixture, 1 μl of α-32P 
dATP (10 μCiμl-1) and 2 μl of diluted T7-polymerase were incubated at room temperature for 
5 minutes. 
The kit contains four different ddNTPs mixes, each containing ddNTP (ddATP, ddCTP, 
ddGTP and ddTTP) and 2.5 μl of each was transferred to separate microfuge tubes. The 
sequence reactions were terminated by adding 4.5 μl of the labelling reaction into each of the 
four tubes, which were incubated at 37C for 5 minutes. The reactions were stopped using 5 
μl of ‘STOP’ solution (Formamide (Deionised) 97.5% (v/v), EDTA (10mM), Xylene cyanol 
(0.3% (w/v)) and bromophenol blue (0.3% (w/v))) and tubes were stored at -20C after this 
step. 
2.11.4 Primer Extension 







1        10        20        30        40        50        60       70 
.        .         .         .         .         .         .         .  
GTAAAACGACGGCCAGTGCCAAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCGAGCT 
         80        90       100       110       120       130       140 
         .         .         .         .         .         .         .  
CGAATTCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACAT 
        150       160       170       180       190       200       210 
         .         .         .         .         .         .         .  
ACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTG 
        220       230       240       250       260       270       280 
         .         .         .         .         .         .         .  
CGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGG 
        290       300       310       320       330       340       350 
         .         .         .         .         .         .         .  
GGAGAGGCGGTTTCCGTATTCCCCCCCACCCTCCTTTTTCTTTTCACCAGTGAGACGGGCAACAGCTGAT 
        360       370       380       390       400       410       420 
         .         .         .         .         .         .         .  
TGCCCTTCACCCCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAA 
        430       440       450       460       470       480       490 
         .         .         .         .         .         .         .  
ATCCTGTTTGATGGTGGTTCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGCCCGAGATAGGGT 
        500       510       520       530       540       550       560 
         .         .         .         .         .         .         .  
TGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAA 
        570       580       590       600       610       620       630 
         .         .         .         .         .         .         .  
AACCGTCTATCAGGGCGATGGCCCACTCAGTGAACCATCACCCAAATCAAGTTTTTTGGGGTCGAGGTGC 
        640       650       660       670       680       690   
         .         .         .         .         .         .    
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCCATTTACACCTTGACCCCCAAAGC 
 
Figure 2.29 A part of M13mp18 sequence 
The figure shows a part of M13mp18 sequence from single stranded circular DNA. It was provided 








aliquot. The RNA was ethanol precipitated as described in section 2.5.2. The pellet was 
resuspended in 30 µl of hybridization buffer (20 mM HEPES, 0.4 M NaCl, 80% (v/v) 
formamide), vortexed and incubated for 5 minutes at 50°C. The tube was vortexed once more, 
briefly centrifuged and incubated for 15 minutes at 75°C and for another 3 hours at 50°C. The 
RNA was ethanol precipitated as described in section 2.5.2. The pellet was resuspended in 31 
µl of RNase free water and mixed with 10 µl of reverse transcriptase buffer (5x) (Promega), 1 
µl of 50 mM DTT, 5 µl of 10 mM dNTPs (Bioline), 2.5 µl of AMV reverse transcriptase 
(Promega) and 0.6 µl of RNasin (Promega). Microfuge tubes were incubated for 60 minutes 
at 37°C and 10 minutes at 72°C (to inactivate the reverse transcriptase enzyme). The 
microfuge tubes were briefly centrifuged and 1 µl of RNase A solution (10 mgml-1) was 
added to reaction to digest the RNA template. The reaction mix was then incubated for 30 
minutes at 37°C.  
The DNA product of the reaction was ethanol precipitated (section 2.5.2) and resuspended in 
6 µl of stop solution. The primer extension product was diluted in 1:5 in stop solution and 
5 µl of the diluted volume was loaded onto 6% (w/v) denatured PAGE (polyacrylamide gel 
electrophoresis), along with the sequence reactions from section 2.11.3. The gel was run at 60 
Watts for 3 hours, dried using vacuum drier and exposed to phosphorimaging screen (Fuji) for 
overnight. The data was visualised by scanning the phosphorimaging screen using BioRad 
molecular imager FX and Quantity one software.  
2.12 Gene doctoring  
There are many gene manipulation techniques are available that are used for addition and 
deletion of certain DNA sequences in the bacterial cells. One of these techniques is “the gene 




been developed by Lee et al. (2009) for modification of the host chromosome. Gene 
doctoring has been used in this study to delete the aggR gene on plasmid pAA2 from the 
EAEC strain DFB042 (Table 2.1).  
2.12.1 An overview of the technique  
Most of the gene manipulation techniques, use the  Red system to carry out recombinant 
modification. The  Red system consists of three proteins: exo generates the single stranded 
DNA overhangs, gam protects the single stranded DNA and bet catalyse the recombination of 
the homologous regions. The technique was developed by Datsenko and Wanner (2000) for 
gene manipulation and they used linear DNA fragments, which were electroporated into 
bacterial cells. These DNA fragments carry an antibiotic resistance cassette and homology 
regions for the DNA sequence of interest. The  Red system genes were provided by a 
plasmid in the host cells.  
This method was further modified by Herring et al. (2003) who used donor plasmid instead of 
linear fragments of DNA. The donor plasmid contained an antibiotic resistance cassette, 
which was flanked by the DNA sequences of the targeted gene. This part of the plasmid was 
also flanked by SceI restriction sites. The genes for  Red were provided on another plasmid 
in the host cells that also contain the SceI meganuclease gene required to produce linear DNA 
fragments from the donor plasmid. All these genes were cloned under an inducible promoter. 
This technique improved the efficiency as more copies of the linear DNA fragments were 
available for DNA recombination. 
In gene doctoring, Lee et al. (2009) modified this technique by adding selection for successful  
recombinants. This method uses a sacB gene cassette from Bacillus subtilis.  The product of 




The cells that have sacB cannot grow in the presence of sucrose (Li et al., 2013). In this 
technique, there are also two plasmids required, like in Herring et al. (2003). The donor 
plasmid consists of sequence of two homology regions around a kanamycin cassette and this 
whole DNA segment is located between two SceI restriction sites. In addition, the donor 
plasmid also has an ampicillin resistance cassette for selection and sacB for sucrose 
sensitivity. After successful recombinations, the host cell loses ampicillin resistance and 
becomes resistant to sucrose. The  Red system and sce-I present on pACBSR, are necessary 
for generating linear DNA fragment, from pDOC-K/aggR401/aggR402 (Figure 2.21). The 
pACBSR also encodes chloramphenicol resistance.  
2.12.2 Gene doctoring methodology 
For gene doctoring, the donor plasmid and pACBSR were co-transformed into EAEC strain 
DFB042 by electroporation and transformants were selected on chloramphenicol (50 gml-1) 
and kanamycin (25 gml-1) LB agar plates. The transformants were re-streaked onto 
chloramphenicol (50 gml-1) and kanamycin (25 gml-1) LB agar plates and kanamycin (25 
gml-1) and sucrose (5% (w/v)) plates simultaneously to check the system works in EAEC 
DFB042. A sucrose sensitive, chloramphenicol resistant and kanamycin resistant colony was 
inoculated into 0.5 ml of LB containing kanamycin (25 gml-1) and incubated at 37C with 
aeration for ~3 hours until the culture turned turbid. The culture was centrifuged at 15700 g 
and washed three times with 0.5 ml of 0.1x LB to remove any traces of antibiotic. The cells 
were then resuspended in 0.1x LB containing 0.3% (w/v) arabinose, to induce  Red and SceI 
and incubated at 37C with shaking for 3 hours. The culture was centrifuged at 15700 g and 
the pellet was resuspended in 0.2 ml of 0.1x LB. This cell suspension was plated onto four LB 




status of the donor plasmid was also determined by inoculating 100 l of 1000-fold dilution 
of pre-induction and post-induction samples onto both LB agar and LB agar supplemented 
with ampicillin (100 gml-1) plates. The cells with donor plasmid that has been linearised will 
be sensitive to ampicillin (100 gml-1) and this indicates the efficiency of SceI digestion in 
producing linear DNA within the cells. All the plates were incubated at room temperature 
until visible colonies appeared. 
2.12.3 Detection of gene doctored cells 
 Colonies which grew on kanamycin (25 gml-1) and sucrose (5% (w/v)) were re-streaked 
onto LB plates with ampicillin (100 gml-1), LB plates with sucrose (5% (w/v)) and LB plates 
with kanamycin (25 gml-1). Ampicillin sensitive and kanamycin resistant colonies that were 
not sensitive to sucrose were tested for DNA modification using colony PCR. The primers 
used for PCR and sequencing reactions are detailed in Table 2.4. The successful candidates 
were then checked for chloramphenicol (50 gml-1) sensitivity to confirm the loss of 
pACBSR plasmid.  
2.13 Biofilm formation 
Overnight cultures were inoculated from freshly grown single colonies of E. coli, EAEC 
DFB042 and EAEC DFB042aggR in 5 ml of LB medium. The overnight cultures were 
diluted 1:100 in 5 ml of DMEM medium and incubated at 37C for 1 hour with shaking and 
from each strain, 150 l of the diluted culture was added to 8 wells of microtitre plate. The 
plate was sealed with Parafilm (TM) to avoid evaporation and incubated at 37C for 
overnight. The next day, media was removed and plate was smacked on the paper towel to 
remove any traces of media. Then 150 l of crystal violet was added to each well and left at 




remove any traces. Then, the plate is submerged into water and water was poured out into 
container again. It was repeated 3 times and the negative control was appearing negative. The 
plate was dried  by smacking on a paper towel and 150 l of ethanol/acetone solution (80 ml 
ethanol and 20 ml acetone) was added to each well. The plate was left on a shaker for 30 
minutes and absorbance was measured at 595 nm by a Labsystems Multiskan MS plate reader 
(Thermo Fisher Scientific Inc). 
2.14 Detection of Pet 
Pet is one of the virulence factors of EAEC 042 that is secreted out of the cell. Pet production 
was detected for its possible AggR-dependent regulation as AggR regulates other virulence 
factors e.g. fimbriae gene expression and pet is present between two regions of AggR-
regulated fimbrial regions. 
2.14.1 Protein precipitation 
Fresh isolated colonies of E. coli K-12, EAEC DFB042, EAEC DFB042aggR (pBAD/aggR) 
and EAEC DFB042aggR, were used to set up overnight cultures. Overnight cultures were 
sub-cultured by 1:100 dilutions into 50 ml of DMEM supplemented with tryptone (1% (w/v)) 
and arabinose (0.2% (w/v)) where appropriate and incubated for different length of time to 
determine different time points. After completion of incubation, the flask was kept on ice for 
10 minutes and culture was transferred into a precooled Falcon tube. The cultures were 
centrifuged using a centrifuge 5810 R (eppendrof) at 2844 g for 20 minutes at 4C. The 
supernatant was filter sterilised through a 0.22 M filter (Acrodisc® syringe filters) and 
transferred into appropriate centrifuge tubes for centrifugation. 5 ml of freshly prepared 100% 
trichloro acetic acid (TCA) was added to 25 ml each filtered supernatant. 




at 4C. The pellet was resuspended in 2 ml of acetone and transferred to 2 ml microfuge tubes 
for subsequent steps. The mixture in acetone was centrifuged in microfuge at 20817 g for 45 
minutes at 4C and poured off supernatant. The pellet was air dried and resuspended in 100 l 
of cracking buffer (10.12 ml of SDS (20% (w/v)), 20 ml of glycerol, 5 mg of bromophenol 
blue, made up to 92 ml by stocking gel buffer (1:10 diluted) and 8.7% (v/v) of β-
mercaptoethanol). If the colour of samples turned yellow due to low pH of the solution 
mixture reaction, this was neutralised by addition of 5 l of Tris-HCl (1.5 M, pH 8.0).  
2.14.2 Western blot 
Samples from 2.14.1 were heated at 100C for 5 minutes and then centrifuged for 1 minute at 
15700 g. The protein was loaded onto a SDS-PAGE gel along with prestained marker. The 
electrophoresis was carried out at 150 V until the blue dye front reached the bottom of the gel 
as described in section 2.4.3. After electrophoresis, the gel was soaked in transfer buffer (25 
mM Tris, 190 mM glycine, 5% (v/v) methanol and 0.1% (w/v) SDS) for 10 minutes.  A piece 
of nitrocellulose membrane (e.g. Hybond-ECL) of the same size as that of the gel was soaked 
into distilled water for 5 minutes and then in transfer buffer for another 5 minutes. Four pieces 
of the filter paper and the blotting pads for transfer apparatus were also soaked in transfer 
buffer for 5 minutes. The western blot transfer apparatus was set up by placing transfer 
membrane towards the anode and gel towards cathode, sandwiched between filter papers and 
blotting pads. The proteins were transferred to the membrane at 30 V for 1 hour using transfer 
buffer (at room temperature). 
Following transfer, the nitrocellulose membrane was washed two times with 25 ml 1x TBS 
(20 mM Tris, 150 mM NaCl, pH 7.6) for 5 minutes at room temperature, with vigorous 




Tween-20 and 5% (w/v) non-fat dry milk) for 1 hour at room temperature followed by three 
washes for 5 minutes each with 25 ml of TBS/T (TBS with 0.1% (w/v) Tween 20) with 
vigorous shaking. 
The membrane was incubated with the primary antibody (anti-passenger domain antibodies) 
1l in 10 ml of blocking buffer with gentle agitation overnight at room temperature in a 
sealed bag. The membrane was rinsed with TBS/T, then washed three times for 5 minutes 
each with 25 ml of TBS/T with vigorous shaking. The membrane was then incubated with 
HRP-conjugated secondary antibody (1 l in 10 ml blocking buffer) with gentle agitation for 
1 hour at room temperature again in a sealed bag. The membrane was washed three times for 
5 minutes each with ~25 ml TBS/T with vigorous shaking. 
The reagents of the ECL detection system were removed from storage at 2-8 C and 
transferred 1 ml of each A and B regents were into 2ml microfuge tubes to equilibrate to room 
temperature. The excess TBS/T drained from the membrane and placed protein side up on a 
sheet of cling film. Both reagents were mixed and pipetted the mixed detection reagent onto 
the surface of the membrane and left for 5 minutes at room temperature. 
The membrane was held with a pair of tweezers and touching the edge against a tissue and the 
excess detection reagent drained. The membrane was wrapped into a fresh sheet of cling film 
with a care to avoid any air bubbles. It was placed into an X-ray cassette with protein side up 
and overlaid with a sheet of autoradiography film (GE Healthcare Limited). The cassette was 
closed and time was noted for exposure to the membrane. The film was removed and 
developed immediately using an x-ray developing machine CURIX 60 (AGFA). Based on the 




















Organisation of the promoter regions of the aggregative 












EAEC is an intestinal pathogen and there are many virulence factors that enable this pathogen 
to attach to the intestine and cause disease in humans. The major virulence factors include 
EAEC adhesins, toxins and AggR (Vila et al., 2000; Morin et al., 2010). The transcription 
factor, AggR, controls the expression of various virulence determinants in EAEC 042 (Morin 
et al., 2013). 
Aggregative adherence fimbriae II (AAF/II) are an important virulence factor that confer “the 
stacked brick” aggregation pattern to EAEC (Nataro et al., 1987). The genes that encode these 
fimbriae are regulated by AggR (Morin et al.2010). Elias et al. (1999) described the 
arrangement of the fimbrial genes in two clusters known as Region 1 and Region 2, both on 
the virulence plasmid of EAEC 042 i.e. pAA2. Region 1 encodes the genes for chaperone 
(aafD), the fimbrial subunit (aafA) and the transcription regulator (aggR). Region 2 contains a 
chaperone pseudogene (afaB) and the genes for the usher protein (aafC) and fimbrial adhesin 
(aafB) (Figure 3.1). Elias et al. (1999) also reported that Region 1 is regulated by AggR, 
whilst Region 2 is not, and gave limited insight about the promoters of these genes. 
The study of Morin et al. (2010), identified AggR-binding sites at the aggR promoter and 
these sites are similar to the binding site of another member of the AraC family, Rns. 
Furthermore, Morin et al. (2013) identified AggR-regulated genes in the EAEC 042 genome 
and found that the fimbrial genes aafA, aafB, aafC and aafD from Region 1 and Region 2 are 
regulated by AggR. However, this study did not predict the promoter elements of these genes. 
The work detailed in this chapter concerns the identification of the AggR-dependent 
promoters of the fimbrial genes of EAEC 042, present in two clusters. DNA fragments of 







Figure 3.1 A Schematic representation of Region 1 and Region 2 of AAF/II 
genes on pAA2 plasmid 
The figure shows a schematic diagram of the pAA2 plasmid from EAEC strain 042 and the 
two regions that encode the attachment adherence fimbriae (AAF/II) Region 1 encodes aafD 
(a chaperone protein), aafA the (fimbrial subunit) and aggR (a transcription activator) genes 
and Region 2 encodes afaB (a chaperone pseudogene), aafC (the usher protein) and aafB (an 






3.2 Analysis of the regulation of Region 1  
3.2.1 Analysis of the upstream DNA sequence of aafD and aafA  
In Region 1 of pAA2, there are two structural genes aafD and aafA, which are likely to be 
transcribed as an operon. In order to locate promoters, which control the expression of aafD 
and aafA, DNA sequences upstream of the genes in Region 1 were cloned into pRW50 
(Figure 2.1). This is a vector that has a promoterless lac operon and any fragment cloned 
upstream of this operon, using the EcoRI and HindIII sites, can serve as a lac operon 
promoter. Thus, lacZ expression depends on the promoter activity of the cloned fragment.  
For the aafD gene, a 433 bp DNA fragment, aafD100, was cloned into pRW50 and 
bioinformatic analysis showed that this fragment contains potential AggR-binding sites 
(Figure 3.2). The schematic diagram of the aafD100 promoter fragment is shown in Figure 
3.3A. The recombinant plasmid, pRW50/aafD100, was transformed into the E. coli K-12 
strain BW25113 ∆lac carrying either pBAD/aggR or pBAD24 vector (Table 2.1). The cells 
were grown in LB medium at 37°C with shaking to mid-logarithmic phase (OD650=0.4-0.6). 
In the recombinant plasmid pBAD/aggR, aggR is cloned under the control of the araBAD 
promoter, so, 0.2% (w/v) arabinose was added to LB medium to induce the expression of 
aggR where appropriate. Promoter activities were determined by measuring β-galactosidase 
levels in lysates of cells containing these plasmids. 
 Results in Figure 3.3B show that during growth in LB with 0.2% (w/v) arabinose, β-
galactosidase levels measured in cells containing pBAD/aggR with pRW50/aafD100 
increased almost 30-fold in the presence of AggR when compared to an AggR negative 
control containing pBAD24 with pRW50/aafD100 (16593 and 524 units, respectively). This 









     433                              400 
      .  .         .         .         .         .         .         .    
GAATTCGCGTAAATAGTTGGAAAAGTTCATGCAGCATGTGGATGCTTACAGCAGATGGTATAACGAGCGGCGT 
                                                                 300 
      .         .         .         .         .         .         .          
ATAAAATTATCGCTGGGTGCAGTCAGCCCTGAAATGTACCGCCAACAATGCGGGCTGGCATAATAAAGCAGTCCA 
 
 .         .         .         .         .         .         .         . 
GGAAATCGTCCGCATCCCCTAACGGTCAAACATCGTGGCCTTGACAGCTCCCTTGGCGCGTAGTATTGCCAACTG 
               200 
      .         .         .         .         .         .         .         
AATCCCCCGTCAATACGGTTCTCACCGTATGCTCACTGCTTACAATTGCCTGACAGTAGCAACCAACTGAGAGGA 
                                        100 
 .         .         .         .         .         .         .         .  
TGCTATCTCACCTGATTTATTCAATAAAGTCTGCACAGTGGTGTTTATTTATCTTTTTAGTAACTTTGTTTTAAG 
                                                                 1 
      .         .         .         .         .         .        . 
TAGCATATTAACTTAATCGTAAAAGCCTCTAAAGAGGATGGAGAATGTATAAAATGAAAATACGGAAAGCTT 
 
Figure 3.2 The DNA base sequence upstream of the aafD gene 
The figure shows the 433 bp DNA sequence of the aafD100 promoter fragment. The open reading 
frame sequence is highlighted red and the potential AggR-binding sites are green. The restriction sites 





Figure 3.3 Analysis of aafD promoter fragment from Region 1  
A. The upper line shows a schematic arrangement of the Region 1 genes of pAA2. The lower 
part illustrates the aafD100 promoter fragment. The grey bar represents the upstream 
sequence of aafD and the red part of the bar represents 13 bp sequence of aafD present on the 
promoter fragment. The potential AggR-binding sites are indicated as green boxes. The DNA 
sequence in this diagram is numbered above the fragment from 1 to 433 and the fragment was 
cloned using EcoRI and HindIII restriction sites into pRW50. This diagram is not to scale. 
B. The panel illustrates β-galactosidase activity measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or aafD100 promoter fragment cloned 
into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells 
were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 
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A study by Elias et al. (1999) has shown that aafA is also an AggR-regulated gene, so, to 
investigate this, another fragment, aafA100, was cloned into pRW50. Bioinformatic analysis 
showed that this fragment also contains potential AggR-binding sites on the forward and the 
reverse strands Figure 3.4). The schematic diagram of the aafA100 promoter fragment is 
shown in Figure 3.5A. The results of β-galactosidase assays showed that cells containing 
pRW50/aafA100 with pBAD/aggR have similar β-galactosidase levels when compared to 
cells containing pRW50/aafA100 with pBAD24 (122 and 95 units, respectively) (Figure 
3.5B). This shows, there is a very weak promoter present upstream of aafA, and this promoter 
is not regulated by AggR. As cells containing pRW50/aafD100 showed β-galactosidase 
activity that was increased by AggR induction, while cells containing pRW50/aafA100 
showed little β-galactosidase activity, with no increase in the presence of AggR, this 
suggestss that an AggR-regulated promoter is present on the aafD100 promoter fragment and 
there is no AggR-regulated promoter on aafA100. This indicates that AggR regulates the 
proposed operon promoter of Region 1 and that the operon promoter is present upstream of 
aafD. 
3.2.2 Identification of the minimal regulatory region of the aafD promoter necessary for 
AggR-mediated activation 
To find out the minimal region of the aafD100 fragment fully induced by AggR, a series of 
nested deletions were made from the aafD100 fragment (aafD99 (333 bp) to aafD94 (73 bp)) 
and cloned into the lacZ expression vector pRW50 (Figure 3.6A and B). The first 3 deletions 
(aafD99 to aafD97) were made by successively deleting 100 bp in each nested fragment and 
the other 3 fragments (aafD96 to aafD94) were made by progressively deleting 20 bp in each 
nested fragment. The β-galactosidase activities measured from lysates of cells containing 











     433                              400 
      .  .         .         .         .         .         .         .  
GAATTCAAATCAACAAACTCTAATTCTAGTACAGAACGAAAAACACGCCGTATTACAGAAAATATAAACCAGTTA 
                                                               300 
    .         .         .         .         .         .         .         . 
CTTGGTCTATGCGGATATATAAGTGCATCATATAATACATCTTGGAATAATATCCTTCTTACTAGATTACTCATA 
 
         .         .         .         .         .         .         .     
CAACCGTAATATAATTGATTACTATGGTAACAAGAAAATCTCAAGAAACCTTATGGCGACATACATATCAAAAAA 
             200 
    .         .         .         .         .         .         .         .    
ATAGTTTCACAGCACAAGATACTAGTATGCATGAATTATTAAGTACTGGACCACCGAAATGGCCATTCTTCTGTT 
                                      100 
         .         .         .         .         .         .         .          
TCAGGTCAGAACGTATCGTAATGATAGAGTGTAAATAAAACGCTCTTTCTTTCTGTAGATGAATAAATATATACG 
                                                              1 
    .         .         .         .         .         .       . 
GAAACCACCTGTATATTTAAATGAAAAATAGATGTATTTTTAGAGGTTGACATGAAAAAAATCAAAGCTT 
 
Figure 3.4 The DNA base sequence upstream of the aafA gene 
The figure shows the 433 bp DNA sequence of the aafA100 promoter fragment. The open reading 
frame sequence is highlighted dark green and the potential AggR-binding sites are light green. The 







Figure 3.5 Analysis of aafA promoter from Region 1  
A. The upper line shows the schematic arrangement of the Region 1 genes on pAA2. The 
lower part illustrates aafA100 promoter fragment. The grey bar represents upstream sequence 
of aafA and the dark green part of the bar represents 13 bp sequence of aafA present in the 
promoter fragment. The potential AggR-binding sites are illustrated as green boxes on the 
forward and the reverse strands. The base sequence is numbered above the fragment from 1 to 
433 and the fragment was cloned using EcoRI and HindIII restriction sites into pRW50.This 
diagram is not to scale.  
B. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or aafA100 promoter fragment cloned 
into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells 
were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 






Figure 3.6 Nested deletion analysis of the aafD regulatory region 
A. The panel illustrates aafD100, aafD99, aafD98, aafD97, aafD96, aafD95 and aafD94 
promoter fragments. The grey bars represent upstream sequence of aafD and red bars 
represent coding sequence of aafD. Green boxes illustrate potential AggR-binding sites. All 
The fragments were cloned into pRW50 using EcoRI and HindIII restriction sites. This 
diagram is not to scale. 
B. The panel shows the sequence of the aafD96 fragment. The AggR-binding site is 
highlighted green, restriction sites grey and the sequence of aafD red. The underline sequence 
adjacent to EcoRI site was deleted to construct the aafD95 promoter fragment.  
C. The panel illustrates β-galactosidase activity measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or aafD100 promoter fragment 
derivatives cloned into pRW50. The cells also carry either pBAD/aggR (green bars) or 
pBAD24 (red bars). Cells were grown in LB medium in presence (+) or absence (-) of 0.2% 
(w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG hydrolysed per 





regulation of almost 30-fold while cells containing pRW50/aafD95 showed only about 4-fold 
increase in the presence of AggR (pBAD/aggR) (15192 and 1402 units, respectively) as 
compared to the AggR negative control (pBAD24). There was no AggR-induction observed 
in cells carrying pRW50/aafD94 (1-73 bp) (Figure 3.6B and C).  
These results show that an AggR-binding sequence is located between the end points of 
aafD95 and aafD96. The DNA binding sequence of AggR is predicted to be the Rns-binding 
site (Munson, 2013; Morin et al., 2010) (Figure 3.7). The AggR-binding site at the aafD 
promoter has TAT (from position 9 to 11) at the downstream end as predicted in other studies 
but has a G at the upstream end, instead of A which was found in the AggR-binding sites 
identified by Morin et al. (2010) (Figure 3.7). The low level of induction in cells containing 
pRW50/aafD95 is due to the AggR-binding site has been partially deleted in this fragment. 
The TATC part of the binding site is present on the fragment and the upstream part is deleted 
(Figure 3.6). 
3.2.3 Identification of the AggR-binding site at the aafD promoter, using mutational 
analysis  
Munson et al. (2010) confirmed the AggR-binding site at the aggR promoter by making point 
mutations in conserved T residues present in the downstream part of the AggR-binding site at 
positions 10 and 12 (Figure 3.7). To investigate the potential AggR-binding site identified at 
the aafD promoter, point mutations were made at positions 10 and 12 of the AggR-binding 
site (Figure 3.7). These positions of the AggR-binding site correspond to positons 90 and 92 
on the aafD96 promoter fragment (Figure 3.8A and B). The recombinant plasmids 
pRW50/aafD96-90C and pRW50/aafD96-92C90C were made by substituting the Ts with Cs 
at positions number 90 and 92. The plasmids were transformed into E. coli K-12 strain 







Figure 3.7 Alignment of the AggR-binding site of the aafD regulatory region 
with consensus sequence  
A. The panel the illustrates consensus sequence from Rns-binding logo by (Munson, 2013). 
The height of each letter corresponds to number of times each letter is present in the 31 Rns-
binding sites identified in the ETEC genome.  
B. The panel shows the sequence of the AggR-binding site identified at the aggR promoter of 
EAEC 042 (Morin et al., 2010).  
C. The panel shows the AggR-binding site from the aafD promoter sequence. The highlighted 
sequence shows the AggR-binding site (from position 3 to position 13) suggested to be 









Figure 3.8 Mutational analysis of AggR-binding site at aafD promoter. 
A. The figure illustrates aafD96, aafD96-90C and aafD96-92C90C promoter fragments. The 
grey bars represent upstream sequence of aafD and red bars represent aafD encoding 
sequence. Green boxes illustrate the potential binding sites of AggR and yellow boxes 
represent potential -10 hexamer element. The arrows with text indicate the positions of the 
point mutation and the base that has been substituted. This diagram is not to scale. 
B. The panel shows the base sequence of the aafD96 fragment. The AggR-binding site is 
highlighted in green, the potential -10 element yellow, the restriction sites grey and the aafD 
sequence is red. The arrows indicate the positions of point mutations and the base that has 
been substituted. 
C. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing aafD promoter derivatives cloned into the lacZ expression vector, pRW50. 
The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown 
in LB medium in the presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase 






medium at 37°C with shaking to mid-logarithmic phase (OD650=0.4-0.6) with and without 
0.2% (w/v) arabinose to express aggR. Promoter activities were determined by measuring β-
galactosidase levels in lysates of cells containing these plasmids. Results in Figure 3.8C show 
that the β-galactosidase activities measured in cells containing pRW50/aafD96-90C is 
decreased slightly when compared to the starting plasmid pRW50/aafD96 (8000 units and 
15500 units, respectively). No substantial AggR-dependant expression was observed in the 
cells containing pRW50/aafD96-92C90C in presence of AggR, in comparison to the AggR 
negative control (193units and 165 units, respectively) (Figure 3.8C). These results show that 
we have identified the AggR-binding site correctly and the T residues at position 90 and 92 
are important for AggR-binding and activation. These results show that mutations are made in 
the AggR-binding site essential for AggR-dependent induction of aafD promoter. Moreover, 
these two thymine bases are likely important for AggR-binding and AggR-dependent 
transcription regulation.  
Morin et al. (2010) identified the AggR-binding site sequence at the aggR promoter and the 
AggR-binding site identified at the aafD promoter is very similar. However, the binding site 
of the aafD promoter has G at position 3 instead of A (Figure 3.7), suggesting that other bases 
may be tolerated at this position. In order to identify the importance of this base, a series of 
mutant promoter fragments were made in which each of the 3 alternate bases were introduced 
at this position and the effect on AggR-dependent regulation was investigated (Figure 3.9A 
and B). Recombinant plasmids were transformed into E. coli K-12 strain BW25113 ∆lac, 
carrying either pBAD/aggR or pBAD24. The cells were grown in LB medium at 37°C with 
shaking to mid-logarithmic phase (OD650=0.4-0.6). The cells were grown in LB with and 
without 0.2% (w/v) arabinose to express the aggR. Promoter activities were determined by 





Figure 3.9 Mutational analysis of the AggR-binding site at the aafD promoter. 
A. The figure illustrates the aafD96, aafD96-99A, aafD96-99C and aafD96-99T promoter 
fragments. The grey bars represent upstream sequence of aafD and red bars represent coding 
sequence of aafD. Green boxes illustrate the potential binding sites of AggR and yellow 
boxes represent the potential -10 hexamer element. The arrow with the text indicates the 
position of point mutations and the base that has been substituted. This diagram is not to 
scale. 
B. The panel shows the base sequence of the aafD96 fragment. The AggR-binding site is 
highlighted green, the potential -10 hexamer element is yellow, the restriction sites grey and 
the coding sequence from aafD red. The arrow with the text indicates position of point 
mutation and the base that has been substituted to make point mutation. 
C. The panel illustrates β-galactosidase activity measured in the E. coli K-12 strain BW25113 
∆lac, containing aafD promoter derivatives cloned into lacZ expression vector, pRW50. The 
cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in 
LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity 




Figure 3.9C show that β-galactosidase activities measured in cells containing these plasmids 
have only two fold increase in activity in presence of AggR, when G was changed to A. Cells 
containing other mutants, had a similar β- galactosidase activity in presence of AggR to the 
starting plasmid, pRW50/aafD96. These results show that other bases can be tolerated at this 
position and suggest this pasition of the AggR-binding site may not play a crucial role in 
AggR-dependant promoter regulation. 
3.2.4 Mapping the transcription start site of the aafD promoter by primer extension 
To investigate the aafD promoter further, we carried out transcription start site mapping, in 
this instance using the aafD96 promoter fragment cloned into pRW50. The plasmid was 
transformed into E. coli K-12 strain BW25113 either containing pBAD/aggR or pBAD24. Cells 
were grown in LB medium with 0.2% (w/v) arabinose in triplicate cultures. The messenger 
RNA (mRNA) was collected in mid-logarithmic phase and purified. A 32P labelled primer 
that anneals downstream of the HindIII site in pRW50 was used to prime the RNA template 
for DNA synthesis, resulting in extension of the primer to the position corresponding to the 5′ 
end of the mRNA. An RNA dependant DNA polymerase was used to copy the messenger into 
DNA. The transcription start site was determined from the length of the extended product. 
Reaction mixes after extension were loaded on to a 6% (w/v) denaturing polyacrylamide gel 
alongside a M13 reference genome sequence, which was used as a sequence ladder (Figure 
3.10A).  
Results in Figure 3.8B show that the primer extension product from the aafD promoter 
fragment produced two bands that are separated by 2 bp and correspond to the 56 and 54 bp 
of aafD96 fragment, respectively. The length of these products were calculated by comparing 
the bands to corresponding base of calibrated M13mp18 reference genome sequence (Figure 






Figure 3.10 Mapping the transcription start site of the aafD promoter 
A. The panel shows an autoradiogram of the gel run to determine the extension products from 
the aafD promoter calibrated with Phage M13 reference sequence (A, C, G and T) which 
serves as nucleotide ladder in this reaction. AggR (+) and AggR (-) represent presence of 
pBAD/aggR, and pBAD24, respectively. Arrows show the bands of the primer extension 
products in the presence of AggR. The length of these bands was calculated by using the 
calibration sequence.  
B. The panel shows the sequence of the aafD96 fragment. The AggR-binding site is 
highlighted green, the potential -10 hexamer element yellow, the restriction sites grey and the 
sequence from aafD red. The bent arrows indicate the transcription start sites of the aafD 
promoter and are marked on the basis of the primer extension product length shown above. 







transcription start sites, the smaller product may be produced after post transcriptional 
processing of an original product (Figure 3.10B). Most probably the longer product reflects 
the transcription start site because it is at the most appropriate distance from a potential -10 
element (TAGCAT). Note, there were no visible bands for AggR negative samples. This 
shows no transcriptional expression of aafD occurs in the absence of AggR (Figure 3.10) and 
the transcript is formed due to AggR-dependent induction of the promoter. 
3.2.5 Identification of the -10 element of the aafD promoter using mutation analysis 
A potential -10 hexamer element was identified on the basis of similarity to consensus 
sequence (TATAAT) and the distance from the transcription start site (Figure 3.10B). There 
are four out of six base matches to the consensus sequence in this potential -10 hexamer 
element. The potential -10 hexamer element was investigated by making point mutations at 
position 2 (corresponds to position 65 bp on aafD96 promoter fragment) and an A present at 
position 65 of the aafD96 was substituted with C to construct aafD96-65C promoter 
fragment, which was cloned into pRW50 (Figure 3.11A and B). 
The plasmids were transformed into E. coli K-12 strain BW25113 ∆lac carrying either 
pBAD/aggR or pBAD24. The cells were grown in LB medium at 37°C with shaking to mid-
logarithmic phase (OD650=0.4-0.6). In the recombinant plasmid pBAD/aggR, aggR is cloned 
under the control of the araBAD promoter, so, 0.2% (w/v) arabinose was added to LB 
medium to induce the expression of aggR where appropriate. Promoter activities were 
determined by measuring β-galactosidase levels in lysates of cells containing these plasmids. 
Results in Figure 3.11C show that β-galactosidase activity measured in cells containing 
pRW50/aafD96-65C (contains a single bp mutation) resulted in the complete loss of AggR-
dependent expression. This confirms that the -10 element has been predicted correctly and 






Figure 3.11 Identification of the -10 element of the aafD promoter 
A. The figure illustrates the aafD96 and aafD96-65C promoter fragments The grey bars 
represent the upstream sequence of aafD and red bars represent the coding sequence of aafD. 
Green boxes illustrate the binding sites of AggR and yellow boxes represent the -10 hexamer 
element. The arrow indicates the position of the point mutation and the base that has been 
substituted. The bent arrows indicate the transcription start sites of the aafD promoter. This 
diagram is not to scale.  
B. The panel shows the sequence of the aafD96 promoter fragment. The AggR-binding site is 
highlighted green, the -10 hexamer element yellow, the restriction sites grey and the sequence 
of aafD red. The arrow indicates the position of the point mutation introduced into the 
fragment and the base that has been substituted. The bent arrows indicate transcription start 
sites of the aafD promoter. 
C The panel illustrates β-galactosidase activity measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or aafD promoter derivatives cloned 
into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells 
were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 




3.2.6 Identification of the translation start site of the aafD operon reading frame 
Bioinformatic analysis of the sequence upstream of aafD open reading frame also showed that 
it contains two possible start codons (in frame ATGs) for aafD translation. Previously, Elias 
et al. (1999) predicted the promoter and translation start site of aafD, whilst Chaudhuri et al. 
(2010) proposed another translation start site. Therefore, to investigate this, the aafD100 
promoter fragment was modified to generate an in frame translational fusion. The translation 
of an mRNA transcript into protein usually starts on the ATG codon, and, in the aafD gene, 
two in-frame ATG codons are just 6 bp apart (Figure 3.12A and B). Elias et al., (1999) 
predicted the upstream ATG as the translational start codon, whilst Chaudhuri et al. (2010) 
reported that the start codon for aafD is two codons downstream. To resolve this, two aafD 
translational fusions, aafD1001 and aafD1002, were made from aafD100 promoter fragments 
by deleting 10 bp and 19 bp, respectively adjacent to HindIII site (Figure 3.12A). These 
derivatives with either both upstream and downstream ATGs (aafD1001) or upstream ATG 
alone (aafD1002) were cloned into pRW225 (Figure 2.17). Plasmid pRW225 is a lacZ fusion 
vector, which lacks a translational start codon and ribosomal binding site (RBS) for lacZ 
gene. Thus, translation depends upon the start codon and RBS of the cloned fragment. Hence, 
β-galactosidase production indicates that translation has occurred. The results in Figure 3.12C 
show that the β-galactosidase level was considerably higher when the downstream ATG was 
fused in-frame to lacZ i.e. pRW225/aafD1001 when compared to the upstream fusion i.e. 
pRW225/aafD1002 (22443 units and 269 units in presence of AggR, respectively). These 
results indicate that the downstream ATG codon encoded by aafD1001 is the translation start 






Figure 3.12 Identification of translational start site of the aafD open reading 
frame 
A. The upper line shows the arrangement of the genes of Region 1 on pAA2. The lower part 
shows two derivatives of the aafD100 promoter fragment: aafD1001 contains the two in 
frame ATG (start codons) and aafD1002 contains only one in frame ATG codon. These 
promoter derivatives were cloned into pRW225 in such a way that the ATG codons from each 
derivative serve as translational start codons for lacZ on pRW225. The green boxes show 
potential AggR-binding sites and the red highlighted ATG is from aafD coding sequence. The 
diagram is not to scale. 
B. The panel shows the sequence from 3' end of the aafD1001 promoter fragment that was 
cloned in pRW225 using HindIII sites. The grey highlighted sequence is the restriction site 
and yellow is the -10 hexamer element. The bent arrows indicate transcription start sites and 
underline sequences show the in-frame ATG codons. 
C The panel illustrates β-galactosidase activity measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW225) or aafD promoter derivatives cloned 
into pRW255. The cells also carried either pBAD/aggR (green bars) or pBAD24 (red bars). 
Cells were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 




3.3 Transcriptional regulation analysis of the Region 2 of pAA2 
3.3.1 Analysis of the upstream DNA sequences of afaB and aafC  
Region 2 of plasmid pAA2 encodes two genes (aafC and aafB) and a pseudogene (afaB). The 
Region 2 genes and the pseudogene are likely to be transcribed as an operon and to identify 
the location of the operon promoter for Region 2, approximately 400 bp of DNA upstream of 
the afaB pseudogene was cloned into pRW50. This sequence carries potential AggR-binding 
sites, as judged by comparing to the proposed AggR-binding sequence suggested by Morin et 
al. (2010) (Figure 3.13). The schematic diagram of the afaB100 promoter fragment is shown 
in Figure 3.14A. 
The recombinant plasmid, pRW50/afaB100 was transformed into E. coli K-12 strain 
BW25113 ∆lac with either pBAD/aggR or pBAD24. The cells were grown in LB medium at 
37°C with shaking to mid-logarithmic phase (OD650=0.4-0.6) and 0.2% (w/v) arabinose was 
added to LB medium to induce the expression of aggR where appropriate. Promoter activity 
was determined by measuring β-galactosidase levels in lysates of cells containing the 
plasmid. Results in the Figure 3.14B show that β-galactosidase activity measured in cells 
containing pRW50/afaB100 increased almost 20-fold in the presence of AggR (pBAD/aggR) 
as compared to AggR negative cells (pBAD24) (558 and 25 units, respectively). These results 
show that there is an AggR-dependent promoter upstream of pseudogene afaB. 
Elias et al. (1999) previously demonstrated that operon promoter for Region 2 was present 
upstream of aafC instead of afaB. To investigate this, 410 bp of DNA sequence upstream of 
aafC was cloned into pRW50 (Figure 3.15). Bioinformatics analysis also showed that this 
fragment carried a potential AggR-binding site on the reverse strand. The schematic diagram 








     413          400 
      .  .         .         .         .         .         .         .      
GAATTCGACATGATAACGAATTAAGCAAGGAGGCTGAACAATTTATAATAAGATAACAAAATACTCCTGTTTTAT 
                                           300 
    .         .         .         .         .         .         .         . 
ATTTTAATGATTCCGTGTTTTTATTATCATTATGTGACATTCCTGCACTGTATCTTTAATAGGTGGGCTGGGCAG 
                                                                    200 
         .         .         .         .         .         .         .      
GTTTGCTATCGTAGATGGACAATAATAAATTAAGGATAAATAATAATTGTTAATTACCTTTCACAGGTAATGCAG 
 
    .         .         .         .         .         .         .         . 
ATGGATTAAAGAAAGTGTGTCGAATAATTTTTACGGAGCTTTCTGGGCTGTATGAATATGCGGGACGTGTTTATA 
                   100 
         .         .         .         .         .         .         .   
TTCGGTGATGTATTGGTAGGGGCCTTATTAGTGGCTATGTTGCTTACATTTTTCTATCAGCAGACGCGCAGGCAG 
                                           1 





Figure 3.13 The DNA base sequence upstream of the pseudogene afaB  
The figure shows the 413 bp DNA sequence of the afaB100 promoter fragment. The sequence from 
afaB pseudogene has been highlighted red and the potential AggR-binding sites are green. The 





Figure 3.14 Identification of the afaB promoter from Region 2  
A. The upper line shows the schematic arrangement of the genes on pAA2 Region 2. The 
lower part illustrates the afaB100 promoter fragment, the grey bar represents upstream 
sequence of afaB and the red bar represents 13 bp sequence of afaB pseudogene present in the 
promoter fragment. The potential AggR-binding sites are indicated as green boxes. The DNA 
sequence in this diagram is numbered above fragment from 1 to 413 and the fragment was 
cloned using EcoRI and HindIII restriction sites into pRW50. This diagram is not to scale. 
B. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or the afaB100 promoter fragment 
cloned into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red 
bars). Cells were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) 
arabinose. β-galactosidase activity was measured as nmol of ONPG hydrolysed per minute 



















     410       400 
      .         .         .         .         .         .         .      
GAATTCAGGCTGACGATAAATGGGAGGAAGGCGATAAGATGATGCTGAATGTACAGCTTTCATTAAGTTATTGTA 
                                        300 
 .         .         .         .         .         .         .         . 
TCAAACTATTTGTTCGCCCGCCAAGAGTGAAGGGACGTCCTGATGAGATGGCAGGAAAAGTAGAGTGGCAGAAGT 
                                                                 200 
      .         .         .         .         .         .         .       
CAGTAACAAACTGAAGGGAATAAACCCGCACCATTTTATATCAATATGTCTGAACTAATGGTGGGAACGGTAAGG 
 
 .         .         .         .         .         .         .         . 
TCCAGTGGACGGTGGTGACGGATTATGGTGGAAGTAGTAAGCAATTTGAGGCCGATCTTAAGGGGTAATAATCTA 
               100 
      .         .         .         .         .         .         . 
GTTAATCATTTTTTCATGAGTTATGAAAGGGTAATAATCCGTGTGTGAATTTTCTCTGTGGCAGATAAAGACAAG 
                                        1 
 .         .         .         .        . 
TCTTACTGCTGTGGCATATTCAGTGATGATGACATGTACATAAGCTT 
 
Figure 3.15 The DNA base sequence upstream of the aafC gene 
The figure shows the 413 bp DNA sequence of the aafC100 promoter fragment. The open reading 
frame sequence is highlighted blue and the potential AggR-binding site is green. The restriction sites 








Figure 3.16 Analysis of the DNA sequence directly upstream of aafC  
A. The upper line shows a schematic arrangement of genes on pAA2 around Region 2. The 
red bar represents the sequence from afaB pseudogene, blue bar represents aafC encoding 
sequence and grey bar represents sequence upstream of aafC. The potential AggR-binding 
site is indicated as green boxes. The DNA sequence in this diagram is numbered above 
fragment from 1 to 410 and the fragment was cloned using EcoRI and HindIII restriction sites 
into pRW50. This diagram is not to scale. 
B. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or aafC100 promoter fragment cloned 
into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells 
were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 





transformed into E. coli K-12 strain BW25113 ∆lac, with either pBAD/aggR or pBAD24. 
The β-galactosidase activity measured in cells containing pRW50/aafC100 showed very low 
levels (15 units) and activity was not increased when AggR expression was induced (Figure 
3.16B). This shows that there is an extremely weak promoter present upstream of aafC which 
is not AggR-regulated.  
These results show that an AggR-regulated promoter is located on the afaB100 promoter 
fragment and there is no AggR-regulated promoter on the aafC100 promoter fragment. Thus, 
we conclude that an AggR-regulated promoter is present upstream of afaB and the proposed 
operon promoter of Region 2 is present upstream of afaB rather than of aafC. 
3.3.2 Mapping of gene regulatory region on Region 2 
The results above indicate that there is a promoter upstream of the afaB pseudogene, which 
directs transcription into Region 2 and this presumably transcribes the entire operon. This 
contradicts the results of Elias et al. (1999) which suggested that the promoter was present 
directly upstream of aafC and not afaB. To investigate, if there is another promoter directly 
upstream of aafC, two large promoter fragments afaBC100 and afaBC99 were cloned into 
pRW50. The afaBC100 fragment was made by cloning all the DNA sequence starting from 
the 5' end of the afaB100 promoter fragment to 3' end of aafC100 fragment (Figure 3.17). The 
other construct afaBC99 was made by cloning the DNA sequence starting from upstream of 5' 
end of afaB to 3' end of aafC100 fragment (Figure 3.18A). The recombinant plasmids were 
transformed into E. coli K-12 strain BW25113 ∆lac with either pBAD/aggR or pBAD24. The 
cells were grown in LB medium at 37°C with shaking to mid-logarithmic phase (OD650=0.4-
0.6) and 0.2% (w/v) arabinose was added to LB medium to induce the expression of aggR 
where appropriate. Promoter activities were determined by measuring β-galactosidase levels 





































Figure 3.17 The DNA base sequence upstream of the aafC  and afaB pseudogene 
The figure shows the 1088 bp DNA sequence of the promoter fragment containing aafC sequence 
shown in blue, upstream of aafC and afaB shown in black and afaB sequence shown in red. The 
potential AggR-binding sites are green highlighted green and the restriction sites EcoRI and HindIII 





Figure 3.18 Analysis of the Region 2 operon promoter  
A. The upper line shows the schematic arrangement of genes on pAA2 around Region 2. The 
lower part illustrates upstream sequence of aafC with potential AggR-binding sites as green 
boxes. The red bars represent the sequence from afaB pseudogene, blue bars represent aafC 
encoding sequence and grey bars represent sequence upstream of afaB pseudogene and aafC. 
These fragments were cloned using EcoRI and HindIII restriction sites into pRW50.  
B. The panel illustrates the β-galactosidase activities measured in the E. coli K-12 strain 
BW25113 ∆lac, containing the lacZ expression vector (pRW50) or one of aafC100, afaBC100, 
afaBC99 and afaB100 promoter fragments cloned into pRW50. The cells also carry either 
pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB medium in presence 
(+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of 






The β-galactosidase activities measured in cells containing these fragments cloned into 
pRW50 show that pRW50/afaBC99 has very low or no promoter activity and expression was 
not induced by AggR. In cells containing pRW50/afaBC100 substantial promoter activity was 
detected and this was AggR-inducible. Furthermore, the β-galactosidase activity observed in 
cells containing pRW50/afaBC99 was comparable to the β-galactosidase activity measured in 
the cells containing pRW50/aafC100 and similarly the level of expression measured in cells 
containing pRW50/afaBC100 was comparable to activity observed in cells containing 
pRW50aafB100  (Figure 3.18B). These results confirm that the Region 2 operon promoter is 
upstream of afaB and it is regulated by AggR, whilst there is no AggR-dependent promoter 
directly upstream of aafC. 
3.3.3 Identification of the minimal regulatory region of the afaB100 promoter necessary 
for AggR-mediated activation 
As AggR was found to activate the afaB promoter substantially, three nested deletions were 
made, (afaB99 to afaB97), by removing 100 bp from 5' end of the afaB100 promoter 
fragment to locate the minimal promoter fragment induced by AggR (Figure 3.19A and B). 
The derivative promoter fragments (afaB99 to afaB97) were then cloned into the lacZ 
expression vector pRW50. The plasmids were transformed into E. coli K-12 strain BW25113 
∆lac with either pBAD/aggR or pBAD24. The cells were grown in LB medium at 37°C with 
shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was added to LB medium to 
induce the expression of aggR where appropriate. Promoter activities were determined by 
measuring β-galactosidase levels in the lysates of cells containing these plasmids. Results in 
Figure 3.19C show that the β-galactosidase activity measured in cells containing 
pRW50/afaB100 was increased in the presence of AggR while the β-galactosidase activity 





Figure 3.19 Deletion analysis of the afaB promoter  
A. The diagram shows the afaB100, afaB99, afaB98 and afaB97 promoter fragments with the 
AggR-binding sites shown as green boxes on the forward and the reverse strand. The grey bar 
represents upstream sequence of afaB and the red bar represents 13 bp sequence of afaB 
pseudogene present in the promoter fragment. The base sequences are numbered from 1 to 
413 on afaB100 promoter fragment and cloned using EcoRI and HindIII restriction sites into 
pRW50. This diagram is not to scale. 
B. The panel shows the sequence of the afaB100 promoter fragment. The AggR-binding sites 
are highlighted green, the restriction sites grey and the sequence from afaB pseudogene red. 
The underlined sequence adjacent to EcoRI was deleted to construct the afaB99 fragment. 
C The panel illustrates the β-galactosidase activities measured in the E. coli K-12 strain 
BW25113 ∆lac, containing the lacZ expression vector (pRW50) or afaB100 promoter fragment 
derivatives cloned into pRW50. The cells also carry either pBAD/aggR (green bars) or 
pBAD24 (red bars). Cells were grown in LB medium in presence (+) or absence (-) of 0.2% 
(w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG hydrolysed per 




showed no increase in levels when AggR-expression was induced. This suggests that the 
AggR-binding site responsible for promoter induction has been deleted or disrupted in afaB99 
fragment. 
3.3.4 Identification of the AggR-binding site on the afaB promoter using mutation 
analysis 
Sequence analysis of the afaB promoter sequence suggest that there were three potential 
AggR-binding sites between the afaB99 and afaB100 promoter fragments. There was one 
potential AggR-binding site on the forward strand and two potential AggR-binding sites on 
the reverse strand (Figure 3.19A and B). To investigate the AggR-binding site required for 
AggR-dependent regulation, point mutations were introduced into the conserved T residues of 
the AggR-binding site on the forward strand and this sequence was aligned with consensus 
sequence inFigure 3.20. In this afaB, AggR-binding site, the Ts at position 10 and 12 of 
AggR-binding site were substituted with Cs. These mutations in the AggR-binding site 
correspond to position 318 and 320 on the afaB100 promoter fragment and substitutions in 
the AggR-binding site were introduced to construct afaB100-320C318C fragment (Figure 
3.21A and B). 
The plasmids were transformed into E. coli K-12 strain BW25113 ∆lac with either 
pBAD/aggR or pBAD24. Cells were grown in LB medium at 37°C with shaking to mid-
logarithmic phase and 0.2% (w/v) arabinose was added to induce the expression of aggR 
where appropriate. Promoter activities were determined by measuring β-galactosidase levels 
in lysates of cells containing these plasmids. The β-galactosidase activity measured in cells 
containing pRW50/afaB100-320C318C showed no increase when AggR expression was 
induced (Figure 3.21C). These results indicate that the AggR-binding site that has been 






Figure 3.20 Alignment of the AggR-binding site of the afaB regulatory region 
with the consensus sequences of Rns and AggR 
A. The panel illustrates consensus binding sequence for Rns, (Munson, 2013). The height of 
each letter corresponds to conservation of sequence in 31 Rns identified on ETEC genome.  
B. The panel shows the sequence of the essential AggR-binding site identified on aggR 
promoter (Morin et al., 2010).  
C. The panel shows the AggR-binding sequence from afaB promoter. The green highlighted 
sequence shows the AggR-bindings sequence (from position 3 to position 13) which is 








Figure 3.21 Mutational analysis of the afaB100 promoter fragment 
A. The figure illustrates the afaB100 and afaB100-320C318C promoter fragments. The grey 
bar represents upstream sequence of afaB and the red bar represents 13 bp sequence of afaB 
pseudogene present in the promoter fragment. Green boxes indicate the potential AggR-
binding sites on the forward and reverse strands and the potential -10 hexamer is presented as 
yellow. These fragments were cloned into pRW50, using EcoRI and HindIII restriction sites. 
The arrows, with text, indicate the positions of point mutations and the bases that have been 
substituted to make these point mutations. This diagram is not to scale.  
B. The panel shows the sequence of afaB100 fragment. The AggR-binding sites are 
highlighted green, the potential -10 hexamer element yellow, the restriction sites grey and the 
sequence from afaB red. The arrows with the text indicate position of the point mutations. 
C The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or afaB promoter derivatives cloned into 
pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells 
were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 





3.3.5 Mapping of the transcription start site of the afaB promoter by primer extension 
To investigate the transcription start site of the afaB promoter, primer extension was used. In 
this method plasmid pRW50/afaB100 was transformed into E. coli K-12 cells, carrying either 
the pBAD/aggR vector or pBAD24. The cell cultures were grown in triplicate to mid-
logarithmic phase in LB in the presence of 0.2% (w/v) arabinose with shaking at 37°C. The 
mRNA was collected in mid-logarithmic phase and purified. A 32P labelled primer that 
anneals downstream of the HindIII site in pRW50 was used to prime DNA synthesis, 
resulting in the extension of the primer to the position corresponding to the 5′ end of the 
message, using RNA dependant DNA polymerase. The transcription start site was then 
determined from the length of the extended primer product.  
Reaction mixes were loaded onto a 6% (w/v) denaturing polyacrylamide gel. The length of 
the products was determined by comparing the bands to the calibrated M13mp18 reference 
sequence (Figure 2.29 and Figure 3.22A). Results in Figure 3.22B show that the two bands 
correspond to the positions 280 and 266 on the afaB100 promoter fragment. These two bands 
could be explained by the presence of two transcription start sites or the smaller product may 
have been produced after the post transcription processing of the original product. In this 
study, only the large product is considered as a transcription start site due to its appropriate 
distance from the potential -10 hexamer element. There were no visible bands in the AggR 
negative samples indicating that no transcription has occurred in the absence of AggR. 
3.3.6 Identification of the -10 element on the afaB promoter using mutational analysis 
At the afaB promoter region a potential -10 hexamer element was identified on the basis of 
resemblance to the consensus sequence (TATAAT) and the distance from the major 
transcription start site seen in primer extension (Figure 3.23A and B). A potential -10 






Figure 3.22 Analysis of the transcription start site of the afaB promoter 
A. The panel shows an autoradiogram of the gel run to determine the extension product of the 
afaB transcript and is calibrated with Phage M13mp18 reference sequence. Phage M13 
reference sequence serves as nucleotide ladder in this reaction (lane A, C, G and T). Arrows 
show the bands of the primer extension product produced in the presence of AggR. The 
length of these bands is calculated by corresponding base in the calibration sequence. 
B. The panel shows the sequence of the afaB100 fragment. The AggR-binding site is 
highlighted green, the potential -10 hexamer element yellow, the restriction sites grey and the 
sequence from afaB pseudogene red. The bent arrows indicate the transcription start sites of 
afaB identified by primer extension product. The M13mp18 reference sequence shown in 







Figure 3.23 Identification of -10 element of the afaB promoter  
A. The figure illustrates the afaB100 and afaB100-293C promoter fragments. The grey bar 
represents upstream sequence of afaB and the red bar represents 13 bp sequence of afaB 
pseudogene present in the promoter fragment. Green boxes indicate potential AggR-binding 
sites on forward and reverse strands. These fragments were cloned into pRW50 using EcoRI 
and HindIII restriction sites. The arrow, with text, indicates positon of point mutation 
introduced. The bent arrows illustrate transcription start sites. This diagram is not to scale. 
B. The panel shows the sequence of the afaB100 fragment. The AggR-binding sites are 
highlighted green, the potential -10 hexamer element is yellow, the restriction sites are grey 
and the sequence from afaB is red. The arrows, with the text, indicate position of the point 
mutation introduced. The bent arrows illustrate the transcription start sites. 
C The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector (pRW50) or afaB promoter derivatives cloned into 
pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells 
were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-
galactosidase activity was measured as nmol of ONPG hydrolysed per minute per milligram 




upstream of the transcription start site. Therefore, a point mutation from A to C at position 2 
of the -10 hexamer element was introduced into the afaB100 promoter fragment. This 
corresponds to position 293 on afaB100 promoter fragment and it resulted in the afaB100-
293C promoter fragment (Figure 3.23A and. B). The plasmids were transformed into E. coli 
K-12 strain BW25113 ∆lac carrying either pBAD/aggR or pBAD24. Cells were grown in LB 
medium at 37°C with shaking to mid-logarithmic phase (OD650=0.4-0.6) and 0.2% (w/v) 
arabinose was added to LB medium to induce the expression of aggR where appropriate. 
Promoter activities were then determined by measuring the β-galactosidase levels in lysates of 
cells containing these plasmids. The β-galactosidase levels measured in cells containing 
pRW50/afaB100-293C were lower when compared to the wild type promoter activity with 
this single base pair mutation (Figure 3.23C). This confirms that it is the -10 hexamer element 
of the afaB promoter and it is required for AggR-dependent expression. 
3.3.7 Comparison of aafD and afaB promoters 
Promoter elements of aafD and afaB have been identified in this study and β-galactosidase 
assays in cells containing pRW50/aafD96 and pRW50/afaB100 showed that the higher 
expression was observed in cells containing aafD96 promoter fragment in comparison to 
afaB100 promoter fragment in the presence of AggR (Figure 3.6 and Figure 3.14). However, 
to compare the expression levels of these promoters correctly the promoters must be cloned 
into a suitable vector. Therefore, to investigate, if there is any difference in promoters strength 
at the transcription level, aafD and afaB promoter fragments were cloned into pRW224, using 
EcoRI and HindIII sites. This plasmid contains its own SD and translational start codon for 
lacZ and thus, any difference in β-galactosidase activity would be completely due to 
transcription regulation. As the aafD promoter fragment already contains a translational start 




site, i.e. the aafD500 fragment. As afaB is a pseudogene and does not contain a translational 
start codon, the afaB100 promoter fragment was cloned into pRW224 (Figure 3.24A and B). 
The plasmids were transformed into E. coli K-12 strain BW25113 ∆lac carrying either 
pBAD/aggR or pBAD24. Cells were grown in LB medium at 37°C with shaking to mid-
logarithmic phase (OD650=0.4-0.6) and 0.2% (w/v) arabinose was added to LB medium to 
induce the expression of aggR where appropriate. Promoter activities were determined by 
measuring β-galactosidase levels in lysates of cells containing these plasmids. The β-
galactosidase levels measured in cells containing pRW224/aafD500 showed an 18-fold higher 
activity in comparison to the cells containing pRW224/afaB100 with AggR-induction (Figure 
3.24C). These results show that the aafD promoter is a consdierably stronger promoter than of 
the afaB promoter. 
3.4 Discussion 
EAEC is a pathogen and it has many virulence factors. The first step in the disease process is 
the attachment of EAEC to the intestinal cells of the human gut, which is mediated by AAF. 
The expression of the fimbrial genes and many other virulence determinants is under the 
control of AggR (Elias et al., 1999; Morin et al., 2013). In this study, the fimbrial promoters 
have been located in both Region 1 and Region 2 and the AggR-binding sites important for 
AggR-dependent regulation, have been identified at these promoters.  
This current work found that the fimbrial encoding genes in Region 1 are transcribed by a 
single operon promoter, present upstream of aafD, which is regulated by AggR. The study by 
Elias et al. (1999) had predicted an AggR-dependent promoter upstream of aafD but the 
promoter elements identified in this present work are different. In Region 2 the fimbrial genes 





Figure 3.24 Comparison of aafD and afaB promoter transcriptional fusions 
A. The figure illustrates the aafD500 and afaB100 promoter fragments. Green boxes indicate 
the potential AggR-binding sites on forward and reverse strands and yellow boxes represent 
the -10 hexamer elements. The upstream sequence of genes is shown as grey bars and red bar 
represent 13 bp of afaB pseudogene. These fragments were cloned into pRW50 using EcoRI 
and HindIII restriction sites. The bent arrows indicate the trancriptional start sites. 
B. The panel shows the sequences of the aafD and afaB promoter elements. The AggR-
binding sites are highlighted green, the -10 elements yellow and the bent arrows illustrate the 
transcription start sites. The distance between -10 hexamer elements and AggR-binding sites 
is 22 bp, marked with a line.  
C The panel illustrates the β-galactosidase activities measured in the E. coli K-12 strain 
BW25113 ∆lac, containing the lacZ expression vector (pRW224), afaB100 promoter fragment 
or aafD500 promoter fragment cloned into pRW224. The cells also carry either pBAD/aggR 
(green bars) or pBAD24 (red bars). Cells were grown in LB medium in presence (+) or 
absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG 




aafC and aafB. The study by Elias et al. (1999) found that the promoter for Region 2 lies 
directly upstream of aafC rather than the afaB pseudogene. The current study has shown that 
the promoter of Region 2 is located upstream of afaB instead of aafC gene.  The differential 
findings from this previous study might be explained by differences in the techniques and 
strains used to map the promoters. 
The AggR-binding sites at the aafD and afaB promoters overlap with the -35 element of the 
promoter and there are 22 bp between the -10 hexamer element and the AggR-binding site 
(Figure 3.24). This result is similar to that observed by Bodero et al. (2007) for 
Rns-dependent promoters (CS17, CS19 and PCF071), as the distance between -10 hexamer 
element and Rns-binding site is 22 bp and overlapping the -35 hexamer element. As no 
structural data is available for AggR, Rns or other closely related members of the AraC 
family, a little information of protein DNA interaction is available. However, Munson (2013) 
showed that Rns binds to one face of the DNA and its recognition HTHs bind to two adjacent 
major grooves (Munson, 2013). As AggR has the same number of amino acids and the 
sequence is conserved in the HTH region, it can be suggested that AggR binds in a similar 
fashion on the promoter as Rns does. The position of the AggR-binding site in relation to the 
other promoter elements at both afaB and aafD, suggests these promoters are Class II 
promoters (Browning and Busby, 2004). 
The results from Figure 3.24C show that the promoter of Region 1 (aafD) is much stronger 
than the promoter of Region 2 (afaB). This is logical as it is physiologically required to 
produce more chaperone and fimbrial subunits than usher protein and adhesion subunits 
(Figure 1.2). To identify, the molecular basis for promoter strength, the promoter sequences 
were aligned and the -10 hexamer element of afaB promoter was found to be closer to the 




the situation and no outstanding differences were evident when the AggR-binding sites of 
both promoters were compared.  A single base difference at position 3 of the AggR-binding 
site was observed between afaB and aafD promoter when compared to the consensus 
sequence of (Morin et al., 2010). However, the difference at this location can be tolerated 
(Figure 3.9). The studies of Rns-dependent promoters have also shown that position 3, can 
also be variable (Munson and Scott, 1999; Munson, 2013). Thus, these differences do not 
explain the difference in promoter strength between the aafD and afaB promoters. The spacer 
element of the aafD promoter is more A-T rich than afaB promoter and it could be important 
for transcription regulation (Figure 3.24). The flanking sequences around promoter elements 
and the AggR-binding sites could also contribute to promoter strength (Singh et al., 2011). 
However, it is not obvious why the strength of the aafD promoter is much higher than afaB at 
this present time.  
Results in Figure 3.12 demonstrate that the translational start site for aafD, proposed by Elias 
et al. (1999) is incorrect and that another translational start site two codons downstream is in 
fact the correct one. This finding matches with the translational start site proposed by 
Chaudhuri et al. (2010). Moreover, the SD sequence of aafD is closer to the consensus 
sequence and it might have further contributed to the strength of aafD promoter to translate its 
transcript into functional protein. 
The work detailed in this chapter has given us understanding of AggR-dependent regulation 
of transcription and the organisation of AggR-dependent promoter. Further characterization of 
AggR and its mechanism of regulation would reveal new insight into this important 











Regulation of dispersin and T6SS gene promoters of the 










4.1 Introduction  
AggR regulates 44 genes present on the genome of EAEC 042 and in this chapter two of the 
operon promoters present upstream of the aap and aai genes are studied (Morin et al., 2013). 
In the first part of this chapter (sections 4.2 and 4.3), deletion and mutational analysis of these 
promoters is detailed. To understand better the organisation of AggR-regulated promoters, 
semi-synthetic promoters were also constructed and these are discussed in the last part of the 
chapter.  
4.2 Regulation of dispersin expression by AggR 
Dispersin is an important virulence determinant and is encoded by the aap (anti-aggregation 
protein) gene. Dispersin was named, due to its ability to bind to the EAEC bacterial surface 
and reduce autoaggregation (Sheikh et al., 2002). This reduction in autoaggregation helps in 
the attachment of cells to intestinal surfaces and facilitates the bacteria in spreading infection 
(Figure 1.5). Hence, an aap depleted strain of EAEC 042 was less virulent when compared to 
the wild type strain (Sheikh et al., 2002).The aap gene is located upstream of aggR on 
plasmid pAA2 and it is regulated by AggR at the level of transcription (Figure 1.4). Dispersin 
is not confined to EAEC strains only but it is also present in other E. coli strains. Although, 
the dispersin protein sequence has been identified in different strains of E. coli including 
EAEC 042, but the promoter elements for aap have not been investigated to date. 
4.2.1 Analysis of the aap DNA upstream sequence of aap 
In order to study the promoter of aap, a 262 bp DNA fragment, aap100, was cloned into the 
lacZ expression vector, pRW50 (Figure 4.1). The schematic diagram of the aap100 promoter 
fragment is shown in Figure 4.2A. The conventional numbering system according to the 








       260                                                         200 
        .         .         .         .         .         .         .  
GAATTCGTATTGTTAAATTACAAATGGATGGTTAACATGTATTATAAAATAATATAAAAATAAAAATGGGCATCC 
 
   .         .         .         .         .         .         .         .      
CTCAGTCGAAACGAGTAACACTCGATATATGTTGCTATTTTTTATCTGGCCGCAACTCTTATTTATGCTAGCCTT 
                 100         
        .         .         .         .         .         .         .  
CTAAAAGGAGGGGCGGCATTGGCTGAATTATAACCTCTAAATATCGTAATTATTTATTGTGAAAAATACCTCTAT 
                                          1 
   .         .         .         .        .  
ATACATGGGGAATATCTAGAGAGAAGTCATATGAAAAAAATTAAAGCTT 
 
Figure 4.1  The DNA base sequence upstream of the aap gene 
The figure shows the 262 bp DNA sequence of the aap100 promoter fragment. The open reading 
frame sequence is highlighted blue and the potential AggR-binding sites are green. The restriction 




Figure 4.2 Analysis of the aap promoter from pAA2  
A. The upper line shows the schematic arrangement of some of the genes on pAA2. The grey bar 
represents the upstream sequence of aap and the blue bar represents the aap coding sequence present 
on the promoter fragment. The potential AggR-binding site is indicated as a green box. The DNA 
sequence in this diagram is numbered above the fragment from 1 to 262 and the fragment was cloned 
into pRW50 using EcoRI and HindIII. This diagram is not to scale. 
B. The panel illustrates the β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the empty lacZ expression vector pRW50 or the aap100 promoter fragment cloned 
into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were 
grown in LB medium in the presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase 
activity was measured as nmol of ONPG hydrolysed per minute per mg of bacterial mass. 
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promoter has not been confirmed. An arbitrary numbering of the bases was chosen, starting 
from the base adjacent to HindIII site. Plasmids were transformed into the E. coli K-12 strain 
BW25113 ∆lac, containing either pBAD/aggR or pBAD24. Cells were grown in LB medium 
at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was added to the LB 
medium to induce the expression of aggR, where appropriate.  Promoter activities were 
determined by measuring β-galactosidase levels in lysates of cells containing these plasmids. 
The results in Figure 4.2B show that the β-galactosidase activity of the cells containing 
aap100 is increased by 2-fold in the presence of AggR-induction when compared to the AggR 
negative control. The results show that the aap100 promoter fragment carries a promoter that 
is AggR-regulated, and expression levels are very high suggesting that it is a very active 
promoter.  
4.2.2 Analysis of the aap500 promoter fragment  
The results of the aap100 promoter fragment showed AggR-dependent activity but the base 
level of expression was very high. The high β-galactosidase activity without AggR could be 
as a result of a very strong promoter fragment or due to presence of more than one promoters. 
This high level of AggR-dependent activity made it difficult to study and interpret the results 
of the aap promoter. During cloning of the aap100 fragment into pRW50, a derivative was 
cloned that had a one bp deletion at position 12 (Figure 4.3A and B) and this aap100∆T12 
was named as aap500. To examine the aap500, cloned into pRW50, the recombinant plasmid 
was transformed into the E. coli K-12 strain BW25113 ∆lac, carrying either pBAD/aggR or 
pBAD24. Cells were again grown in LB medium at 37°C with shaking to mid-logarithmic 
phase and 0.2% (w/v) arabinose was added to LB medium to induce the expression of aggR 
where appropriate. Promoter activities were determined by measuring β-galactosidase levels 




Figure 4.3 Comparison of the aap100 and the aap500 promoter fragments 
A. The figure illustrates the aap100 and aap500 promoter fragments. The aap500 fragment is a 
derivative of aap100 in which the T at position 12 is deleted. The grey bar represents upstream 
sequence of aap and the blue bar represents aap open reading frame that is present on the promoter 
fragment. A green box illustrates the potential binding site of AggR. The red arrow with  indicates 
the position of the one base deleted in aap500. This diagram is not to scale.  
B. The panel shows the sequence of the aap100 promoter fragment. The AggR-binding site is 
highlighted green, the restriction sites are grey and the aap coding sequence is blue. The red arrow 
with  indicates the position of the deletion in the aap500 promoter fragment.  
C The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the empty lacZ expression vector pRW50 or aap promoter derivatives cloned into pRW50. 
Cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars) and were grown in LB medium 
in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol 




in cells containing pRW50/aap500 was much lower than the original aap100 fragment in the 
presence of AggR. Results in the Figure 4.3C also show that the β-galactosidase activity 
measured from lysate of cells containing pRW50/aap500 was increased eight-fold by AggR, 
when compared to AggR negative control (744 units and 90 units, respectively). The one bp 
deletion has shifted the reading frame and this change may had made the mRNA unstable and 
resulted in low β-galactosidase levels. Thus, pRW50/aap500 containing cells showed lower 
β-galactosidase levels without AggR. As the -galactosidase levels are lower using the 
aap500 fragment, further analysis of the aap promoter region was carried out using this 
fragment. 
4.2.3 Identification of the AggR-binding site on the aap500 promoter fragment 
Bioinformatic analysis of the aap promoter region suggested that a potential AggR-binding 
sequence is present on the aap500 promoter fragment, which is similar to the Rns-binding 
weblogo by Munson (2013) and the AggR-binding site identified by Morin et al. (2010) 
(Figure 4.4). To investigate this potential AggR-binding site, point mutations were introduced 
at positions 10 and 12 of the AggR-binding site, corresponding to positons 151 and 149 of the 
aap500 promoter fragment (Figure 4.5A and B). The recombinant promoter fragment 
aap500-151C149C was made by substituting the Ts at positions 151 and 149 with Cs in the 
aap500 fragment. This fragment was cloned into pRW50 and recombinant plasmids were 
transformed into the E. coli K-12 strain BW25113 ∆lac, containing either pBAD/aggR or 
pBAD24. Cells were grown in LB medium at 37°C with shaking to mid-logarithmic phase 
and 0.2% (w/v) arabinose was added to LB medium to induce the expression of aggR where 
appropriate. Promoter activities were determined by measuring β-galactosidase levels in 
lysates of cells containing these plasmids. Results in Figure 4.5C show that the β-








Figure 4.4 Alignment of the AggR-binding site from the aap regulatory region with 
consensus sequences of Rns and AggR  
A. The panel illustrates the consensus sequence from Rns-binding logo (Munson, 2013). The 
height of each letter corresponds to number of times each letter is present in the 31 Rns-
binding sites identified in the ETEC genome.  
B. The panel shows the sequence of the essential AggR-binding site identified at the aggR 
promoter of EAEC 042 (Morin et al., 2010).  
C. The panel shows the proposed AggR-binding site from the aap promoter. The highlighted 
sequence shows the potential AggR-binding site (from position 3 to position 13) suggested to 
be important for AggR-binding. The flanking sequence of the AggR-binding site from the aap 






Figure 4.5 Mutational analysis of the AggR-binding site at the aap promoter 
A. The figure illustrates the aap500 and aap500-151C149C promoter fragments. The grey bar 
represents upstream sequence of aap and the blue bar represents the 13 bp of the aap coding sequence 
present on the promoter fragment. The red arrow with  indicates the position of the base deleted from 
the aap100 fragment. Green boxes illustrate the potential AggR-binding site. The black arrows, 
indicate the positions of the point mutations introduced into the aap500 fragment. This diagram is not 
to scale. 
B. The panel shows the nucleotide base sequence of the aap100 fragment. The AggR-binding site is 
highlighted green, the restriction sites are grey and the aap coding sequence is blue. The red arrow 
with  indicates the position of the base deleted in the aap500 fragment. The black arrows indicate 
positions of the mutations introduced into the aap500151C149C promoter fragment. 
C. The panel shows the β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector (pRW50) or aap promoter derivatives cloned into pRW50. The 
cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured 





increased when AggR-expression was induced. These results indicate that this AggR-binding 
site has been disrupted at the aap promoter and is essential for AggR-dependent transcription 
activation. 
4.2.4 Identification of the -10 hexamer element of the aap promoter  
Inspection of the aap500 DNA sequence identified a potential -10 hexamer element 22 bp 
downstream of the AggR-binding site, which resembled the consensus sequence TATAAT.  
This potential -10 element has a three out of six base match to the consensus sequence and a 
TG motif (extended -10 hexamer element) present one bp upstream of the -10 hexamer 
element. To investigate this promoter element further, a point mutation A to C was introduced 
at position 2 of -10 hexamer element, corresponding to position 124 of the aap500 promoter 
fragment, resulting in the aap500-124C promoter fragment (Figure 4.6A and B). This 
fragment was cloned into pRW50 and recombinant plasmids were transformed into the E. coli 
K-12 strain BW25113 ∆lac, harbouring either pBAD/aggR or pBAD24. Cells were grown in 
LB medium at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was 
added to LB medium to induce the expression of aggR where appropriate. Promoter activities 
were determined by measuring β-galactosidase levels in lysates of cells containing these 
plasmids. Results in Figure 4.6C show that the β-galactosidase levels measured from lysate of 
cells containing pRW50/aap500-124C was much lower than the cells carrying the starting 
aap500 fragment. This suggests that this substitution has disrupted the -10 hexamer element 
of the aap promoter. It is interesting to note that although the aap promoter carries an 





Figure 4.6 Identification of the -10 hexamer element of the aap promoter 
A. The figure illustrates the aap500 and aap500-124C promoter fragments. The grey bar represents 
the upstream sequence of aap and the blue bar represents the 13 bp of the aap coding sequence present 
on the promoter fragment. The red arrow with  indicates the position of the base deleted during 
aap500 construction. Green boxes illustrate the potential binding site of AggR, yellow boxes the -10 
hexamer element and the aap sequence is in blue. The black arrow indicates the position of point 
mutation introduced. This diagram is not to scale.  
B. The panel shows the sequence of the aap100 fragment. The AggR-binding site is highlighted green, 
the -10 element yellow, restriction sites grey and the aap sequence is blue. The red arrow with  
indicates the position of the base deleted in the aap500 promoter fragment. The black arrow with text 
indicates the position of 124C point mutation. 
C The panel illustrates the β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector pRW50 or the aap promoter derivatives cloned into 
pRW50. Cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in 
LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was 




4.3 Transcription regulation of the EAEC 042 chromosomally 
encoded T6SS operon  
AggR-regulated genes are present on the chromosome of EAEC strain 042 as well as on the 
pAA2 plasmid. EAEC 042 has two operons that encode for T6SS and they are named as sci-1 
and sci-2. Expression of sci-1 is not affected by the presence of AggR but a study by Morin et 
al. (2010), using microarray methods found that genes located in the sci-2 region are AggR-
regulated. Dudley et al. (2006) also identified an AggR-regulated operon of 25 genes (aaiA to 
aaiY) present in the sci-2 region on the EAEC genome. The later study used proteomic and 
genomic techniques to investigate the AggR-dependent operon present on the chromosome 
and used a promoter fragment of 766 bp length (carrying 466 bp upstream of the translation 
start site of aaiA gene and 300 bp of the coding sequence) to study the AggR-dependent 
promoter. Although, they identified the approximate location of the aaiA promoter, but they 
did not investigate the promoter elements. 
4.3.1 Analysis of the aaiA upstream DNA sequence 
In order to understand the AggR-dependent regulation of the T6SS expression from EAEC 
042, the aaiA100 promoter fragment (carrying 466 bp upstream of aaiA and 13 bp of the 
coding sequence of aaiA) was cloned into the lacZ expression vector, pRW50 (Figure 4.7). 
The schematic diagram of the aaiA100 promoter fragment is shown in Figure 4.8A. The 
promoter fragment was constructed using the same upstream sequence of aaiA used by 
Dudley et al. (2006) but they had included 300 bp downstream sequence from the translation 
start site of aaiA and cloned this fragment into a different lacZ expression vector pRS551. 
While in the present study, only 13 bp was included downstream of the translational start site 








              470        
               .         .         .         .         .         .      
GAATTCTCCTTTGTTTTATGGATAGTTTTCTGCATCAGGCGTCGTTCTGTTCTGGGGATTGGTGTTATGATCGGC 
         400        
.         .         .         .         .         .         .         .      
ATCGCTCAGTCCGGTTGGTGATTTTTTCTTTTTGGCGATTGATCAGATCGCACAATCCGGGCTGAGTTCCCTCAA 
                                  300        
     .         .         .         .         .         .         .      
AGTGACCTACTATTCCGCGCAGCTATTTAGTTAGTAAATACGAAAAATTATATAGAGTTATATCATTAATCAGCA 
                                                           200       
.         .         .         .         .         .         .         .      
AAAATGTATCACATGCTCACTTTCTTTTTATGGTATCACTATATAGAATCCATGAATATAACAAGAGATTGATAC 
     
     .         .         .         .         .         .         .      
AATCTTTTGCCAAAGATATAACTTTATATCAGATATTTTCACTTTCGAAAACATCTGTGCGGTAGCTATGGTATT 
         100         
.         .         .         .         .         .         .         .      
TAGGTCATATAATTATGCTATGTTCATCAATATTATGATAGTAGATTATAGTGTTCTTAATAAAAAAGAATTTAA 
                                  1 
     .         .         .        . 
AAGCTGTTTGTAGGATAGAAACATGAGCAATACACAAGCTT 
 
Figure 4.7 The DNA base sequence upstream of the aaiA gene 
The figure shows the 479 bp DNA sequence of the aaiA100 promoter fragment. The open reading 
frame sequence is highlighted red and the potential AggR-binding sites are green. The restriction sites 




Figure 4.8 Analysis of the aaiA promoter from EAEC 042  
A. The upper line illustrates the aaiA gene from the chromosome of EAEC 042 and the lower part 
represents aaiA100 promoter fragment. The grey bar represents the upstream DNA sequence of aaiA 
and the red bar represents the 13 bp of the aaiA coding sequence present on the fragment. Potential 
AggR-binding sites are indicated as green boxes. The DNA sequence in this diagram is numbered 
above fragment from 1 to 479 and the fragment was cloned into pRW50 using EcoRI and HindIII 
sites. This diagram is not to scale. 
B. The panel illustrates β-galactosidase activity measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50) or the aaiA100 promoter fragment cloned into pRW50. 
Cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured 




promoter fragment, there are four potential AggR-binding sites on the forward strand and four 
potential sites on the reverse strand (Figure 4.8A). Plasmids were transformed into the ∆lac E. 
coli K-12 strain, BW25113, carrying either pBAD/aggR or pBAD24. Cells were grown in LB 
medium at 37°C with shaking to mid-logarithmic phase, and 0.2% (w/v) arabinose was added 
to LB medium to induce the expression of aggR where appropriate. Promoter activities were 
then determined by measuring β-galactosidase levels in lysates of cells containing these 
plasmids. Results in Figure 4.8B show that the β-galactosidase levels observed in cells 
containing pRW50/aaiA100 is increased 4-fold by AggR-induction in comparison to the 
AggR negative control. This shows that the aaiA100 promoter fragment carries the aaiA 
promoter and that the promoter is activated by AggR. Note, there is considerable AggR-
independent activity without AggR-induction, which this could be due to the presence of a 
strong promoter or more than one promoters on the aaiA100 promoter fragment. 
4.3.2 Identification of the minimal regulatory region of the aaiA100 promoter necessary 
for AggR-mediated activation 
To find the minimal regulatory region of the aaiA100 fragment that is induced by AggR, a 
series of nested deletion mutants were made from the aaiA100 fragment (i.e. the aaiA99 
(307-bp) to aaiA95 (144-bp) promoter fragments) which were all cloned into the lacZ 
expression vector pRW50 (Figure 4.9A and B). Plasmids were transformed into the E. coli K-
12 strain BW25113 ∆lac containing either pBAD/aggR or pBAD24. Cells were again grown 
in LB medium at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was 
added to induce the expression of aggR where appropriate. Promoter activities were 
determined by measuring β-galactosidase levels in lysates of cells containing these plasmids. 




Figure 4.9 Deletion analysis of the aaiA regulatory region 
A. The panel illustrates the aaiA100, aaiA99, aaiA98, aaiA97, aaiA96 and aaiA95 promoter 
fragments. The grey bar represents upstream sequence of aaiA and the red bar represents the 13 bp of 
the aaiA coding sequence present on each promoter fragment. Green boxes illustrate the potential 
binding sites of AggR. All the fragments were cloned into pRW50 using EcoRI and HindIII sites. This 
diagram is not to scale. 
B. The panel shows the sequence of aaiA98 fragment and the potential AggR-binding sites are 
highlighted green, restriction sites are grey and the aaiA sequence is red. The underline sequence 
adjacent to EcoRI site was deleted to construct the aaiA97 promoter fragment.  
C. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50 or aaiA100 promoter derivatives cloned into pRW50. 
The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured 
as nmol of ONPG hydrolysed per minute per mg of bacterial mass. 
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pRW50/aaiA99 and pRW50/aaiA98 is increased by AggR while for pRW50/aaiA97, and 
smaller deletions, no increase was detected in comparison to the AggR negative control. 
These results show that essential AggR-binding site, required for AggR-dependent regulation 
is present on aaiA98 but it has been deleted or disrupted on aaiA97. It is also important to 
note that the AggR-independent activity of cells containing pRW50/aaiA99 and 
pRW50/aaiA98 is higher than the cells containing pRW50/aaiA100 (Figure 4.9C). This could 
be the result of deletion of some repressor element during this deletion analysis in aaiA99 and 
aaiA98. Furthermore, high -galactosidase activity was observed in cells containing 
pRW50/aaiA97 or smaller promoter fragments cloned into pRW50, so there is possibility of 
presence of other promoter that is still present.  
4.3.3 Identification of the AggR-binding sites at the aaiA promoter using mutational 
analysis 
The results suggest that an essential AggR-binding sequence is present on the aaiA98 
promoter fragment and, that it is disrupted or deleted on the aaiA97 promoter fragment 
(Figure 4.9A and B). This potential AggR-binding site (from 261 bp to 251 bp) is similar to 
Rns-binding weblogo proposed by Munson, 2013 and the AggR-binding site identified by 
Morin et al. (2010) (Figure 4.10). To investigate this, point mutations were introduced into 
positions 10 and 12 of the AggR-binding site shown in Figure 4.10, that correspond to 
positions 254 and 252 on the aaiA98 promoter fragment (Figure 4.11A and B). The 
recombinant promoter fragment aaiA98-254C252C was made by substituting the Ts at 
positions number 254 and 252 with Cs and was cloned into pRW50. Plasmids were 
transformed into the E. coli K-12 strain BW25113 ∆lac containing either pBAD/aggR or 
pBAD24. Cells were again grown in LB medium at 37°C with shaking to mid-logarithmic 






Figure 4.10 Alignment of the AggR-binding site from the aaiA regulatory 
region with the consensus sequences of Rns and AggR  
A. The panel illustrates the consensus sequence from the Rns-binding logo (Munson, 2013). 
The height of each letter corresponds to number of times each letter is present in the 31 Rns- 
binding sites identified in the ETEC genome.  
B. The panel shows the sequence of the essential AggR-binding site identified at the aggR 
promoter of EAEC 042 (Morin et al., 2010).  
C. The panel shows the AggR-binding site from the aaiA promoter sequence. The highlighted 
sequence shows the potential AggR-binding site (from position 3 to position 13) suggested to 
be important for AggR-binding. The flanking sequence of AggR-binding site from the aaiA 








Figure 4.11 Mutational analysis of the AggR-binding site at the aaiA promoter 
A. The figure illustrates the aaiA98 and aaiA98-254C252C promoter fragments. The grey bar 
represents the upstream sequence of aaiA and the red bar represents the 13 bp of the aaiA of coding 
sequence present on the promoter fragment. Green boxes illustrate potential binding sites of AggR. 
The arrows indicate the positions of point mutations introduced into the fragment. This diagram is not 
to scale. 
B. The panel shows the base sequence of the aaiA98 fragment. The AggR-binding sites are 
highlighted green, restriction sites are grey and aaiA sequence red. The arrows, indicate positions of 
point mutations introduced into the aaiA98 promoter fragment. 
C. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50, aaiA promoter derivative cloned into pRW50. Cells 
also carry either pBAD/aggR (green bars) or pBAD24 (red bars) and were grown in LB medium in 
presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of 
ONPG hydrolysed per minute per mg of bacterial mass. 
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where appropriate. Promoter activities were determined by measuring β-galactosidase levels 
in lysates of cells containing these plasmids. Results in Figure 4.11C show that the β-
galactosidase activity measured from lysates of cells containing pRW50/aaiA98-254C252C, 
did not increase when compared to the AggR negative control. These results show that the 
AggR-binding site has been disrupted on the aaiA98-254C252C promoter fragment. 
Moreover, there is a decrease in AggR-independent activity for aaiA98-254C252C, indicating 
that these mutations may have disrupted promoter elements, important for aaiA expression. 
4.3.4 Analysis of the -10 hexamer element of the aaiA promoter  
A potential -10 hexamer element (TATCAC) was identified 23 bp downstream of the AggR-
binding site, which resembles the consensus sequence, TATAAT. In this case, four out of the 
six bases matched the consensus sequence of the -10 hexamer element and it also has an 
extended -10 element (an upstream TG motif). To investigate this promoter element, a point 
mutation was introduced at position 2 of -10 hexamer element, corresponding to position 226 
of the aaiA98 promoter fragment, resulting in the aaiA98-226C fragment (Figure 4.12A and 
B). This fragment was cloned into pRW50 and transformed into the E. coli K-12 strain 
BW25113 ∆lac harbouring either pBAD/aggR or pBAD24. Cells were grown in LB medium 
at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was added to LB 
medium to induce the expression of aggR where appropriate. Promoter activities were then 
determined by measuring β-galactosidase levels in lysates of cells containing these plasmids. 
Results in the Figure 4.12C show that the β-galactosidase levels measured in cells containing 
pRW50/aaiA98-226C showed only a small decrease in promoter activity, indicating that this 
mutation had a little effect on the promoter. This could be explained by the presence of the 
TG motif on aaiA98 promoter fragment as this could compensate for the mutation introduced. 




Figure 4.12 Identification of the -10 hexamer element of the aaiA promoter 
A. The figure illustrates the aaiA98 and aaiA98-226C promoter fragments. The grey bar represents the 
upstream sequence of aaiA and the red bar represents the 13 bp sequence of the aaiA coding sequence 
present on the promoter fragment. Green boxes illustrate potential binding sites of AggR and yellow 
boxes represent the -10 hexamer elements. The arrow with text indicates position of the point mutation 
introduced in the aaiA98-226C promoter fragment.  
B. The panel shows the sequence of the aaiA98 promoter fragment. The AggR-binding sites are 
highlighted green, the -10 hexamer element is yellow, the restriction sites are grey and the aaiA coding 
sequence is red. The arrow indicates position of point mutation introduced into the aaiA98-226C 
promoter fragment. 
C The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50 or aaiA promoter derivatives cloned into pRW50. Cells 
also carry either pBAD/aggR (green bars) or pBAD24 (red bars) and were grown in LB medium in 
presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of 




4.4 Construction of AggR-dependent semi-synthetic promoters  
For further understanding of AggR-binding sites and AggR-dependent promoters, a series of 
semi-synthetic promoters were constructed. A well studied CRP-dependent semi-synthetic 
promoter was used as starting promoter fragment in this study (i.e. CC(-41.5)) (Figure 4.13). 
The AggR-binding site sequence from aafD promoter was cloned into CC(-41.5) to generate a 
series of semi-synthetic promoters. To understand promoter architecture at AggR-dependent 
promoters, the fragments used in this study were aligned. 
4.4.1 Alignment of the AggR-binding sites and the -10 hexamer elements from AggR-
regulated promoters 
In this project, a number of AggR-dependent promoters from EAEC 042 have been 
investigated with important AggR-binding sites identified at the AAF/II, T6SS and dispersin 
promoters. These AggR-binding sites are in general very similar but a few differences in 
important regions have been noted. The differences in AggR-dependent promoters that have 
been investigated also have different levels of AggR-dependent expression, with some 
promoters displaying considerable AggR-independent activity. To highlight the differences 
and similarities between the AggR-binding sites and promoter elements, these promoter 
sequences were aligned (Figure 4.14A). Furthermore, to find an AggR consensus sequence, 
the AggR-binding sequences, including flanking bases, were copied into the weblogo website 
software and a weblogo was generated (Figure 4.14B). In each case a 16 bp sequence was 
used, which is the same fragment length used by Munson et al. (2001) for Rns. The sequences 
from the aafD, afaB, aap and aaiA promoters from this study and the aggR promoter Morin et 
al. (2010) were copied into the input box of http://weblogo.berkeley.edu to generate the 
weblogo (Figure 4.14B) (Crooks et al., 2004). The height of each letter corresponds to the 

















-80       -70       -60       -50       -40       -30       -20       -10  
  .         .         .         .         .         .         .         .  
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGTGATGTACATCACATGGATCCCCCCTCACTCCTGCCATA 
        +1      +10        +20     +30       +40 
        .        .         .         .         .   
ATTCTGATATTCCAGGAAAGAGAGCCATCCATGAATACAGATAAAGCTT 
 
Figure 4.13 The promoter sequence of CC(-41.5) used to make semi-synthetic 
promoter fragments containing AggR-binding sites 
 The panel shows the DNA sequence of the CC(-41.5) promoter fragment from Savery et al. (1995b), 
numbered in relation to the start site of transcription (+1). The CRP-binding site centred at position -



























Figure 4.14 Alignment of DNA sequences from AggR-dependent promoters  
A. The panel illustrates the sequences of AggR-dependent promoters investigated in this study. The 
AggR-binding sites are highlighted green and the -10 hexamer elements yellow. The underline 
sequences show the distance between AggR-binding sites and -10 hexamer elements. The red line on 
the top of the sequences with the numbers from 1 to 16 represents the part of promoter used to make 
the weblogo shown in panel B. 
B. The panel illustrates the consensus sequence for AggR. The n represents the number of sequences 
used to create the weblogo (n=5). The weblogo was generated using http://weblogo.berkeley.edu 
website. The height of each letter corresponds to number of times each letter is present in the five 







absence of a sequence at certain position represents high variability of bases at this position. 
In order to find a more reliable consensus sequence, more AggR-binding sites are required, 
however, this weblogo gives us an idea about the AggR-binding motif. 
4.4.2 Analysis of semi-synthetic AggR-dependent promoters 
The alignment of promoter sequences in Figure 4.14A shows that AggR-binding sites are 
generally located 22 or 23 bp upstream from the -10 hexamer elements.. In order to 
investigate, if an AggR-binding site can be transplanted into a promoter that is not normally 
AggR-binding site and its flanking sequence from the aafD promoter (Figure 4.15A). The 
aafD AggR-binding site was cloned at different distances from the -10 hexamer element (i.e. 
ranging from 20 bp to 23 bp) and the resultant promoter fragments named DAM20 to DAM23. 
These fragments were cloned into the lacZ expression vector pRW50. Plasmids were 
transformed into the E. coli K-12 strain BW25113 ∆lac also carrying, either pBAD/aggR or 
pBAD24. Cells were grown in LB medium at 37°C with shaking to mid-logarithmic phase 
and 0.2% (w/v) arabinose was added to LB medium to induce the expression of aggR where 
appropriate. Promoter activities were determined by measuring β-galactosidase levels in 
lysates of cells containing these plasmids. The β-galactosidase activity measured in cells 
containing CC(-41.5) and DAM20 showed no increase in the presence of AggR. However, the 
β-galactosidase activity observed in cells containing DAM21, DAM22 and DAM23 showed a 
4, 8 and 2-fold increase in expression levels, respectively, when compare to the AggR 
negative control (Figure 4.15B). This shows that the AggR-binding site can be transplanted 
into a promoter to make it AggR-dependent and that the distance between the AggR-binding 
site and the -10 hexamer element is important for AggR-dependent activity. The results also 
show that a spacing of 22 bp is optimal for AggR-dependent induction. Interestingly, 




Figure 4.15 Transplantation of the aafD AggR-binding site into the CC(-41.5) 
promoter fragment 
A. The figure shows part of the DNA sequence of the CC(-41.5) promoter fragment and the DAM20 to 
DAM23 promoters. In the DAM20 to DAM23 promoters the AggR-binding site has been transplanted 
at different distance from the -10 hexamer elements (20 bp to 23 bp, respectively). In CC(-41.5) 
underling represents the CRP-binding half-sites and the red colour text of AggR-binding site and 
flanking sequence shows the sequence transplanted from the aafD promoter into CC(-41.5). Green 
boxes indicate the AggR-binding site and yellow boxes indicate the -10 hexamer elements. Fragments 
were cloned into pRW50 using EcoRI and HindIII. 
B. The panel illustrates the β-galactosidase activities measured in the E. coli K-12 strain BW25113 
∆lac, containing the lacZ expression vector pRW50, CC(-41.5), or DAM promoter derivatives cloned 
into pRW50. Cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown 
in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was 





and reduces the AggR-dependent induction by 2 fold (Figure 4.15B and Figure 4.9C). 
4.4.3 Disruption of the AggR-binding site at the DAM22 promoter  
The β-galactosidase activity results in Figure 4.15 show that the aafD promoter 
AggR-binding site can be transplanted into an AggR-independent promoter to change its 
regulation. To confirm that the aafD AggR-binding site was responsible for this regulation, 
the AggR-binding site in the DAM22 promoter fragment was mutated by introducing point 
mutations into the conserved Ts within the site (Figure 4.16A). These positions correspond to 
positons -38 and -36 on the DAM22 promoter fragment and this generated the DAM22-(-38C-
36C) fragment, which was cloned into pRW50. The recombinant plasmids were transformed 
into the E. coli K-12 strain BW25113 ∆lac, carrying either pBAD/aggR or pBAD24. Cells 
were grown in LB medium at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) 
arabinose was added to LB medium to induce the expression of aggR where appropriate. 
Promoter activities were determined by measuring β-galactosidase levels in lysates of cells 
containing these plasmids. Results in the Figure 4.16B show that the β-galactosidase activity 
measured in cells containing pRW50/DAM22-(-38C-36C) showed no increase when AggR-
expression was induced. These results confirm that the aafD AggR-binding site is essential 
for AggR-dependent activation of the DAM22 promoter fragment. 
 4.5 Discussion  
AggR regulates many virulence genes, for example, aap which is located on the pAA2 
plasmid. The results of this study have shown that expression from the aap100 promoter 
fragment is increased in the presence of AggR and this is consistent with other studies (Morin 
et al., 2013). The essential AggR-binding site at the aap promoter differs from the consensus 




Figure 4.16 Mutational analysis of the AggR-binding site at the DAM22 
promoter fragment 
A. The figure illustrates the DAM22 and DAM22-(-38C-36C) promoter fragments. Green boxes 
illustrate the binding sites of AggR and yellow boxes represent the -10 element. The arrows, with text, 
indicate the positions of the point mutations introduced into DAM22 promoter. This diagram is not to 
scale. 
B. The panel shows the nucleotide base sequence of the DAM22 fragment. The AggR-binding site is 
highlighted green, the potential -10 element is yellow and restriction sites are grey. The arrow 
indicates position of point mutations introduced into DAM22 to generate the DAM22-(-38C-36C) 
promoter fragment. 
C. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50 or DAM22 promoter derivatives cloned into pRW50. 
The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured 
as nmol of ONPG hydrolysed per minute per mg of bacterial mass. 
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lacZ expression from the aap100 promoter fragment was extremely high, the results were not 
very conclusive. For this reason, a derivative of the aap100 promoter fragment, i.e. 
aap10012T (aap500) was used in this study to understand the aap promoter in more detail. 
The distance between the -10 hexamer element and the AggR-binding site is 22 bp, which is 
optimal and likely contributes to the high expression levels of the promoter. During infection, 
high levels of expression of aap is needed by EAEC as dispersin forms a coat around the 
bacterium. It is important to mention that dispersin is secreted by the system encoded in a 
separate operon (i.e. aatPABCD operon), and this arrangement ensures that there is high level 
production of dispersin and that the optimal number of its secretory system proteins are 
produced.  
Similarly, the data from the aaiA operon analysis shows that an AggR-dependent promoter 
lies upstream of aaiA. The AggR-binding site identified at the aaiA promoter is similar to the 
Rns- binding weblogo and the aggR promoter AggR-binding site at conserved positions. The 
β-galactosidase levels measured from cell lysates containing pRW50/aaiA100 without 
induction were very high and this could be either due to the presence of the TG motif of the 
promoter or the presence of an additional AggR-independent promoter. In the presence of 
AggR, there was only a four-fold induction, which is less than that observed in the previous 
study by Dudley et al. (2006) that was an 8-fold increase. The promoter fragment used by 
Dudley et al. (2006), possessed the same DNA upstream of the translation start site, but had 
an additional 287 bp downstream in comparison to the fragment used in this study. Thus, this 
difference in expression could be explained by the difference in strains, plasmids or 
constructs used. Another important finding to note was, that AggR-induction was reduced 
from 4 fold to 2 fold when the promoter fragment was truncated to 272 bp (i.e. the aaiA98 
promoter fragment) due to the increase in basal activity of the aaiA98 promoter fragment 
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(Figure 4.9). This increase in basal level could be a result of the deletion of a repressor 
element.  
Results in this study show that AggR-binding sites overlap the -35 hexamer elements of the 
promoters it regulates and this suggests that AggR activates transcription by a Class II 
mechanism (Browning and Busby, 2004).The alignment of all AggR-binding sites and the 
promoter elements of the genes investigated in this study shows the variations in the 
AggR-binding site sequences, the -10 hexamer elements, the distance between AggR-binding 
sites and the -10 hexamer elements (Figure 4.14). To identify the appropriate distance 
between the -10 hexamer element and AggR-binding sites using semi-synthetic promoters, I 
have shown that 22 bp is the optimal distance for AggR-dependent activation (Figure 4.15). A 
similar observation has been found by Bodero et al. (2008), for Rns-dependent promoters.  
This study has given an insight into the organisation of AggR-dependent promoters and 
AggR-binding sites. The mutational analysis of AggR has increased our understanding of 
AggR-dependent activation and the semi-synthetic promoters have enhanced our 











Mutational analysis of AggR and effects of AggR on pet 








5.1 Introduction  
AggR is the master virulence regulator of EAEC strains and it regulates a number of 
promoters. In order to understand the organisation of AggR-regulated promoters, a mutational 
analysis of AggR was carried out. AggR mutants were studied in-vivo by measuring activities 
of both semi-synthetic and AAF/II promoters. In the first part of the chapter, I have described 
the activation by AggR mutants on AggR-dependent promoters. In the second part of this 
chapter, I have detailed a study on pet (plasmid encoded toxin) expression and how AggR 
may affect pet expression. 
5.2 Mutational Analysis of the AggR protein 
The results in this study indicate that, at target promoters, AggR binds near the -35 hexamer 
element, and so it is likely that it interacts with the RNAP directly, as other AraC family 
members (Grainger et al., 2004). Results in the Figure 4.15B shows that the optimal distance 
between the -10 hexamer element and an AggR-binding site is 22 bp and suggest that AggR-
regulated promoters can be categorised as Class II promoters (Browning and Busby, 2004). 
AggR is closely related to other members of the AraC family, particularly Rns, which has the 
same number of amino acids and has considerable sequence similarity to AggR. Both 
transcription factors have two HTHs for DNA binding, present towards the C-terminal of 
each protein, and this HTH arrangement is conserved in AraC family members, playing an 
important role in AggR-dependent regulation (Figure 1.12) (Munson, 2013). Basturea et al. 
(2008), showed that the N-terminal domain of Rns is also important in Rns-dependent 
regulation at ETEC promoters. In this work, they introduced many substitutions into Rns and 
found that, at position 14, an isoleucine to threonine (I14T) substitution, and at position 16, an 
asparagine to aspartic acid (N16D) substitution, was important for Rns-dependent regulation. 






1         10        20        30        40        50      60 
.         .         .         .         .         .        . 
MKLKQNIEKEIIKINNIRIHQYTVLYTSNCTIDVYTKEGSNTYLRNELIFLERGINISVR 
MDFKYTEEKETIKINNIMIHKYTVLYTSNCIMDIYSEEEKITCFSNRLVFLERGVNISVR 
*.:* . *** ****** **:********* :*:*::* . * : *.*:*****:***** 
 
70        80        90       100       110       120 
.         .         .         .         .         . 
LQKKKSTANPFIAIRLSSDTLRRLKDALMIIYGISKVDACSCPNWSKGIIVADADDSVLD 
MQKQILSEKPYVAFRLNGDMLRHLKDALMIIYGMSKIDTNACRSMSRKIMTTEVNKTLLD 
:**:  : :*::*:**..* **:**********:**:*: :* . *: *:.::.:.::** 
 
130       140       150      160        170       180 
.         .         .         .         .         . 
TFKSIDNNDDSRITSDLIYLISKIENNKKIIESIYISAVSFFSDKVRNIIEKDLSKRWTL 
ELKNINSHDNSAFISSLIYLISKLENNEKIIESIYISSVSFFSDKVRNLIEKDLSRKWTL 
:*.*:.:*:* : *.*******:***:*********:**********:******::*** 
 
190       200       210       220       230       240 
.         .         .         .         .         . 
AIIADEFNVSEITIRKRLESEYITFNQILMQSRMSKAALLLLDNSYQISQISNMIGFSST 
GIIADAFNASEITIRKRLESENTNFNQILMQLRMSKAALLLLENSYQISQISNMIGISSA 
.**** **.************  .******* **********:*************:**: 
 
250      260   265 




Figure 5.1 Alignment of AggR and Rns sequence 
The figure shows amino acid sequence of AggR and Rns. Standard abbreviations are used to represent 
amino acids. The black text represents the AggR sequence and blue text represents Rns. Amino acids 
are numbered from the N-terminus from 1 to 265. The symbols below show the similarity between the 
two proteins; (*) represents same amino acid at that position, (:) indicates amino acids have similar 
biochemical properties, (.) indicate that amino acids have somewhat similar biochemical properties 







investigate if these amino acid residues are important in AggR-dependent regulation, 
substitutions I14T and N16D were introduced into AggR. In parallel, two versions of AggR 
carrying substitutions at C-terminal regions, were constructed following a study on MelR 
(Grainger et al., 2004). The study on MelR showed that aspartic acid and threonine amino 
acids in the C-terminal region of MelR interact directly with 4 domain of the RNAP, and the 
alignment of MelR with AggR shows these positions correspond to 230 and 234 in AggR 
(Figure 5.2). To investigate whether AggR interacts with RNAP via same position as MelR, 
glutamine at position 230 and methionine at position 234 in AggR were substituted with 
glycine. The AggR mutants were cloned into pBAD30 using EcoRI and XbaI restriction sites, 
placing them under the control of the araBAD promoter. 
The introduction of substitutions into proteins can be detrimental to their stability. In order to 
find out if any of the substitutions in AggR affected the stability of the protein, the ability of 
AggR derivatives to repress and activate the transcription of a number of promoters was 
examined. Bodero et al. (2007) found that expression of nlpA (which encodes an inner 
membrane protein present in ETEC and EAEC) is repressed by Rns and AggR. Using in vitro 
experiments, it was shown that Rns binds to the promoter fragment, around the transcription 
start site, and sterically blocks RNAP from binding to the promoter. To confirm that 
substitutions introduced into AggR in this study do not alter DNA binding, the regulation of 
nlpA was studied. A 408 bp promoter fragment, nlpA100, (carrying 356 bp upstream of nlpA 
and 52 bp of the nlpA coding sequence) was cloned into the lacZ expression vector pRW50 
using EcoRI and HindIII. Plasmids were transformed into the E. coli K-12 strain BW25113 
∆lac, also carrying either pBAD/aggR, pBAD/aggR-I14T, pBAD/aggR-N16D, pBAD/aggR-
Q230G, pBAD/aggR-M234G or pBAD24. The cells were grown in LB medium at 37°C with 








Figure 5.2 Multiple alignment of proteins belonging to the AraC/XylS family 
The figure shows part of aligned sequence of AggR with some of the AraC/XylS family members. 
The numbering shown at in the top row is according to AggR amino acids. Green highlighted letters 
represent conserved amino acids in AggR according to Gallegos et al. (1997) and all aligned 
sequences at this position are also highlighted. Blue highlighted amino acids of MelR found important 
for interaction with 4 domain (Grainger et al., 2004).Blue highlighted amino acids of AggR represent 






















induce the expression of aggR. Promoter activities were determined by measuring β-
galactosidase levels in lysates of cells containing these plasmids. Results in the Figure 5.3A 
shows that the β-galactosidase levels measured in plasmids containing pRW50/nlpA100 
decreased almost 2 fold in the presence of wild type AggR as well as all cells carrying the 
AggR mutants constructs. These results argue that all the AggR mutants are stable and can 
bind to DNA sequences effectively to repress expression from the nlpA promoter. 
Since each mutant version of AggR represses the nlpA promoter, the ability of each AggR-
mutation to activate transcription was studied using the aafD96 and afaB100 promoter 
fragments, and the semi-synthetic promoter fragment, DAM22. All the promoter fragments 
were cloned into pRW50 and plasmids were transformed into the E. coli K-12 strain 
BW25113 ∆lac, carrying either pBAD/aggR-I14T, pBAD/aggR-N16D, pBAD/aggR-Q230G, 
pBAD/aggR-M234G or pBAD24 plasmids. Results shown in Figure 5.3B show that the β-
galactosidase levels measured in cells containing pRW50/DAM22 showed similar increase in 
promoter activity for the pBAD/aggR, pBAD/aggR-Q230G and pBAD/aggR-M234G 
constructs when compared to AggR negative control. This indicates that AggR Q230G and 
M234G substitutions did not affect the ability of AggR to activate transcription, even though 
this region is part of the AggR HTH. However, little β-galactosidase activity was observed in 
cells carrying pBAD/aggR-I14T and pBAD/aggR-N16D when compared to cells containing 
pBAD/aggR. This finding highlights the importance of N-terminal amino acids in AggR-
dependent activation.  
Results in the Figure 5.4A and B show the β-galactosidase levels measured from cells lysates 
containing pRW50/aafD96 or pRW50/afaB100 carrying either wild type or mutant AggR 




Figure 5.3 AggR-dependent regulation of the nlpA and DAM22 promoters 
A. The panel shows β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50 or the nlpA100 promoter fragment cloned into pRW50. 
The cells also carried either pBAD/aggR (green bars), pBAD/aggR-I14T(purple bars), pBAD/aggR-
N16D (light blue bars), pBAD/aggR-Q230G (orange bars), pBAD/aggR-M234G (blue bars) or 
pBAD24 (red bars) plasmids. Cells were grown in LB medium in presence (+) or absence   (-) of 0.2% 
(w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG hydrolysed per minute per 
mg of bacterial mass. 
B. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector (pRW50) or the DAM22 promoter cloned into pRW50. The cells 
also carry either pBAD/aggR (green bars), pBAD/aggR-I14T(purple bars), pBAD/aggR-N16D (light 
blue bars), pBAD/aggR-Q230G (orange bars), pBAD/aggR-M234G (blue bars) or pBAD24 (red bars) 
plasmids. Cells were grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-





Figure 5.4 AggR-dependent regulation of the aafD and afaB promoters 
A. The panel shows β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50 or the aafD96 promoter fragment cloned into pRW50. 
Cells also contained either pBAD/aggR (green bars), pBAD/aggR-I14T (purple bars), pBAD/aggR-
N16D (light blue bars), pBAD/aggR-Q230G (orange bars), pBAD/aggR-M234G (blue bars) or 
pBAD24 (red bars) plasmids.  Cells were grown in LB medium in the presence (+) or absence (-) of 
0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG hydrolysed per minute 
per mg of bacterial mass. 
B. The panel shows β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector pRW50 or the afaB100 promoter fragment cloned into pRW50. 
Cells also contained either pBAD/aggR (green bars), pBAD/aggR-I14T (purple bars), pBAD/aggR-
N16D (light blue bars), pBAD/aggR-Q230G (orange bars), pBAD/aggR-M234G (blue bars) or 
pBAD24 (red bars) plasmids. Cells were grown in LB medium in the presence (+) or absence (-) of 
0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG hydrolysed per minute 





presence of pBAD/aggR-I14T and pBAD/aggR-N16D when compared to cells containing 
pBAD/aggR. This finding again demonstrates the importance of N-terminal domain of AggR 
in transcription regulation. The β-galactosidase levels measured in cells containing 
pRW50/aafD96 or pRW50/afaB100 showed very little decrease in the presence of 
pBAD/aggR-Q230G and pBAD/aggR-M234G, when compared to the cells containing 
pBAD/aggR (Figure 5.4).  
At all three promoters, the AggR mutations showed similar trends in their ability to activate 
transcription with the N-terminal mutations displaying a defect in activation, while mutations 
at C-terminal positions did not have an effect. These results show that N-terminal amino acids 
are important for AggR-dependent regulation, while the Q230G and M234G of C-terminal 
amino acids are not.  
5.3 Investigation of pet expression 
Pet is one of the important toxins secreted by EAEC 042 and plays an essential role in 
pathogenesis. The pet gene is present on the pAA2 plasmid, between Region 1 and Region 2 
encoding AAF/II in EAEC 042 (Figure 1.4). Both regions are regulated by AggR but the pet 
gene is known to be regulated by global transcription regulators, CRP and FIS. The location 
of pet between two AggR-regulated operons could be important for gene regulation, or it 
could be a random insertion of gene at this location. This is why I began to investigate 
potential AggR effects on pet expression. 
5.3.1 Investigation of the pet promoter fragment 
In order to investigate any effects of AggR, the pet regulatory region was investigated 
(Rossiter et al., 2011). A promoter fragment with the pet upstream sequence, AER1 cloned 
into pRW50 using EcoRI and HindIII sites, was acquired from Douglas Browning and its
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sequence is shown in Figure 5.5A. The recombinant plasmid pRW50/AER1 was transformed 
into the E. coli K-12 strain BW25113 ∆lac, carrying either pBAD/aggR or pBAD24. Cell 
were grown in LB medium at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) 
arabinose was added to LB medium to induce the expression of aggR where appropriate. 
Promoter activities were determined by measuring β-galactosidase levels in lysates of cells 
containing these plasmids. The β-galactosidase levels in cells containing pBAD/aggR and 
pRW50/AER1 showed no substantial difference, when compared to cells containing pBAD24 
as AggR negative control and pRW50/AER1 (Figure 5.5B). These results show that the 
promoter fragment, AER1 is not regulated by AggR. However, AggR-binding sites are located 
on the pAA2 plasmid, present both upstream (afaB) and downstream (aafD) of pet at ~1.8 kb 
and ~6.5 kb, respectively (Figure 1.4). These binding sites might come into play if DNA 
looping or coiling was involved. To investigate this, an experiment was designed to measure 
expression in EAEC 042 in presence and absence of AggR. 
5.3.2 Deletion of aggR from EAEC strain DFB042 
For the investigation of possible effects of AggR on pet expression, a comparative approach 
was used. I deleted the aggR gene from the EAEC strain DFB042 to construct EAEC 
DFB042ΔaggR (Table 2.1). The gene doctoring technique was used for deletion (section 
2.12), and the deletion was confirmed by a phenotype characteristic, the ability to form a 
biofilm in the presence of AggR (section 2.13).  
For biofilm formation, overnight cultures of EAEC DFB042, EAEC DFB042ΔaggR, and 
E. coli K-12 were diluted 1:100 in 5 ml of DMEM media with a high glucose concentration 
(Sigma Aldrich). The cultures were incubated at 37°C for one hour and then each strain was 
added to 8 wells (A to H) of a 96-well microtitre plate. The microtitre plate was sealed with 





Figure 5.5 Measurement of AggR-dependent activity of AER1 promoter fragment 
A. The panel shows the base sequence of the AER1 fragment (Rossiter et al., 2011). The -10 hexamer 
element is highlighted yellow and the restriction sites grey. The bent arrow indicates the position of 
the transcription start site. 
B. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing AER1 promoter cloned into lacZ expression vector, pRW50. Cells also carry either 
pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB medium in presence (+) or 
absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of ONPG 





with 0.1% (w/v) crystal violet, rinsed with water to remove excess stain. Then 
ethanol/acetone was added in each well of microtitre plate to dissolve the dye retained by 
biofilm. The absorbance of blue dye dissolved in ethanol/acetone was measured using 595 nm 
filter in Labsystems Multiskan MS plate reader (Thermo Fisher Scientific Inc.) and it 
corresponded to biofilm formation phenotype of the strain.  
The results of the plate showed that there was dark blue colour in the wells containing, EAEC 
DFB042 and there was faint blue colour in the wells containing DMEM medium only, E. coli 
K-12 and EAEC DFB042ΔaggR (Figure 5.6A). When the absorbance of the solutions, in the 
microtitre plate wells, was measured at 595 nm using Labsystems Multiskan MS plate reader 
(Thermo Fisher Scientific Inc.), EAEC DFB042 containing wells showed high absorbance 
when compared to absorbance measured from the wells containing DMEM medium, E. coli 
K-12 and EAEC DFB042ΔaggR (Figure 5.6B). These results showed that biofilm is only 
formed in wells containing EAEC DFB042 and as AggR plays an important role in biofilm 
formation, so it proves that aggR has been deleted in EAEC DFB042aggR. 
5.3.3 Detection of pet expression  
To investigate the effect of AggR on pet expression, two EAEC strains DFB042 and EAEC 
DFB042ΔaggR were compared using western blotting. The overnight cultures of EAEC 
DFB042, EAEC DFB042ΔaggR and E. coli K-12 were diluted 1:100 in 50 ml of DMEM 
medium with high glucose concentration and incubated at 37°C for 6 hours. The cultures 
were transferred into 50 ml Falcon tubes, cells were harvested and supernatant was filtered 
using 0.2 µm syringe filters. The supernatant was acid precipitated and electrophoresed by 
SDS-PAGE. Proteins were transferred to nitrocellulose membrane and detected using anti-
passenger domain antibodies raised in rabbit. The results of the western blotting in Figure 






Figure 5.6 Biofilm formation by EAEC strain DFB042 
A. The panel shows part of 96 well microtiter plate, each column of the plate contains technical 
repeats of same sample. Column 1 contains only DMEM, coulmn 2 contains E. coli K-12 in DMEM, 
column 3 has EAEC strain DFB042 and column 4 contains EAEC DFB042aggR. The blue colour 
development corresponds to biofilm formed, and stained with crystal violet.  
B. The bar chart represents the absorbance of blue colour of microtiter plate columns shown in panel 










Figure 5.7  pet expression in different E . coli strains  
A. The panel shows western blot scan detected using antipassenger domain antibodies for Pet. For this 
experiment, the bacterial strains were grown in DMEM medium at 37°C for 6 hours. Lane 1, 2 and 3 
contained proteins from supernatants of EAEC DFB042, EAEC DFB042aggR, E. coli K-12, 
respectively. Lane 4 shows the prestained protein ladder and band sizes are labelled.  
B. The panel shows western blot scan detected using antipassenger domain antibodies for Pet, when 
the bacterial strains are grown in DMEM medium supplemented with tryptone at 37°C. Lane 1 shows 
the prestained protein ladder and bands sizes are labelled. Lane 2, 3 and 4 show no detectable bands 
and these contained proteins from supernatants of EAEC DFB042, EAEC DFB042aggR and EAEC 
DFB042 (pBAD/aggR), respectively grown in DMEM medium supplemented with tryptone and 
arabinose (0.2% (w/v)) at 37°C for 2 hours. Lane 5 and 6 show bands while lane 7 shows no 
detectable band. These contained proteins from supernatants of EAEC DFB042, EAEC 
DFB042aggR and EAEC DFB042 (pBAD/aggR), respectively grown in DMEM medium 





and it is detected using anti-passenger domain antibodies of pet, suggests, it is Pet. It was 
detected in EAEC DFB042, EAEC DFB042ΔaggR and no band was detected for E. coli K-12 
(Figure 5.7A). This experiment showed the specificity of antibodies but no difference was 
observed in pet expression in both strains EAEC DFB042 and EAEC DFB042ΔaggR. 
Moreover, when EAEC DFB042 was grown in DMEM medium, low level of pet expression 
was observed. To increase pet expression in DMEM medium, it was supplemented with 
tryptone (Betancourt-Sanchez and Navarro-Garcia, 2009). So, another experiment was 
designed using DMEM medium supplemented with tryptone to express pet in EAEC DFB042 
and EAEC DFB042ΔaggR. In this experiment, another strain EAEC DFB042 with 
(pBAD/aggR) was also used to overexpress AggR. The overnight cultures of EAEC DFB042, 
EAEC DFB042ΔaggR and EAEC DFB042 with (pBAD/aggR) were diluted 1:100 in 50 ml of 
DMEM medium with high glucose concentration, and supplemented with tryptone and 0.2% 
(w/v) arabinose. For each of the 3 strains mentioned above, 2 set of cultures diluted and 
incubated at 37°C with shaking. One set of cultures was incubated for 2 hours and the other 
was incubated for 6 hours. After incubation, the cultures were transferred into 50 ml Falcon 
tubes and centrifuged at 2844 g for 15 minutes. The supernatant of each culture was filtered 
after centrifugation, acid precipitated, and run on SDS-PAGE. The protein was transferred to 
nitrocellulose membrane and detected using anti-passenger domain antibodies.   
The results of western blotting showed that there were no detectable bands seen, in the 
supernatant of cultures, when the supernantant was analysed after 2 hours of incubation 
(Figure 5.7B). While the pet expression was detected in the supernatant of EAEC DFB042 
and EAEC DFB042ΔaggR cultures incubated for 6 hours at 37°C, but no pet expression was 
seen for EAEC DFB042(pBAD/aggR) (Figure 5.7B). These results suggest that the over 
expression of AggR in EAEC DFB042(pBAD/aggR) has inhibited pet expression. This shows 
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that AggR has a repressive effect on pet expression, and high AggR concentration is 
important for pet repression. The major bands detected were thick and degraded protein can 
be seen all the way down in the gel. This could be due to breakdown of Pet during acid 
precipitation. 
These findings need to be validated with more sensitive techniques, e.g. quantitative real time 
PCR and also making more EAEC DFB042 mutants, like deletion of confirmed AggR-
binding sites present upstream (afaB promoter) and downstream (aafD promoter) of pet that 
are possibly involved in repression. I could not validate the results by alternate methods, due 
to time constraints.  
5.4 Discussion  
AggR is one of AraC family members and it regulates many virulence determinants of EAEC 
strains. AggR-dependent activation of promoters was studied in this chapter by introducing 
point mutations in the N-terminal and C-terminal domains of AggR. The N-terminal domain 
mutations were reported to be important for Rns-dependent activation of promoters in ETEC 
(Basturea et al., 2008). The results of present study also showed a similar trend for 
AggR-dependent promoter activation, as AggR-dependent promoters are not activated with 
AggR-I14T and AggR-N16D but these mutants can still repress expression of nlpA100. The 
lack of activation by mutants indicate that these amino acids are important for AggR-
dependent activation and repression of nlpA100 shows that these mutants are stable proteins. 
The N-terminal domain of AraC family members are usually important for dimerization, 
however, there are conflicting opinions, as whether AggR exists as a homo-dimer. Thus, it is 
unclear of the N-terminal domain of AggR interacts with RNAP on AggR-activated 
promoters or if it is involved in dimerization. A study by Grainger et al. (2004), showed the 
 
225 
C-terminal domain of MelR is important but the results of present study showed that the 
mutations in corresponding positions in AggR, showed no effect on AggR-dependent 
activation (Figure 5.2 and 5.3B). These results indicate that AggR might not interact in the 
same manner as MelR or these proteins have different folding patterns that might have 
affected the positon of interacting amino acids. 
The expression of pet is effected by over expression of AggR in EAEC DFB042 (Figure 5.7). 
This suggests that AggR plays a role in pet expression, and pet location between two AggR-
regulated regions has some physiological importance. This finding is not mentioned by Morin 
et al. (2013), who found that 44 genes of EAEC 042 are regulated by AggR. The possible 
explanation is, AggR expresses when EAEC 042 is grown in DMEM medium and does not 
express when the bacterium is grown in LB medium, whilst pet is exactly the opposite to 
AggR. The pet toxin expresses when EAEC 042 is grown in LB medium and does not express 
well when grow in DMEM medium (Betancourt-Sanchez and Navarro-Garcia, 2009). So the 
effect of AggR, on pet expression, might have been masked due to this fact. 
This study has increased our understanding of AggR-dependent activation and the study on 
pet expression has depicted that AggR might has more crucial rule in EAEC virulence than 















Organisation of the AggR-regulated fimbrial promoter in 










AggR is the transcription factor that regulates fimbrial gene expression in many strains of 
EAEC (Zamboni et al., 2004). The attachment adherence fimbriae I (AAF/I) is found in 
EAEC strain 17-2. The AAF/I is formed by a chaperone usher system and the genes that 
encode this system in EAEC 17-2 are present on the pAA plasmid in two clusters, i.e. Region 
1 and Region 2 (Figure 6.1). The genes that encode structural components of AAF/I are 
present in Region 1 and the transcription regulator, AggR that regulates this system is present 
in Region 2 (Savarino et al.,1994). The aggregation pattern of EAEC 17-2 was disrupted by 
deleting either the genes that encode the chaperone usher system or AggR itself. These results 
proved that fimbrial genes expression requires AggR, as well as the structural proteins 
encoding genes, but to date no study has investigated the AggR-dependent promoters from 
EAEC 17-2 in detail. The transcription factor AggR, from both strains EAEC 042 and EAEC 
17-2 is similar with only four amino acid differences (Figure 6.2). In this study, the aggD 
promoter from EAEC 17-2 was studied in E. coli K-12 strain BW25113, and AggR from 
EAEC 042 was used to induce the AggR-dependent regulation.  
EAEC strains have been found in foodborne outbreaks and the strains found in outbreaks also 
have AAF/I. Analysis of the promoter region upstream of aggD from EAEC 17-2 had shown 
that there is a run of six 5'-TCAAGT-3' hexamer repeats present (Savarino et al., 1999). 
Moreover, the strain of EAEC that was involved in the foodborne outbreaks in Europe has 
AAF/I and the upstream sequence had greater number of 5' -TCAAGT-3' repeats. This 
finding of the aggD promoter made it important to look into the comparative activity of the 
promoter regions from different strains with different number of repeats that might be 






Figure 6.1 A schematic representation of Region 1 and Region 2 on the pAA plasmid 
from EAEC 17-2 
The figure shows a schematic diagram of the pAA plasmid from EAEC strain 17-2 and the two 
regions that are important for the expression of the attachment adherence fimbriae type I (AAF/I).  
Region 1 encodes aafD (the chaperone protein), aafC (the usher protein) aafB (the fimbrial adhesin) 
and aafA (the fimbrial subunit) genes and Region 2 encodes aggR, transcription activator. This 








1         10        20        30        40       50       60    
.         .         .         .         .         .        . 
MKLKQNIEKEIIKINNIRIHQYTVLYTSNCTIDVYTKEGSNTYLRNELIFLERGINISVR 
MKLKQNIEKEIIKINNIRIHQYTVLYTSNCTIDVYTKEGSNTYLRNELIFLERGINISVR              
************************************************************ 
         70        80        90       100       110      120    
         .         .         .         .         .         . 
LQKKKSTANPFIAIRLSSDTLRRLKDALMIIYGISKVDACSCPNWSKGIIVADADDSVLD             
LQKKKSTVNPFIAIRLSSDTLRRLKDALMIIYGISKVDACSCPNWSKGIIVADADDSVLD         
*******.**************************************************** 
        130       140       150       160       170      180    
         .         .         .         .         .         . 
TFKSIDNNDDSRITSDLIYLISKIENNKKIIESIYISAVSFFSDKVRNIIEKDLSKRWTL 
TFKSIDHNDDSRITSDLIYLISKIENNRKIIESIYISAVSFFSDKVRNTIEKDLSKRWTL               
******:********************:******************** *********** 
        190       200       210       220       230      240    
         .         .         .         .         .         .          
AIIADEFNVSEITIRKRLESEYITFNQILMQSRMSKAALLLLDNSYQISQISNMIGFSST            
AIIADEFNVSEITIRKRLESEYITFNQILMQSRMSKAALLLLDNSYQISQISNMIGFSST              
************************************************************ 
        250       260  265    





Figure 6.2 Alignment of AggR from EAEC 042 and EAEC 17-2 
The figure shows amino acid sequence of AggR from EAEC 042 and EAEC 17-2. Standard 
abbreviations are used to represent amino acid. The black colour alphabets represent AggR sequence 
from EAEC 042 and blue colour alphabets represent AggR sequence from EAEC 17-2. Amino acids 
are numbered from N-terminal to C-terminal from 1 to 265 and shown above black alphabets. The 
symbols below blue alphabets show the similarity between two proteins; (*) represents the same 
amino acid at that position, (:) represents amino acid replaced has similar biochemical properties, (.) 
represent amino acid replaced has somewhat similar biochemical properties and space means the two 







In the previous chapters, I have discussed, how AggR regulates the fimbrial genes in EAEC 
042 and in this chapter, fimbrial gene regulation of EAEC 17-2 will be discussed. AggR also 
regulates the other fimbrial systems AAF/III in EAEC strain 55989 and AAF/IV in EAEC 
C1010-00 and the promoters of these systems are also predicted and aligned with AAF/I and 
AAF/II promoters in the last part of this chapter. 
6.2 Analysis of the regulation of Region 1 on pAA from EAEC 17-2 
6.2.1 Analysis of the DNA sequence upstream of the aggDCBA operon 
Region 1 encodes for the structural genes of the EAEC 17-2 fimbriae system and Region 2 
encodes for the transcription regulator, AggR (Figure 6.1) (Nataro et al., 1992). It has been 
proposed that the AggR-regulated promoter of Region 1 is upstream of aggD and all the 
structural genes are transcribed as a single operon. To investigate this, a 413 bp DNA 
fragment, aggD100, which carries the DNA upstream sequence of aggD, was cloned into the 
lacZ expression vector, pRW50. Bioinformatic analysis indicated that there are two potential 
AggR-binding sites on the forward strand and one potential AggR-binding site on the reverse 
strand of the aggD100 promoter fragment (Figure 6.3). The schematic diagram of the 
aggD100 promoter fragment is shown in Figure 6.4A. 
The aggD100 promoter fragment was cloned into pRW50 and the recombinant plasmid 
pRW50/aggD100 was transformed into the E. coli K-12 strain BW25113 ∆lac, carrying either 
pBAD/aggR or pBAD24. The cells were grown in LB medium at 37°C with shaking to mid-
logarithmic phase and 0.2% (w/v) arabinose was added to LB medium to induce the 
expression of aggR where appropriate. Promoter activities were determined by measuring β-
galactosidase levels in lysates of cells containing these plasmids. During growth with 0.2% 












        410       400        
         .         .         .         .         .         .         . 
GAATTCTTCTGGTGCTTCAGGTGTGTGACATGGGAACTCATTCTGGATGGTTACTCTGAAAGCTCATATTCTGCC 
                                           300        
    .         .         .         .         .         .         .         . 
ACACCCCGATTTGCAGCCTCCAGGCTGCCGTGGTTCAGGAAATCGTCCACATCCCCTTAACGGACTTCGGGGGAA 
                                                                    200 
         .         .         .         .         .         .         .  
AACGTGTATTTTTCGTTATCCTATTTACCTCTTTCAGGGAGTTTAGTTTCCAGGATTTCCGGGACGGCCTAGCTA 
    
    .         .         .         .         .         .         .         . 
ATAACGTGATAAATAATTATCTTTATGCGAAAAGTGTAATTTTTGGAGAAAATGGGGGCGGAATCCTAGTGTTAG 
                  100         
         .         .         .         .         .         .         .   
AAGATTGAAATATGTTAAATAATGCTATTTTTTTAGCGTTATATGATTTGAGTCTTTATATAATCAAGTTCAAGT 
                                           1 
    .         .         .         .        .  
TCAAGTTCAAGTTCAAGTTCAAGTGATAGCGATGAAGATTCGAAAAGCTT 
 
Figure 6.3 The DNA base sequence upstream of the aggD gene 
The figure shows the 413 bp DNA sequence of the aggD100 promoter fragment cloned from EAEC 
strain 17-2. The open reading frame sequence is highlighted red and the potential AggR-binding sites 
are green. The restriction sites EcoRI and HindIII are highlighted grey. This figure is adapted from 






Figure 6.4 Analysis of the aggD promoter from Region 1 of pAA 
A. The upper line shows the schematic arrangement of the fimbrial genes of pAA plasmid from EAEC 
17-2 from the Region 1. The lower part illustrates aggD100 promoter fragment. The grey bar 
represents upstream sequence of aggD and the red part of the bar represents 13 bp sequence of aggD 
coding sequence present on the fragment. Potential AggR-binding sites are indicated as green boxes. 
The DNA sequence in this diagram is numbered above fragment from 1 to 413 and the fragment was 
cloned using EcoRI and HindIII restriction sites into pRW50. This diagram is not to scale. 
B. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector (pRW50) or aggD100 promoter fragment cloned into pRW50. 
The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose.   β-galactosidase activities were 






increased almost 5-fold, when compared to cells containing pBAD24 as the AggR minus 
control (Figure 6.4B). This shows that the aggD100 fragment contains an AggR-regulated 
promoter, and this AggR-regulated promoter is present upstream of aggD.  
6.2.2 Identification of the minimal regulatory region of the aggD promoter necessary for 
AggR-mediated activation  
To investigate the AggR-regulated promoter upstream of aggD in Region 1 of pAA plasmid, 
three nested deletions were made, (aggD99 to aggD97), by deleting sequence from the 
upstream of the aggD100 promoter fragment (Figure 6.5A and B). Once more, each promoter 
fragment (aggD99 to aggD97) was cloned into the lacZ expression vector pRW50. Plasmids 
were transformed into the E. coli K-12 strain BW25113 ∆lac, containing either pBAD/aggR 
or pBAD24. The cells were grown in LB medium at 37°C with shaking to mid-logarithmic 
phase and 0.2% (w/v) arabinose was added to LB medium to induce the expression of aggR 
where appropriate. Promoter activities were determined by measuring β-galactosidase levels 
in lysates of cells containing these plasmids. Results in Figure 6.5C show that the 
β-galactosidase activities measured from lysates of cells containing aggD100, aggD99 and 
aggD98 cloned into pRW50 were increased 5-fold when AggR was induced. However, in 
cells containing pRW50/aggD97 no increase was observed when AggR was induced. These 
results suggest that the AggR-binding site or the promoter itself has been deleted or disrupted 
in the aggD97 fragment whilst it is intact in aggD98 fragment. 
The results of deletion analysis also showed a decrease in promoter activity in the absence of 
AggR as the number of bases are reduced. This may be due to the presence of second 





Figure 6.5 Deletion analysis of the aggD regulatory region 
A. The panel illustrates the aggD100, aggD99, aggD98 and aggD97 promoter fragments. The grey bar 
represents upstream sequence of aggD and the red part of the bar represents 13 bp sequence of aggD 
coding region present on the fragment. Green boxes illustrate potential binding sites for AggR. All the 
fragments were cloned into pRW50 using EcoRI and HindIII restriction sites. The diagram is not to 
scale. 
B. The panel shows the sequence of aggD98 fragment and the AggR-binding site is highlighted green, 
restriction sites are grey and aggD sequence red. The underline sequence adjacent to EcoRI site was 
deleted to in the aggD97 promoter fragment.  
C. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector (pRW50) or aggD100 promoter fragment derivatives cloned 
into pRW50. The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were 
grown in LB medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activities 





6.2.3 Identification of an essential AggR-binding site at the aggD promoter using 
mutational analysis 
Inspection of the DNA sequence upstream of aggD suggests that an essential AggR-binding 
sequence is present on the aggD98 promoter fragment, which has been disrupted in the 
aggD97 promoter fragment. This AggR-binding site is similar to the Rns-binding weblogo 
prepared by Munson (2013) and the AggR-binding site identified by Morin et al. (2010), with 
an upstream A at position 3, a downstream G at position 12, instead of a T, as found at other 
sites (Figure 6.6) (Morin et al., 2010; Munson, 2013).  
Previously, AggR-binding sites have been confirmed by introducing point mutations at the 
conserved T residues present in the downstream part of the AggR-binding site (Morin et al., 
2010). To investigate this potential AggR-binding site in more detail, a point mutation was 
introduced at position 10 of the binding site (Figure 6.6). This corresponds to position 86 on 
the aggD98 promoter fragment (Figure 6.7A and B) and the recombinant aggD98-86C 
fragment was made by substituting the T with C at position 86. The aggD98-86C fragment 
was cloned into pRW50 and plasmids were transformed into the E. coli K-12 strain BW25113 
∆lac, containing either pBAD/aggR or pBAD24. The cells were grown in LB medium at 
37°C with shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was added to LB 
medium to induce the expression of aggR where appropriate. Promoter activities were 
determined by measuring β-galactosidase levels in lysates of cells containing these plasmids. 
Results in Figure 6.7C showed that the β-galactosidase activity measured in cells containing 
pRW50/aggD98-86C, does not increase when AggR expression was induced. This indicates, 







Figure 6.6  Alignment of the AggR-binding site from the aggD regulatory region with 
the consensus sequences of Rns and AggR  
A. The panel illustrates consensus sequence from the Rns-binding logo devised by (Munson, 
2013). The height of each letter corresponds to no of times each letter is present in the 31 
Rns-binding sites identified in the ETEC genome.  
B. The panel shows the sequence of the essential AggR-binding site identified at the aggR 
promoter of EAEC 042 (Morin et al., 2010).  
C. The panel shows the proposed AggR-binding site from the aggD promoter. The 
highlighted sequence shows the potential AggR-binding site (from position 3 to position 13) 
suggested to be important for AggR-binding and activation. The flanking sequence of AggR-







Figure 6.7 Mutational analysis of the AggR-binding site at the aggD promoter 
A. The figure illustrates the aggD98 and aggD98-86C promoter fragments. The grey bars represent 
upstream sequence of aggD and the red part of the bars represent 13 bp sequence of aggD coding 
sequence present on the promoter fragment. Green boxes illustrate potential binding sites of AggR and 
yellow boxes represent the proposed -10 element. The arrow, indicates the position of point mutation. 
B. The panel shows the base sequence of the aggD98 fragment. The AggR-binding site is highlighted 
green, the potential -10 hexamer element yellow, the restriction sites grey and the aggD coding 
sequence red. The arrow with text indicates the position of the point mutation introduced into aggD98 
promoter fragment. 
C. The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing pRW50 or aggD promoter derivatives cloned into lacZ expression vector, pRW50. Cells 
also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB medium in 
presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activity was measured as nmol of 




6.2.4 Identification of the -10 hexamer element on the aggD promoter by mutation 
analysis 
A potential -10 hexamer element was identified 21 bp downstream of the AggR-binding site 
based on its resemblance to the -10 hexamer consensus sequence (TATAAT). A point 
mutation (A to C) at position 2 of the -10 hexamer element was introduced which corresponds 
to position 60 on aggD98 promoter fragment and resulted in the aggD98-60C promoter 
fragment (Figure 6.8A and B).  
Plasmids were transformed into the ∆lacZ E. coli K-12 strain BW25113, carrying either 
pBAD/aggR or pBAD24. The cells were grown in LB medium at 37°C with shaking to mid-
logarithmic phase and 0.2% (w/v) arabinose was added to LB medium to induce the 
expression of aggR where appropriate. Promoter activities were determined by measuring β-
galactosidase levels in lysates of cells containing these plasmids. Results in Figure 6.8C show 
that little β-galactosidase activity could be detected in cells containing pRW50/aggD98-60C, 
confirming that this is the -10 hexamer element of the aggD promoter. The basal activity of 
promoter has decreased substantially, indicating that promoter elements have been disrupted.  
6.3 Comparison of the aggD promoter from two EAEC strains 
Promoter analysis of the upstream sequence of aggD had shown that there was a run of six 5' 
-TCAAGT-3' hexamer repeats (Savarino et al., 1994). Interestingly, the strain that was 
involved in the foodborne outbreaks in Europe also had AAF/I and the upstream sequence of 
aggD had a higher number of 5'-TCAAGT-3' hexamer repeats. To investigate the role these 
repeats in AggR-dependent promoter regulation, constructs with different number of repeats 
were made to study promoter regulation. 





Figure 6.8 Identification of the -10 hexamer element of the aggD promoter 
A. The figure illustrates the aggD98 and aggD98-60C promoter fragments. The grey bars represent 
the upstream sequence of aggD and the red part of the bars represent the 13 bp sequence of the aggD 
coding sequence present on the promoter fragment. Green boxes illustrate potential binding sites of 
AggR and yellow boxes represent the -10 hexamer element. The arrow, with text indicates position of 
point mutation. 
B. The panel shows the sequence of the aggD98 fragment, the AggR-binding site is highlighted green, 
the -10 hexamer element yellow, the restriction sites grey and aggD sequence red. The arrow, with 
text indicates position of point mutation introduced into the aggD98 promoter fragment and the base 
that has been substituted to make point mutation.  
C The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector (pRW50) or aggD promoter derivatives cloned into pRW50. 
The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activities were 
measured as nmol of ONPG hydrolysed per minute per mg of bacterial mass. 
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repeats in the promoter. An aggD promoter based on the sequence form EAEC strain C227-
11, that has 15 repeats was synthesised by Life Technologies TM and it is labelled as aggD101 
(Figure 6.9A). A derivative of aggD101 was made by mega-primer PCR (section 2.4.3) with 
14 repeats and denoted aggD102.  
The aggD fragments were cloned into pRW50 and plasmids were transformed into the E. coli 
K-12 strain BW25113 ∆lac, containing either pBAD/aggR or pBAD24. The cells were grown 
in LB medium at 37°C with shaking to mid-logarithmic phase and 0.2% (w/v) arabinose was 
added to LB medium to induce the expression of aggR where appropriate. Promoter activities 
were determined by measuring β-galactosidase levels in lysates of cells containing these 
plasmids. The results show that during growth in LB with 0.2% (w/v) arabinose, β-
galactosidase levels in cells containing pBAD/aggR with pRW50/aggD99, pRW50/aggD101 
or pRW50/aggD102 increased almost 7-fold in the presence of AggR, when compared to 
cells containing pBAD24 as AggR negative control (Figure 6.9B). The β-galactosidase 
activity showed that the number of repeats in the different promoters do not affect promoter 
regulation in this experiment. So, it indicates that these repeats may not be playing any critical 
role in gene regulation.  
6.4 Alignment of AggR-dependent AAF promoters from different strains 
Five AAF systems (AAF/I-AAF/V) have been identified on the basis of fimbrial antigen 
differences, present in different strains of EAEC. AAF/I and AAF/II are present in EAEC 17-
2 and EAEC 042, respectively, and the promoters of these strains have been discussed earlier. 
AAF/III and AAF/IV are present in EAEC 55989 and EAEC C1010-00, respectively, and the 
fimbrial promoters sequences have been predicted on the basis of results of this study. AAF/V 




Figure 6.9 Comparison of the aggD promoter from two EAEC strains 
A. The sequence of aggD101 and aggD102 is representing the aggD promoter fragment derivatives 
from EAEC C227-11 strain and aggD99 is representing the aggD promoter fragment from EAEC 17-
2. There are difference number of 5' -TCAAGT-3' repeats are different in each fragment and 
numbering represents the number of this hexamer repeats in each fragment.  The AggR-binding site is 
highlighted green, the -10 hexamer elements yellow, the restriction sites grey and the aggD coding 
sequence red. 
B.  The panel illustrates β-galactosidase activities measured in the E. coli K-12 strain BW25113 ∆lac, 
containing the lacZ expression vector (pRW50) or aggD promoter derivatives cloned into pRW50. 
The cells also carry either pBAD/aggR (green bars) or pBAD24 (red bars). Cells were grown in LB 
medium in presence (+) or absence (-) of 0.2% (w/v) arabinose. β-galactosidase activities were 








strain. An alignment of the fimbrial promoter sequences of AAF/I-AAF/IV is shown in Figure 
6.10. The AggR-dependent promoter has been predicted on the basis of AggR-binding site as 
mentioned by Morin et al. (2010). AggR-binding site has been predicted on the basis of 
TATC with presence of A at the upstream at mentioned position (Figure 6.6). The -10 
hexamer element have been predicted on the basis of appropriate distance from the AggR-
binding site and there was exact match to the consensus the -10 hexamer element. The -10 
hexamer element of agg3D is present at 21 bp distance from AggR-binding site and the -10 
hexamer element of agg4D is present at 22 bp distance from AggR-binding site. The exact 
match to consensus -10 hexamer elements and exact match of the AggR-binding site (on the 
basis of Rns weblogo and AggR study) indicate the presence of a strong promoters of agg3D 
and agg4D.  
6.5 Discussion  
The four structural genes of chaperone usher system for EAEC 17-2 are present in in Region 
1 on pAA and these four genes are located in an operon (Figure 6.1) (Savarino et al.,1994).  
The promoter for this operon is present upstream of aggD, and the -10 hexamer element of 
the promoter matches in all six bp with the consensus sequence but the AggR-binding site has 
shown one bp variation in the conserved region at position 12 (Figure 6.6). Moreover, the 
distance between the AggR-binding site and the -10 hexamer element is 21 bp, whilst the 
optimum distance, found in a previous study as well as in other promoters of present study, 
between the -10 element and AggR-binding site is 22 bp. The variation of the nucleotide 
seperates AggR-binding site from consensus sequence and the distance variation between 
AggR-binding site and -10 hexamer element could be important to neutralise the effect of 
variation in the consensus spacer region. Another explanation for the slight difference in the 








Figure 6.10  Alignment of AAF fimbrial promoters 
The figure shows fimbrial promoters from AAF/I to AAF/IV. The AggR-binding sites are highlighted 
green, the -10 hexamer element yellow, the spacer distance between AggR-binding sites and -10 
hexamer elements are marked by black line and distance is mentioned as bp numbers. agg3D and 









acid of HTHs of each protein (Munson, 2013). This can be investigated by introducing point 
mutations at certain positions of AggR binging site to identify the tolerance of different bases 
and an increasing in the distance between -10 hexamer element and AggR-binding site to 22 
to study the effects of these changes on promoter regulation. The AggR-binding site has also 
shown a variation at position 3 from the consensus sequence of AggR and Rns-binding 
sequence (Figure 6.6). However, the results of the mutational analysis in Chaper 3on aafD 
promoter AggR-binding site has shown that any base at this position can be tolerated.  
AAF are divided into 5 systems AAF/I to AAF/V on the basis of fimbrial subunit homology 
(Prager et al., 2014). The fimbrial systems have similarities like the genes for these systems 
are present on plasmids, transcription is regulated by AggR, fimbriae are synthesised by the 
chaperone usher system and have conserved sequence of chaperon and usher proteins (Elias et 
al., 1999, Prager et al., 2014).). The alignment of structural operon promoters of four AAF 
systems has given an insight about promoter structure and prediction about AggR-binding 
sites. The AggR-binding sites overlap the -35 hexamer elements of the promoters. The 
location of AggR-binding sites on these promoters suggest that it is a Class II promoter 
(Browning and Busby, 2004). The alignment of four AAF promoters with AggR-binding sites 
has also shown the appropriate distance between the -10 hexamer element and the AggR-
binding sites is 21bp and 22 bp (Figure 6.10). The results from another study have shown that 
the distance between Rns-binding site and -10 element is 22 bp for Rns dependent promoters 
(Bodero et al., 2008). This difference in spacer distance in AAF/I and AAF/III could have 
come up during evolution.  
AAF/I is more important to discuss as it has been reported in foodborne outbreaks pathogens. 
The aggD promoters has a run of 5' -TCAAGT-3' hexamer repeats and these repeats occur in 
higher number in pathogens from outbreak strains (Figure 6.9). The promoter fragments with 
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different number of repeats were studied by observing the β-galactosidase activities from cells 
containing these promoters. The results did not show substantial difference in the 
β-galactosidase activities measured from cells containing these promoters cloned in lacZ 
expression vector. These findings indicate either there is no role of these repeats in the 
promoter regulation or the technique I have used may not be sensitive enough to point out the 
difference in gene expression by these promoters.  
This experiment can be repeated in EAEC strains instead of E. coli K-12 strain and more 
sensitive techniques like qPCR may be used to measure the gene expression. This study has 
given insight of organisation of AggR-dependent promoters and the AggR-binding sites 




























EAEC has been investigated intensively in the last two decades due to its pathogenicity in 
humans, with researchers studying the epidemiology, physiology, protein structure, genome 
sequence and genetic expression of EAEC. A large amount of data has been gathered about 
EAEC from pathogenesis to antibiotic susceptibility but only a few studies have tried to 
understand gene expression in EAEC. In this study, I have examined the various mechanisms 
of gene expression in EAEC strains, particularly focusing on the transcriptional regulator, 
AggR. Thus, the study of AggR-regulated genes has enhanced the understanding of AggR-
dependent promoters and helped me to suggest a model for AggR-dependent promoter 
activation, i.e. AggR-dependent promoters are regulated by a Class II transcriptional 
mechanism (Figure 7.1) (Browning and Busby, 2004).  
7.1 AggR-dependent promoters  
EAEC 042 is one of the first EAEC strains that was shown to be pathogenic in volunteer 
studies (Nataro et al., 1995). Infection starts with attachment of bacteria to the gut epithelium 
by means of fimbriae and the genes encoding these fimbriae are located on the large 
attachment adherence plasmids found in many EAEC strains (Ito et al., 2014). There are four 
genes that are generally involved in formation of fimbriae in EAEC 042 and these are present 
in two regions on pAA2; Region 1 and Region 2 (Elias et al., 1999). In EAEC strain 17-2, all 
four genes required for fimbriae production are present in Region 1 on pAA (Nataro et al., 
1994). Although, in these two strains the organisation of the fimbrial genes is different, the 
transcription of these genes is regulated in the similar manner, i.e. the promoters upstream of 
each encoding region are regulated by the AggR transcription factor (section 3.2, 3.3 and 6.2).  
By analysing the upstream sequence of each operon, which encodes the fimbrial genes, I 










Figure 7.1 A model of AggR-dependent promoter activation 
The figure illustrates an AggR-dependent promoter model, with the gray bar represents DNA double 
helix, the -35 and -10 hexamer elements are shown yellow, the blue structure represents RNAP and 










This finding, that fimbrial genes are regulated by AggR, is consistant with the finding that 
other AraC family members, e.g. Rns/CfaD, RegA, PerA, and Virf, regulate the fimbrial 
genes present in ETEC, Citrobacter rodentium, EPEC and Shigella flexneri, respectively 
(Santiago et al., 2014; Tobe et al., 1993). An important finding in this study is with regard to 
the fimbrial operon promoter of Region 2 EAEC 042 (section 3.3). Elias et al. (1999) 
previously showed that Region 2 in EAEC 042 contains the afaB, aafC and aafB genes, and 
suggested that the promoter was located upstream of aafC gene, but not the upstream of the 
afaB pseudogene (Figure 1.4). Moreover, they suggested that Region 2 genes were not 
regulated by AggR and that only the genes of Region 1 are AggR-dependent. The results of 
this present study indicate that the operon promoter is present upstream of afaB and it is 
regulated by AggR. The regulation of Region 2 by AggR also indicates that aafC and aafB 
expression is tightly controlled in a similar manner to that of aafD and aafA making it 
possible for the bacterium to regulate the chaperone usher system using a single transcription 
regulator. In EAEC strain 17-2, an AggR-dependent promoter is also present upstream of 
aggD, indicating that the chaperon usher system in this EAEC strain is regulated by the same 
system confirming AggR as the master transcription regulator of EAEC strains. 
In section 3.3.7, of this study results showed that the promoter for Region 1 of plasmid pAA2 
in EAEC 042 is stronger than the promoter upstream of Region 2. This difference is 
important, because for a chaperon usher system more chaperon and fimbrial subunits are 
required than usher and adhesins subunits. By controlling the expression of these subunits at 
the level of transcription in EAEC 042 the bacterium is able to produce the required amounts 
of each fimbrial protein. In EAEC 17-2, as all four genes are transcribed from a single 
AggR-dependent promoter, the different expression levels for these genes, might be regulated 
at the level of translation.  
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As AggR is the master virulence regulator of EAEC, it also regulates other virulence genes in 
EAEC 042, in addition to fimbrial genes (Morin et al., 2013). Thus, I also investigated the 
upstream sequence of aap encoded on plasmid pAA2 and aaiA, present on the chromosome 
(sections 4.2 and 4.3). Strong AggR-regulated promoters were identified upstream of both 
genes, in line with the studies of Sheikh et al. (2002) and Dudley et al. (2006). On both pAA 
and pAA2, aap is present upstream of aggR whilst its secretion system (aatPABCD) is 
encoded by a separate operon which is also regulated by AggR. The most probable 
explanation for this secretion system being in a separate operon is that dispersin (Aap) is 
needed in large amounts and is regulated by a strong promoter (Figure 4.2), while its secretion 
is likely to only require a few secretion system proteins (Figure 1.5). Thus, they are encoded 
at separate loci but regulated by AggR-dependent promoters so secretion of dispersin occurs 
in coherent manner. The aaiA promoter is an operon promoter that regulates the whole operon 
encoding for the T6SS encoded in sci-2 PAI in EAEC 042. It is also a strong promoter and the 
production of various T6SS proteins in different amount might be controlled at the level of 
translation in EAEC.  
Many of the aap and aaiA promoter fragments used in this study possess relatively high 
AggR-independent expression levels indicating the presence of either strong promoters or the 
presence of more than one promoters on these fragments. A TG-motif is present on both 
promoters upstream of each -10 hexamer element, and so the high AggR-independent 
expression levels seen for these promoters could be attributed to the presence of this TG-
motif (Figure 4.14). The presence of a second promoter is also possible as the deletion 
analysis of the aaiA promoter first showed an increase and then a gradual decrease in the 
activity even in the absence of AggR (Figure 4.9). In this study, I have focused on AggR-
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dependent promoters, so the presence of alternate promoters has been acknowledged but was 
not investigated further. 
7.2 AggR-binding sites at EAEC promoters 
There is little information available on AggR-binding sites but other AraC family members, 
such as Rns has been studied in detail and an Rns binding site consensus sequence has been 
proposed (Munson, 2013). AggR is very similar to Rns on amino acid level, and it has been 
shown to induce transcription regulation of Rns-dependent promoters in vivo in ETEC, 
suggesting structural and functional similarity between the two proteins (Bodero et al., 2007). 
A study on the aggR EAEC 042 promoters showed that AggR-binding sites are conserved at 
position 3 and 10-13 similar to Rns weblogo (Figure 4.14) (Morin et al., 2010). In this study, 
I have used deletion and mutational analysis to define the essential AggR-binding sites on the 
aafD, afaB, aap, aaiA and aggD promoters. The AggR-binding sites at these promoters are 
conserved in the downstream part of the sequence of the AggR-binding motif, as in Rns but 
the upstream base at position 3 is variable (Figure 4.14). Thus a mutational analysis of the 
aafD promoter AggR-binding site at position 3 was carried out to determine the most 
appropriate base for this position (Figure 3.7). Results showed that AggR-dependent 
activation occurs if any base is present at this position but an A was optimal (Figure 3.9). 
These finding suggest that this position is less important in AggR-binding. 
The central sequence of AggR-binding sites is highly AT rich and this seems to an play 
important role in AggR-binding. The aaiA promoter AggR-binding site has G at position 9, 
and promoter is activity increased by only 2 fold in the presence of AggR. These findings 
suggest that the sequence between conserved bases (4 to 9) may directly interact with the 
AggR, or DNA folding or bending may have effected due to presence of C or G base. The 
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weblogo of Rns has shown, a C or G base can be present at position 8 or 9, but the probability 
is quite low (Munson, 2013).  
A weblogo was generated using the five AggR-binding sequences from EAEC 042 aafD, 
afaB, aap and aaiA promoters (this study) and aggR promoter (Morin et al., 2010). The 
resulting logo showed conservation at positions 10 to13 whilst position 3 showed variability. 
As the AggR weblogo was generated using only 5 AggR-binding sequences, more sequences 
would be required for generating a weblogo with more confidence. The weblogo of AggR 
(n=5) is similar to Rns weblogo (n=31), except positions 2 and 3 in AggR weblogo are highly 
variable. All Rns-binding sites have A or G at position 3, but AggR does not have any 
specific base at this position. This difference could be explained, as there are few amino acids 
difference in the HTHs of both proteins, so each protein might have slightly different 
preferences for DNA-binding sites (Figure 5.1). 
7.3 Understanding the principles of AggR-dependent regulation 
The aim of the study was to understand the mechanism of AggR-dependent regulation at 
AggR-dependent promoters. The AggR-binding sites were identified and the promoter 
elements were located for different genes in this study and an AggR-binding site weblogo was 
generated. The AggR-binding site from the aafD promoter was transplanted into the well 
studied CRP-dependent promoter CC(-41.5) at different distances from the -10 element, 
indicating that the most appropriate spacing between the -10 hexamer and the AggR-binding 
was 22 bp (Figure 4.15). As, the AggR-binding site overlaps with the potential -35 elements 
of AggR-dependent promoters this suggests that AggR regulates promoters by a Class II 
mechanism. The distance between the AggR-binding site and the -10 hexamer elements at 
aafD, afaB and aap promoters was 22 bp. Bodero et al. (2007) showed that at Rns-dependent 
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promoters, there is a 22 bp spacing between the -10 hexamer element and the Rns-binding 
sites, suggesting that AggR and Rns regulate by the same mechanism. 
The semi-synthetic promoters were constructed by transplanting the AggR-binding motif at 
various distances from the -10 hexamer elements and AggR-dependent activity was found to 
decrease by addition or deletion of one bp from optimal length of 22 bp. This shows, that by 
decreasing or increasing distance of AggR-binding site, the AggR position is twisted along 
with DNA helix and the appropriate alignment cannot be made between AggR and RNAP. 
Another gene, pet is important in EAEC 042 pathogenesis but its expression is inhibited by 
AggR over expression from pBAD/aggR in EAEC 042 (Figure 5.7). This findng is supported 
by the fact that Pet is needed after attachment in pathogenesis (Hebbelstrup Jensen et al., 
2014). AggR represses pet expression in the beginning and then this repression might release 
in later stage of pathogenesis (Santiago et al., 2016) . 
Analysis of the AggR protein has shown that substitutions at N-terminal positions 14 and 16 
affect the ability of AggR to activate at various promoters (Figure 5.3 and Figure 5.4). These 
results suggest that AggR-dependent activity involves the N-terminus and position 14 and 16 
are important for AggR-dependent activation. The substitutions might have resulted in a 
change in the folding or structure of these proteins that may have resulted in a change in the 
interaction with RNAP. These results are in agreement with a mutational study of Rns and 
their effect on Rns-dependent promoters (Basturea et al., 2008). 
7.4 Concluding remarks  
AggR is a master transcription regulator of EAEC pathogenesis and it regulates promoters 
from both the chromosome and the large virulence plasmid. This study has enhanced our 
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understanding of AggR-dependent promoter organisation, AggR-binding sites and AggR-
dependent regulation with the following novel findings; 
 The promoter elements at the aafD, afaB, aap and aggD promoters, which were 
located on virulence plasmids (pAA and pAA2) identified and those of the 
chromosome aaiA locus, were also identified.  
 Pet expression is inhibited by over expression of AggR in EAEC strain DFB042. 
 AggR-binding sites were identified and compared with those at the aggR promoter, as 
well as, with the Rns-binding logo.  
 AggR-dependent promoters are regulated by a Class II mechanism. 
 The distance between the AggR-binding motif and the -10 hexamer element is very 
important for AggR-dependent regulation. A 22 bp distance between AggR-binding 
site and -10 hexamer element is optimal.  
 AggR from one strain can activate AggR-dependent promoters from another EAEC 
strain. 
 The N-terminus of AggR is important for AggR-dependent activation. 
7.5 Future Work 
This project has generated some exciting results that could be investigated further to enhance 
our understanding of AggR-dependent activation, specifically: 
 The investigation of transcription regulation at the dispersin promoter (aap) and its 
secretion system (aatPABCD)in the EAEC strain 042.  
 The AggR-dependent expression from chromosomal promoter fragment, aaiA100 
could also be investigated to identify the multiple promoter elements.  
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 The rules for AggR-dependent promoter regulation uncovered by this study could be 
used to investigate the promoters of other attachment adherence fimbriae (AAF) 
encoding genes present in different EAEC strains.  
 The experiments from this study were carried out in E. coli K-12 strain, they could be 
repeated in EAEC strains, though it is likely that they will be similar.  
 In-vivo results could also be supported by in-vitro experiments such as, band shifts 
and DNase footprinting to investigate the interaction of AggR with promoter DNA.  
 An extensive mutagenesis of AggR itself could be helpful in understanding the 
interaction of AggR with promoter DNA and RNAP. 
 To uncover the AggR-dependent transcriptome of various EAEC strains, RNA-seq 
and ChIP-seq could be employed, leading to a better understanding of AggR-
dependent regulation across the whole genome.  
 Understanding the factors that switch on AggR is also essential as AggR is the master 
virulence regulator.  
 Regulation of AggR has important clinical applications as it could be a potential target 
for anti-infective chemical inhibitors (Koppolu et al., 2013). 
The above work will enhance our understanding about AggR-dependent transcription 
regulation of in EAEC in particular and this can provide a model to investigate  the 
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